Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
14281006 213670 0 None - 1 Human 9.2 pEC50 = 9.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 440 8 2 7 3.3 COC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL90804 213670 0 None - 1 Human 9.2 pEC50 = 9.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 440 8 2 7 3.3 COC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
14281026 174750 0 None - 1 Human 9.0 pEC50 = 9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 7 2 5 4.5 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL431799 174750 0 None - 1 Human 9.0 pEC50 = 9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 7 2 5 4.5 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
14281025 213564 0 None - 1 Human 9.0 pEC50 = 9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 396 7 2 5 4.1 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL90237 213564 0 None - 1 Human 9.0 pEC50 = 9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 396 7 2 5 4.1 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
1711 6865 15 None 1 7 Rat 9.0 pEC50 = 9.0 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 553 9 7 15 -0.9 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O 10.1021/jm020046y
5310983 6865 15 None 1 7 Rat 9.0 pEC50 = 9.0 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 553 9 7 15 -0.9 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O 10.1021/jm020046y
CHEMBL336208 6865 15 None 1 7 Rat 9.0 pEC50 = 9.0 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 553 9 7 15 -0.9 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(OP(=O)(O)O)O)O 10.1021/jm020046y
3352 9150 28 None -4 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human P2Y12 receptorAgonist activity at human P2Y12 receptor
ChEMBL 439 18 4 5 4.3 CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N 10.1021/jm900945d
5280879 9150 28 None -4 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human P2Y12 receptorAgonist activity at human P2Y12 receptor
ChEMBL 439 18 4 5 4.3 CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N 10.1021/jm900945d
5863 9150 28 None -4 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human P2Y12 receptorAgonist activity at human P2Y12 receptor
ChEMBL 439 18 4 5 4.3 CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N 10.1021/jm900945d
CHEMBL509456 9150 28 None -4 4 Human 8.9 pEC50 = 8.9 Functional
Agonist activity at human P2Y12 receptorAgonist activity at human P2Y12 receptor
ChEMBL 439 18 4 5 4.3 CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N 10.1021/jm900945d
1756 7251 10 None 38 2 Human 8.9 pEC50 = 8.9 Functional
The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
5310954 7251 10 None 38 2 Human 8.9 pEC50 = 8.9 Functional
The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
CHEMBL336292 7251 10 None 38 2 Human 8.9 pEC50 = 8.9 Functional
The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against phospholipase C coupled human P2Y purinoceptor 12 (P2Y12)
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
5492386 213265 4 None - 1 Human 8.0 pEC50 = 8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 397 7 2 6 3.4 O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
CHEMBL88245 213265 4 None - 1 Human 8.0 pEC50 = 8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 397 7 2 6 3.4 O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
135434015 210703 11 None - 1 Human 7.0 pEC50 = 7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 384 6 1 5 2.6 CN(C(=O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2)C1CCCCC1 10.1021/jm00092a019
CHEMBL69139 210703 11 None - 1 Human 7.0 pEC50 = 7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 384 6 1 5 2.6 CN(C(=O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2)C1CCCCC1 10.1021/jm00092a019
14281041 213762 0 None - 1 Human 7.0 pEC50 = 7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.3 CC(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91359 213762 0 None - 1 Human 7.0 pEC50 = 7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.3 CC(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14280990 112908 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.0 O=C(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL313463 112908 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.0 O=C(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
135409400 211680 77 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 255 0 1 3 1.9 O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1 10.1021/jm00092a019
CHEMBL760 211680 77 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 255 0 1 3 1.9 O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1 10.1021/jm00092a019
15005606 213336 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 366 6 3 4 3.9 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
CHEMBL88707 213336 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 366 6 3 4 3.9 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
14281012 112786 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 368 5 1 6 3.0 Cn1c(O)nc2nc3ccc(OCCCC(=O)N4CCCCC4)cc3cc21 10.1021/jm00092a019
CHEMBL313282 112786 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 368 5 1 6 3.0 Cn1c(O)nc2nc3ccc(OCCCC(=O)N4CCCCC4)cc3cc21 10.1021/jm00092a019
14281011 213594 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 354 5 2 5 2.9 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
CHEMBL90414 213594 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 354 5 2 5 2.9 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
15005605 213337 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 380 6 2 4 4.3 CN(C(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88708 213337 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 380 6 2 4 4.3 CN(C(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005586 113701 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 275 4 4 6 0.5 OCC(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL314763 113701 0 None - 1 Human 4.9 pEC50 = 4.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 275 4 4 6 0.5 OCC(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005565 213683 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 329 6 2 6 2.9 CC(C)OC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90881 213683 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 329 6 2 6 2.9 CC(C)OC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281001 213926 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 420 6 3 5 4.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
CHEMBL92264 213926 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 420 6 3 5 4.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
14281010 213778 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 6 1 6 4.2 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL91422 213778 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 6 1 6 4.2 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
14281011 213594 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 354 5 2 5 2.9 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
CHEMBL90414 213594 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 354 5 2 5 2.9 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
440317 28520 17 None -2 4 Rat 5.9 pEC50 = 5.9 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 523 8 7 14 -1.5 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(O)(O)=S)[C@@H](O)[C@H]1O 10.1021/jm020046y
CHEMBL131890 28520 17 None -2 4 Rat 5.9 pEC50 = 5.9 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 523 8 7 14 -1.5 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(O)(O)=S)[C@@H](O)[C@H]1O 10.1021/jm020046y
15005591 213285 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 282 5 2 5 2.8 N#CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88377 213285 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 282 5 2 5 2.8 N#CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005580 213552 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 300 5 3 5 1.7 CNC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90168 213552 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 300 5 3 5 1.7 CNC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281024 213343 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 424 7 1 6 4.6 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL88764 213343 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 424 7 1 6 4.6 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
14281020 113316 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 5 2 5 2.5 CC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL314093 113316 0 None - 1 Human 5.9 pEC50 = 5.9 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 5 2 5 2.5 CC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14280990 112908 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.0 O=C(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL313463 112908 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 287 5 3 5 2.0 O=C(O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281023 213706 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 7 1 6 4.2 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91044 213706 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 7 1 6 4.2 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005608 213733 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 352 5 2 4 3.5 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
CHEMBL91204 213733 0 None - 1 Human 4.8 pEC50 = 4.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 352 5 2 4 3.5 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
14281005 214141 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 3 5 3.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCCC1 10.1021/jm00092a019
CHEMBL93688 214141 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 3 5 3.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCCC1 10.1021/jm00092a019
15005569 118236 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 Cn1c(O)nc2cc3cc(OCCCC(=O)O)ccc3nc21 10.1021/jm00092a019
CHEMBL327580 118236 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 Cn1c(O)nc2cc3cc(OCCCC(=O)O)ccc3nc21 10.1021/jm00092a019
5492386 213265 4 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 397 7 2 6 3.4 O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
CHEMBL88245 213265 4 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 397 7 2 6 3.4 O=S(=O)(CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
14281004 213761 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 2 6 3.4 Cn1c(O)nc2nc3ccc(OCCCC(=O)NC4CCCCC4)cc3cc21 10.1021/jm00092a019
CHEMBL91356 213761 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 2 6 3.4 Cn1c(O)nc2nc3ccc(OCCCC(=O)NC4CCCCC4)cc3cc21 10.1021/jm00092a019
15005588 213927 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 268 4 2 5 2.5 N#CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL92269 213927 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 268 4 2 5 2.5 N#CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005581 213694 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 314 5 2 5 2.0 CN(C)C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90958 213694 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 314 5 2 5 2.0 CN(C)C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14280996 213821 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1 10.1021/jm00092a019
CHEMBL91634 213821 0 None - 1 Human 5.7 pEC50 = 5.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1 10.1021/jm00092a019
14280992 213307 8 None - 1 Human 5.7 pEC50 = 5.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 259 3 3 5 1.2 O=C(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88525 213307 8 None - 1 Human 5.7 pEC50 = 5.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 259 3 3 5 1.2 O=C(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005576 213293 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 454 9 2 7 3.7 CCOC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88444 213293 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 454 9 2 7 3.7 CCOC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005584 213558 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 245 3 3 5 1.1 OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90195 213558 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 245 3 3 5 1.1 OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005574 213800 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 8 2 5 4.5 CN(C(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91527 213800 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 8 2 5 4.5 CN(C(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
5487281 213317 14 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 213 0 2 3 2.4 Cc1ccc2[nH]c3nc(O)nc-3cc2c1C 10.1021/jm00092a019
CHEMBL88583 213317 14 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 213 0 2 3 2.4 Cc1ccc2[nH]c3nc(O)nc-3cc2c1C 10.1021/jm00092a019
14281001 213926 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 420 6 3 5 4.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
CHEMBL92264 213926 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 420 6 3 5 4.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
14281015 118353 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 426 7 2 7 2.7 CCOC(=O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
CHEMBL328149 118353 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 426 7 2 7 2.7 CCOC(=O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
15005605 213337 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 380 6 2 4 4.3 CN(C(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88708 213337 0 None - 1 Human 6.7 pEC50 = 6.7 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 380 6 2 4 4.3 CN(C(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
10016898 213626 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 4 2 6 1.7 CCOC(=O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90566 213626 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 4 2 6 1.7 CCOC(=O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005600 213262 1 None - 1 Human 5.6 pEC50 = 5.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 243 3 3 4 1.7 OCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88224 213262 1 None - 1 Human 5.6 pEC50 = 5.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 243 3 3 4 1.7 OCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
136677322 10069 24 None 77 9 Rat 7.6 pEC50 = 7.6 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm020046y
1739 10069 24 None 77 9 Rat 7.6 pEC50 = 7.6 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm020046y
656725 10069 24 None 77 9 Rat 7.6 pEC50 = 7.6 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm020046y
CHEMBL1160031 10069 24 None 77 9 Rat 7.6 pEC50 = 7.6 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm020046y
14281027 213477 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 407 7 2 8 3.7 Oc1nc2cc3cc(OCCCCc4nnnn4C4CCCCC4)ccc3[nH]c-2n1 10.1021/jm00092a019
CHEMBL89679 213477 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 407 7 2 8 3.7 Oc1nc2cc3cc(OCCCCc4nnnn4C4CCCCC4)ccc3[nH]c-2n1 10.1021/jm00092a019
15005586 113701 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 275 4 4 6 0.5 OCC(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL314763 113701 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 275 4 4 6 0.5 OCC(O)COc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005573 213758 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 6 0 6 3.4 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)n(C)c(=O)n3C)C1CCCCC1 10.1021/jm00092a019
CHEMBL91340 213758 0 None - 1 Human 4.6 pEC50 = 4.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 6 0 6 3.4 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)n(C)c(=O)n3C)C1CCCCC1 10.1021/jm00092a019
15005599 213333 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 295 3 2 5 2.5 COC(=O)/C=C/C=C/c1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88697 213333 0 None - 1 Human 5.6 pEC50 = 5.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 295 3 2 5 2.5 COC(=O)/C=C/C=C/c1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281000 213473 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 356 5 2 6 1.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCOCC1 10.1021/jm00092a019
CHEMBL89660 213473 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 356 5 2 6 1.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCOCC1 10.1021/jm00092a019
15005601 118574 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 271 5 3 4 2.5 OCCCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL328755 118574 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 271 5 3 4 2.5 OCCCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005566 213363 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C 10.1021/jm00092a019
CHEMBL88877 213363 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C 10.1021/jm00092a019
15005603 170892 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 299 5 2 5 2.7 COC(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL420980 170892 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 299 5 2 5 2.7 COC(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005579 119415 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 286 5 3 5 1.4 NC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL330280 119415 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 286 5 3 5 1.4 NC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005571 213749 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 7 3 5 2.8 O=C(O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91295 213749 0 None - 1 Human 5.5 pEC50 = 5.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 7 3 5 2.8 O=C(O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
1713 7308 68 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
5957 7308 68 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
91 7308 68 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
CHEMBL14249 7308 68 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
DB00171 7308 68 None -190 10 Rat 5.5 pEC50 = 5.5 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 507 8 7 14 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(O)O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
14281034 118204 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 CC(=O)OCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL327374 118204 0 None - 1 Human 6.5 pEC50 = 6.5 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 CC(=O)OCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005572 170593 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C)C1CCCCC1 10.1021/jm00092a019
CHEMBL420618 170593 0 None - 1 Human 4.5 pEC50 = 4.5 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C)C1CCCCC1 10.1021/jm00092a019
15005566 213363 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C 10.1021/jm00092a019
CHEMBL88877 213363 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 7 2.2 COC(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C 10.1021/jm00092a019
15005564 172203 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CCOC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL423864 172203 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CCOC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005578 213809 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 398 6 3 6 2.3 O=C(O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
CHEMBL91570 213809 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 398 6 3 6 2.3 O=C(O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
5487281 213317 14 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 213 0 2 3 2.4 Cc1ccc2[nH]c3nc(O)nc-3cc2c1C 10.1021/jm00092a019
CHEMBL88583 213317 14 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 213 0 2 3 2.4 Cc1ccc2[nH]c3nc(O)nc-3cc2c1C 10.1021/jm00092a019
15005594 213646 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 383 6 2 6 3.0 O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
CHEMBL90677 213646 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 383 6 2 6 3.0 O=S(=O)(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)c1ccccc1 10.1021/jm00092a019
14281005 214141 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 3 5 3.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCCC1 10.1021/jm00092a019
CHEMBL93688 214141 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 3 5 3.8 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCCC1 10.1021/jm00092a019
15005584 213558 0 None - 1 Human 8.4 pEC50 = 8.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 245 3 3 5 1.1 OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90195 213558 0 None - 1 Human 8.4 pEC50 = 8.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 245 3 3 5 1.1 OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
9999105 213260 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 368 6 3 5 3.4 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
CHEMBL88218 213260 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 368 6 3 5 3.4 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
135973538 10482 33 None -12 10 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
1728 10482 33 None -12 10 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
2966 10482 33 None -12 10 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
4261196 10482 33 None -12 10 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
5361 10482 33 None -12 10 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
CHEMBL265502 10482 33 None -12 10 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
DB04786 10482 33 None -12 10 Rat 5.4 pEC50 = 5.4 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 1296 16 12 17 6.7 O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 10.1021/jm020046y
15005608 213733 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 352 5 2 4 3.5 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
CHEMBL91204 213733 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 352 5 2 4 3.5 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)N1CCCCC1 10.1021/jm00092a019
14281003 213740 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 354 6 3 5 3.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCC1 10.1021/jm00092a019
CHEMBL91259 213740 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 354 6 3 5 3.0 O=C(CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCC1 10.1021/jm00092a019
15005603 170892 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 299 5 2 5 2.7 COC(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL420980 170892 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 299 5 2 5 2.7 COC(=O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005598 213339 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 283 3 2 5 2.3 CCOC(=O)/C=C/c1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88730 213339 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 283 3 2 5 2.3 CCOC(=O)/C=C/c1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005602 213719 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 4 2 5 2.3 CCOC(=O)CCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91127 213719 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 4 2 5 2.3 CCOC(=O)CCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
135434015 210703 11 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 384 6 1 5 2.6 CN(C(=O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2)C1CCCCC1 10.1021/jm00092a019
CHEMBL69139 210703 11 None - 1 Human 6.4 pEC50 = 6.4 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 384 6 1 5 2.6 CN(C(=O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2)C1CCCCC1 10.1021/jm00092a019
15005578 213809 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 398 6 3 6 2.3 O=C(O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
CHEMBL91570 213809 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 398 6 3 6 2.3 O=C(O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
14281031 213866 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 273 5 2 5 2.2 CCOCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91899 213866 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 273 5 2 5 2.2 CCOCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005606 213336 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 366 6 3 4 3.9 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
CHEMBL88707 213336 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 366 6 3 4 3.9 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC1CCCCC1 10.1021/jm00092a019
14281026 174750 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 7 2 5 4.5 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL431799 174750 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 7 2 5 4.5 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
14281016 213765 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 2 5 3.7 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91368 213765 0 None - 1 Human 8.3 pEC50 = 8.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 382 6 2 5 3.7 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
14281018 213941 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL92363 213941 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCC1 10.1021/jm00092a019
14281036 213334 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 397 6 1 7 3.1 Cn1c(O)nc2nc3ccc(OCCCS(=O)(=O)c4ccccc4)cc3cc21 10.1021/jm00092a019
CHEMBL88698 213334 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 397 6 1 7 3.1 Cn1c(O)nc2nc3ccc(OCCCS(=O)(=O)c4ccccc4)cc3cc21 10.1021/jm00092a019
15005592 213546 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 325 6 3 7 1.7 Oc1nc2cc3cc(OCCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
CHEMBL90120 213546 0 None - 1 Human 4.3 pEC50 = 4.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 325 6 3 7 1.7 Oc1nc2cc3cc(OCCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
15005572 170593 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C)C1CCCCC1 10.1021/jm00092a019
CHEMBL420618 170593 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 1 6 3.8 CN(C(=O)CCCOc1ccc2nc3c(cc2c1)nc(O)n3C)C1CCCCC1 10.1021/jm00092a019
44323790 213348 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 418 6 3 4 4.6 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
CHEMBL88799 213348 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 418 6 3 4 4.6 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
14281024 213343 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 424 7 1 6 4.6 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL88764 213343 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 424 7 1 6 4.6 CN(C(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
15005574 213800 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 8 2 5 4.5 CN(C(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91527 213800 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 410 8 2 5 4.5 CN(C(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005592 213546 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 325 6 3 7 1.7 Oc1nc2cc3cc(OCCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
CHEMBL90120 213546 0 None - 1 Human 5.3 pEC50 = 5.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 325 6 3 7 1.7 Oc1nc2cc3cc(OCCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
15005585 213794 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 273 5 3 5 1.9 OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91478 213794 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 273 5 3 5 1.9 OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005565 213683 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 6 2 6 2.9 CC(C)OC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90881 213683 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 6 2 6 2.9 CC(C)OC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281006 213670 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 440 8 2 7 3.3 COC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL90804 213670 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 440 8 2 7 3.3 COC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
134687118 199562 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human P2Y12RActivation of human P2Y12R
ChEMBL 387 4 1 2 4.6 COc1ccc(Cl)c(C(=O)NCC23CC4(F)CC(F)(CC(F)(C4)C2)C3)c1 10.1021/acs.jmedchem.1c01571
CHEMBL5179763 199562 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human P2Y12RActivation of human P2Y12R
ChEMBL 387 4 1 2 4.6 COc1ccc(Cl)c(C(=O)NCC23CC4(F)CC(F)(CC(F)(C4)C2)C3)c1 10.1021/acs.jmedchem.1c01571
CHEMBL5221347 199562 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Activation of human P2Y12RActivation of human P2Y12R
ChEMBL 387 4 1 2 4.6 COc1ccc(Cl)c(C(=O)NCC23CC4(F)CC(F)(CC(F)(C4)C2)C3)c1 10.1021/acs.jmedchem.1c01571
14281008 213374 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 2 5 4.1 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL88955 213374 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 6 2 5 4.1 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCCC1 10.1021/jm00092a019
15005588 213927 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 268 4 2 5 2.5 N#CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL92269 213927 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 268 4 2 5 2.5 N#CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005579 119415 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 286 5 3 5 1.4 NC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL330280 119415 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 286 5 3 5 1.4 NC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005564 172203 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CCOC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL423864 172203 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CCOC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005604 213269 0 None - 1 Human 4.2 pEC50 = 4.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 5 3 4 2.6 O=C(O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88265 213269 0 None - 1 Human 4.2 pEC50 = 4.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 285 5 3 4 2.6 O=C(O)CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005590 213355 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 311 5 3 7 1.3 Oc1nc2cc3cc(OCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
CHEMBL88835 213355 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 311 5 3 7 1.3 Oc1nc2cc3cc(OCCCc4nnn[nH]4)ccc3[nH]c-2n1 10.1021/jm00092a019
10017729 213242 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 COC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88136 213242 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 301 5 2 6 2.1 COC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
1712 7076 69 None -1 6 Rat 7.2 pEC50 = 7.2 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
6022 7076 69 None -1 6 Rat 7.2 pEC50 = 7.2 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
CHEMBL14830 7076 69 None -1 6 Rat 7.2 pEC50 = 7.2 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
135838395 112929 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 289 5 2 5 0.9 O=C(O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2 10.1021/jm00092a019
CHEMBL313609 112929 0 None - 1 Human 5.2 pEC50 = 5.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 289 5 2 5 0.9 O=C(O)CCCOc1ccc2c(c1)CN1CC(=O)NC1=N2 10.1021/jm00092a019
14281016 213765 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 2 5 3.7 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL91368 213765 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 2 5 3.7 CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
14281010 213778 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 6 1 6 4.2 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
CHEMBL91422 213778 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 410 6 1 6 4.2 CN(C(=O)CCCOc1ccc2nc3nc(O)n(C)c3cc2c1)C1CCCCCC1 10.1021/jm00092a019
15005580 213552 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 300 5 3 5 1.7 CNC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL90168 213552 0 None - 1 Human 4.1 pEC50 = 4.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 300 5 3 5 1.7 CNC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281033 119580 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 259 4 3 5 1.5 OCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL330677 119580 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 259 4 3 5 1.5 OCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281004 213761 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 2 6 3.4 Cn1c(O)nc2nc3ccc(OCCCC(=O)NC4CCCCC4)cc3cc21 10.1021/jm00092a019
CHEMBL91356 213761 0 None - 1 Human 5.1 pEC50 = 5.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 382 6 2 6 3.4 Cn1c(O)nc2nc3ccc(OCCCC(=O)NC4CCCCC4)cc3cc21 10.1021/jm00092a019
14281025 213564 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 7 2 5 4.1 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL90237 213564 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 396 7 2 5 4.1 CN(C(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
15005576 213293 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 454 9 2 7 3.7 CCOC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88444 213293 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 454 9 2 7 3.7 CCOC(=O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
1755 7077 17 None -32 6 Rat 7.1 pEC50 = 7.1 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
5310996 7077 17 None -32 6 Rat 7.1 pEC50 = 7.1 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
CHEMBL335206 7077 17 None -32 6 Rat 7.1 pEC50 = 7.1 Functional
Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)Antagonist activity against phospholipase C coupled rat P2Y purinoceptor 12 (P2Y12)
ChEMBL 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 10.1021/jm020046y
10017729 213242 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRPInhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRP
ChEMBL 301 5 2 6 2.1 COC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL88136 213242 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRPInhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma PRP
ChEMBL 301 5 2 6 2.1 COC(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281035 213504 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 4 2 6 1.7 CC(=O)OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL89876 213504 0 None - 1 Human 6.1 pEC50 = 6.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 287 4 2 6 1.7 CC(=O)OCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005567 213855 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 7 2 6 2.9 COC(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91837 213855 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 7 2 6 2.9 COC(=O)CCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
14281015 118353 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 426 7 2 7 2.7 CCOC(=O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
CHEMBL328149 118353 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 426 7 2 7 2.7 CCOC(=O)C1CCN(C(=O)CCCOc2ccc3[nH]c4nc(O)nc-4cc3c2)CC1 10.1021/jm00092a019
15005585 213794 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 273 5 3 5 1.9 OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91478 213794 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 273 5 3 5 1.9 OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005577 213237 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 426 8 3 6 3.2 O=C(O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88108 213237 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 426 8 3 6 3.2 O=C(O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
14280999 213289 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 6 1 7 2.5 COC(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1 10.1021/jm00092a019
CHEMBL88395 213289 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 329 6 1 7 2.5 COC(=O)CCCCOc1ccc2nc3nc(O)n(C)c3cc2c1 10.1021/jm00092a019
15005570 213811 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 6 1.7 Cn1c(=O)n(C)c2nc3ccc(OCCCC(=O)O)cc3cc21 10.1021/jm00092a019
CHEMBL91579 213811 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 5 1 6 1.7 Cn1c(=O)n(C)c2nc3ccc(OCCCC(=O)O)cc3cc21 10.1021/jm00092a019
14280998 213857 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 COC(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL91843 213857 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 COC(=O)CCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
15005583 213904 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CC(=O)OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
CHEMBL92158 213904 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 315 6 2 6 2.5 CC(=O)OCCCCOc1ccc2[nH]c3nc(O)nc-3cc2c1 10.1021/jm00092a019
44323790 213348 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 418 6 3 4 4.6 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
CHEMBL88799 213348 0 None - 1 Human 6.0 pEC50 = 6.0 Functional
Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)Inhibition of platelet aggregation using Adenosine diphosphate (ADP) as activating agent in rabbit platelet rich plasma (PRP)
ChEMBL 418 6 3 4 4.6 O=C(CCCCc1ccc2[nH]c3nc(O)nc-3cc2c1)NC12C[C@H]3C[C@@H](C1)C[C@@H](C2)C3 10.1021/jm00092a019
15005577 213237 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 426 8 3 6 3.2 O=C(O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
CHEMBL88108 213237 0 None - 1 Human 5.0 pEC50 = 5.0 Functional
Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)Inhibition of platelet aggregation using adenosine diphosphate (ADP) as activating agent in human platelet rich plasma (PRP)
ChEMBL 426 8 3 6 3.2 O=C(O)CN(C(=O)CCCOc1ccc2[nH]c3nc(O)nc-3cc2c1)C1CCCCC1 10.1021/jm00092a019
44443919 101191 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 553 14 6 13 0.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL251024 101191 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 553 14 6 13 0.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
23649184 197115 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 416 5 1 7 3.6 CCOC(=O)c1cc(C#N)c(N2CCC(c3nnc(-c4ccccc4)[nH]3)CC2)nc1C 10.1016/j.ejmech.2021.113924
CHEMBL5176593 197115 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 416 5 1 7 3.6 CCOC(=O)c1cc(C#N)c(N2CCC(c3nnc(-c4ccccc4)[nH]3)CC2)nc1C 10.1016/j.ejmech.2021.113924
1776 7574 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
5006 7574 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
9854012 7574 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
CHEMBL334966 7574 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
DB06441 7574 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)The compound was evaluated for antagonist activity against platelet P2Y purinoceptor 12 (P2Y12)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm020046y
44443921 175533 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 551 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL437204 175533 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 551 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
1776 7574 38 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
5006 7574 38 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
9854012 7574 38 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
CHEMBL334966 7574 38 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
DB06441 7574 38 None -2 4 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor by [35S]GTPgammaS binding assay
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/jm901691y
44555026 118719 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 468 8 1 7 3.1 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288134 118719 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 468 8 1 7 3.1 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
11526078 98082 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402251 98082 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68910943 98876 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL2419497 98876 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.bmcl.2016.04.030
44443917 101157 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 552 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1ncn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL250832 101157 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregationAntagonist activity at human P2Y12 receptor assessed as ADP-induced human platelet aggregation
ChEMBL 552 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1ncn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
24751997 69602 2 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc4ccccc34)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784212 69602 2 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc4ccccc34)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
68550683 197836 0 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 486 8 1 7 3.2 CCCC(=O)c1cc(C#N)c(N(C(=O)C2CCNCC2)S(=O)(=O)Cc2cccc(F)c2)nc1C 10.1016/j.ejmech.2021.113924
CHEMBL5187308 197836 0 None - 1 Human 7.0 pIC50 = 7 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 486 8 1 7 3.2 CCCC(=O)c1cc(C#N)c(N(C(=O)C2CCNCC2)S(=O)(=O)Cc2cccc(F)c2)nc1C 10.1016/j.ejmech.2021.113924
45485968 204526 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571599 204526 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24752128 69577 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784187 69577 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45269461 202973 0 None - 1 Human 4.0 pIC50 = 4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 539 11 2 7 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561406 202973 0 None - 1 Human 4.0 pIC50 = 4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 539 11 2 7 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24752129 69584 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784194 69584 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44457371 17134 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1010 26 6 21 3.3 CCCCCCCC1O[C@H]2[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(CCCCCCC)O[C@H]34)O[C@H](n3ccc(=O)[nH]c3=O)[C@H]2O1 10.1021/jm701348d
CHEMBL1162189 17134 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1010 26 6 21 3.3 CCCCCCCC1O[C@H]2[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(CCCCCCC)O[C@H]34)O[C@H](n3ccc(=O)[nH]c3=O)[C@H]2O1 10.1021/jm701348d
10098947 17112 0 None -4 4 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 546 8 7 12 0.3 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm701348d
CHEMBL1162163 17112 0 None -4 4 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 546 8 7 12 0.3 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm701348d
11786496 17123 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162176 17123 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
53233471 69611 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL1784220 69611 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
68911088 98056 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402142 98056 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11504760 98066 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 534 7 1 8 3.9 CC(C)CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402151 98066 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 534 7 1 8 3.9 CC(C)CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
53233471 69611 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784220 69611 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751998 69598 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1784208 69598 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485965 203551 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565409 203551 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485910 204301 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 706 14 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570151 204301 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 706 14 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45267751 201667 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540672 201667 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24751300 69586 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 483 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784196 69586 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 483 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751998 69598 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784208 69598 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751575 69601 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 4 1 5 4.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784211 69601 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 4 1 5 4.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751709 69619 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784228 69619 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650877 207978 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 463 7 0 7 3.1 Cc1c(OCCN2CCN(Cc3ccccc3)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60353 207978 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 463 7 0 7 3.1 Cc1c(OCCN2CCN(Cc3ccccc3)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
45272846 202433 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 540 12 3 8 1.6 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556446 202433 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 540 12 3 8 1.6 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24801416 17147 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 562 8 4 9 2.4 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
CHEMBL1162205 17147 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 562 8 4 9 2.4 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)O)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
45268630 202867 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560748 202867 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44457278 17116 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1040 18 6 25 2.8 Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@@H]3OC(Cc4ccccc4)O[C@H]23)[C@@H]2OC(Cc3ccccc3)O[C@@H]21 10.1021/jm701348d
CHEMBL1162167 17116 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1040 18 6 25 2.8 Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@@H]3OC(Cc4ccccc4)O[C@H]23)[C@@H]2OC(Cc3ccccc3)O[C@@H]21 10.1021/jm701348d
45485930 203973 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNCC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568128 203973 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNCC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485858 204101 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 13 3 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568824 204101 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 13 3 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485949 204326 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570256 204326 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751438 69576 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784186 69576 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
15650865 107558 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 317 4 0 6 1.9 CC(=O)COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL292978 107558 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 317 4 0 6 1.9 CC(=O)COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
15650880 107813 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 425 5 0 9 3.0 Cc1c(OCc2nnnn2C2CCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL294588 107813 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 425 5 0 9 3.0 Cc1c(OCc2nnnn2C2CCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650878 207997 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 417 7 1 8 0.9 Cc1c(OCCN2CCN(CCO)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60362 207997 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 417 7 1 8 0.9 Cc1c(OCCN2CCN(CCO)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44452737 103666 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 452 6 3 9 1.7 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL265707 103666 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 452 6 3 9 1.7 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
44457411 17140 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1028 18 9 22 0.9 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@@H](O)[C@H]3O)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
CHEMBL1162197 17140 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1028 18 9 22 0.9 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@@H](O)[C@H]3O)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
16739157 17125 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 506 7 4 10 1.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162179 17125 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 506 7 4 10 1.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(c3ccccc3)O[C@H]21 10.1021/jm701348d
44610522 118710 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 500 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)c(F)c3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288125 118710 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 500 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)c(F)c3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
11712235 98096 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 457 5 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402265 98096 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 457 5 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
11620159 98877 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419498 98877 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
68916097 98068 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
CHEMBL2402153 98068 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
45485943 203896 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCO)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567709 203896 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCO)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485960 203905 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N(CC)CC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567772 203905 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N(CC)CC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485928 204222 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569722 204222 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
24937181 204228 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569732 204228 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485900 204296 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570093 204296 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24752269 69575 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784185 69575 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
131257 209550 6 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 4 0 5 4.7 Cc1c(OCc2cccc3ccccc23)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62094 209550 6 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 4 0 5 4.7 Cc1c(OCc2cccc3ccccc23)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44452879 168068 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2ccc(C(=O)O)cc2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL412171 168068 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2ccc(C(=O)O)cc2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45269473 203119 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 554 13 2 8 2.2 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562406 203119 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 554 13 2 8 2.2 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485896 203558 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565470 203558 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485934 203755 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566613 203755 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485941 203800 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567064 203800 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751996 69624 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784233 69624 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650899 209746 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 5 0 7 1.9 Cc1cc2c(=O)cc(N3CCOCC3)oc2c(C)c1OCCN1CCN(C)CC1 10.1021/jm00066a012
CHEMBL63016 209746 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 5 0 7 1.9 Cc1cc2c(=O)cc(N3CCOCC3)oc2c(C)c1OCCN1CCN(C)CC1 10.1021/jm00066a012
71740705 98069 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 526 6 1 8 2.9 CCCS(=O)(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402154 98069 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 526 6 1 8 2.9 CCCS(=O)(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45270300 202176 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552022 202176 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650869 209918 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 335 5 0 6 2.7 CSCCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL64144 209918 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 335 5 0 6 2.7 CSCCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
15650870 209921 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 376 8 1 7 1.6 CCN(CCO)CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL64149 209921 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 376 8 1 7 1.6 CCN(CCO)CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
45270321 202298 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 648 12 3 8 3.7 NCC1CCN(c2cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N3CCN(C(=O)OCCC4CCCC4)CC3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553856 202298 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 648 12 3 8 3.7 NCC1CCN(c2cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N3CCN(C(=O)OCCC4CCCC4)CC3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
11706300 98063 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 520 7 1 8 3.6 CCCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402149 98063 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 520 7 1 8 3.6 CCCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15982392 98094 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 485 7 2 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402263 98094 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 485 7 2 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
45485969 203546 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 705 14 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565363 203546 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 705 14 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485902 204204 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569629 204204 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485955 204334 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 12 2 9 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570289 204334 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 12 2 9 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485964 204347 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570388 204347 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
24752560 69578 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3OC)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784188 69578 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3OC)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485853 204132 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569053 204132 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45269438 202780 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560009 202780 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24968874 98874 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
CHEMBL2419495 98874 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
11273179 10074 5 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1021/jm701348d
1770 10074 5 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1021/jm701348d
CHEMBL1162175 10074 5 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1021/jm701348d
DB05553 10074 5 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1021/jm701348d
11273179 10074 5 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1016/j.bmcl.2008.01.038
1770 10074 5 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1016/j.bmcl.2008.01.038
CHEMBL1162175 10074 5 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1016/j.bmcl.2008.01.038
DB05553 10074 5 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 10.1016/j.bmcl.2008.01.038
90644282 118707 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 494 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288122 118707 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 494 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
16739124 17133 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 568 8 4 10 2.8 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162188 17133 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 568 8 4 10 2.8 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
45485966 203622 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 15 3 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565836 203622 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 15 3 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485906 204273 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569988 204273 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485952 204332 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570275 204332 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45271155 202419 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556330 202419 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24751579 69593 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3OC)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784203 69593 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3OC)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44457276 17115 0 None -87 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 878 15 8 21 -1.4 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(c5ccccc5)O[C@@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162166 17115 0 None -87 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 878 15 8 21 -1.4 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(c5ccccc5)O[C@@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
44457392 17137 0 None -114 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 900 20 8 21 -0.4 CCCCCCCC1O[C@@H]2[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@@H](O)[C@H]3O)O[C@@H](n3ccc(=O)[nH]c3=O)[C@@H]2O1 10.1021/jm701348d
CHEMBL1162194 17137 0 None -114 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 900 20 8 21 -0.4 CCCCCCCC1O[C@@H]2[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@@H](O)[C@H]3O)O[C@@H](n3ccc(=O)[nH]c3=O)[C@@H]2O1 10.1021/jm701348d
44610468 118712 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 500 9 1 8 3.5 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288127 118712 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 500 9 1 8 3.5 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
54586076 69328 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1782536 69328 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
73345971 98074 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 414 5 1 5 3.4 C=C(NC(=O)N1CCN(c2ncc(C(=O)OCC)cc2Cl)CC1)c1ccccc1 10.1016/j.ejmech.2013.04.007
CHEMBL2402243 98074 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 414 5 1 5 3.4 C=C(NC(=O)N1CCN(c2ncc(C(=O)OCC)cc2Cl)CC1)c1ccccc1 10.1016/j.ejmech.2013.04.007
45485937 204026 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568384 204026 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485859 204239 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569764 204239 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751581 69292 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 5 1 5 2.9 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782078 69292 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 5 1 5 2.9 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54586076 69328 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782536 69328 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45269484 202444 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 671 14 2 9 3.1 CN(CCS(C)(=O)=O)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCCC3CCCC3)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL556493 202444 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 671 14 2 9 3.1 CN(CCS(C)(=O)=O)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCCC3CCCC3)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45271145 201708 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 659 16 2 9 3.1 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL541745 201708 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 659 16 2 9 3.1 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
69224603 98861 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 448 7 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CC3CCCCC3)C2)nc1C 10.1021/jm400820m
CHEMBL2419481 98861 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 448 7 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CC3CCCCC3)C2)nc1C 10.1021/jm400820m
15983052 98862 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3C)C2)nc1C 10.1021/jm400820m
CHEMBL2419482 98862 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3C)C2)nc1C 10.1021/jm400820m
24752130 69580 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784190 69580 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752420 69612 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784221 69612 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
71740819 98070 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 491 5 1 7 3.5 CCOC(=O)c1ccc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402155 98070 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 491 5 1 7 3.5 CCOC(=O)c1ccc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485857 204256 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 13 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569909 204256 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 13 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485938 204305 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 12 2 9 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570155 204305 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 12 2 9 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44631970 201628 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by chronolog PRP aggregometry assayAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by chronolog PRP aggregometry assay
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539733 201628 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by chronolog PRP aggregometry assayAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by chronolog PRP aggregometry assay
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54585885 69604 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 6 1 5 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784214 69604 2 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 6 1 5 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44457274 17114 0 None 7 2 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 994 18 6 21 1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@H]34)[C@@H]3OC(Cc4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162165 17114 0 None 7 2 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 994 18 6 21 1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@H]34)[C@@H]3OC(Cc4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
44554515 118708 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 118708 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
69224555 98867 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419487 98867 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
68556549 118706 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 482 8 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C(C)c3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288121 118706 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 482 8 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C(C)c3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
11503160 98088 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402257 98088 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
24752131 69615 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784224 69615 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45269454 202897 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561007 202897 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271100 203453 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564552 203453 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650861 209470 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 352 4 0 6 2.9 Cc1c(OCc2ccccn2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL61623 209470 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 352 4 0 6 2.9 Cc1c(OCc2ccccn2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15983175 98866 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419486 98866 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
45485945 203857 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567468 203857 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485947 204325 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570242 204325 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45272055 201672 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540737 201672 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24751995 69592 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784202 69592 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751708 69620 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784229 69620 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650881 209922 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 399 4 0 9 2.3 Cc1c(OCc2nnnn2C(C)(C)C)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64153 209922 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 399 4 0 9 2.3 Cc1c(OCc2nnnn2C(C)(C)C)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44453107 162086 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 466 6 3 9 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL403010 162086 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 466 6 3 9 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45272035 201868 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 556 12 2 8 2.4 COCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL549727 201868 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 556 12 2 8 2.4 COCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
11570029 98081 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 529 5 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402250 98081 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 529 5 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
16739091 17121 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 580 8 4 10 3.3 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162172 17121 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 580 8 4 10 3.3 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
24752557 69579 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784189 69579 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485916 203680 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566176 203680 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
54584960 69628 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784240 69628 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45272842 202403 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 10 3 8 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556239 202403 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 10 3 8 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
16739125 17122 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 586 10 4 10 2.7 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162173 17122 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 586 10 4 10 2.7 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
68916926 146469 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 491 6 1 9 3.1 CCc1cnc(-c2cc(C#N)c(N3CC(C(=O)NS(=O)(=O)c4ccc(Cl)s4)C3)nc2C)o1 10.1016/j.bmcl.2016.04.030
CHEMBL3798029 146469 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 491 6 1 9 3.1 CCc1cnc(-c2cc(C#N)c(N3CC(C(=O)NS(=O)(=O)c4ccc(Cl)s4)C3)nc2C)o1 10.1016/j.bmcl.2016.04.030
11684912 98076 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402245 98076 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11561528 98098 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402267 98098 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68842714 98099 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 460 7 2 6 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2CCC(=O)O)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402268 98099 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 460 7 2 6 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2CCC(=O)O)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485911 204287 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570028 204287 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751572 69329 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 432 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Br)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782537 69329 2 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 432 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Br)c1 10.1016/j.bmcl.2011.03.088
44453110 162087 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 561 8 3 10 3.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)c2cccs2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL403011 162087 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 561 8 3 10 3.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)c2cccs2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
15983053 98865 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419485 98865 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
69224054 98872 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419493 98872 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
45485961 203784 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 13 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566913 203784 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 13 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24750723 69587 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 515 4 1 6 4.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784197 69587 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 515 4 1 6 4.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485954 204333 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570285 204333 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270322 201561 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 623 12 2 9 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538415 201561 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 623 12 2 9 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24750719 69627 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 394 4 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784238 69627 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 394 4 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24799317 17109 0 None -5 3 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 529 8 4 12 0.9 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]2O[C@@H](Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162160 17109 0 None -5 3 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 529 8 4 12 0.9 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]2O[C@@H](Cc3ccccc3)O[C@H]21 10.1021/jm701348d
16739092 17120 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 588 12 4 10 3.4 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162171 17120 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 588 12 4 10 3.4 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
44457422 17143 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1028 18 9 22 0.9 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4O[C@@H](Cc5ccccc5)O[C@@H]34)[C@@H](O)[C@H]2O)c(=O)n1 10.1021/jm701348d
CHEMBL1162200 17143 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1028 18 9 22 0.9 O=C(Nc1ccc(F)cc1)Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4O[C@@H](Cc5ccccc5)O[C@@H]34)[C@@H](O)[C@H]2O)c(=O)n1 10.1021/jm701348d
68918061 98057 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402143 98057 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
11699088 98062 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 506 6 1 8 3.2 CCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402148 98062 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 506 6 1 8 3.2 CCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24752711 69608 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784218 69608 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45271154 202449 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556522 202449 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
25022501 101857 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 510 9 3 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL255349 101857 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 510 9 3 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
44452925 173203 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 558 9 3 11 1.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)(=O)CC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL427723 173203 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 558 9 3 11 1.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)(=O)CC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
44452982 101898 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 558 9 3 11 1.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)(=O)CC(C)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL255553 101898 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 558 9 3 11 1.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CS(=O)(=O)CC(C)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
23649325 7329 56 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 7329 56 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 7329 56 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
68911289 98086 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402255 98086 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL5206028 98086 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
23649325 7329 56 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
7360 7329 56 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
CHEMBL2419490 7329 56 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
11993787 98873 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 512 8 1 8 3.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C(C)C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419494 98873 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 512 8 1 8 3.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C(C)C)cc3)CC2)nc1C 10.1021/jm400820m
44452926 104192 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 559 9 3 9 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCc2ccccc2F)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL269934 104192 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 559 9 3 9 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCc2ccccc2F)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45273798 202467 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 11 3 8 1.8 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556723 202467 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 11 3 8 1.8 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
68913927 98093 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402262 98093 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
11532836 98103 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402272 98103 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68554177 198060 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 482 9 1 7 3.2 CCCC(=O)c1cc(C#N)c(N(C(=O)C2CCNCC2)S(=O)(=O)CCc2ccccc2)nc1C 10.1016/j.ejmech.2021.113924
CHEMBL5190691 198060 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assayInhibition of 2-MeS-ADP induced P2Y12 (unknown origin) signalling expressed in CHO cells membrane incubated for 45 mins by 35S-GTPgammaS assay
ChEMBL 482 9 1 7 3.2 CCCC(=O)c1cc(C#N)c(N(C(=O)C2CCNCC2)S(=O)(=O)CCc2ccccc2)nc1C 10.1016/j.ejmech.2021.113924
24751574 69327 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1782535 69327 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.ejmech.2013.04.007
24751999 69591 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1784201 69591 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485892 203814 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567189 203814 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485884 203997 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568250 203997 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485848 204166 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 571 14 2 9 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569319 204166 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 571 14 2 9 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485890 204262 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569915 204262 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485967 204324 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 707 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570238 204324 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 707 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24751574 69327 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782535 69327 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.bmcl.2011.03.088
24751999 69591 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784201 69591 2 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650866 208103 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 360 7 0 6 2.7 CCN(CC)CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL60422 208103 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 360 7 0 6 2.7 CCN(CC)CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
45273812 202535 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL557535 202535 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44610518 118709 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3Cl)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288124 118709 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3Cl)CC2)nc1C 10.1016/j.bmcl.2014.04.001
90644279 118718 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 496 10 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CCC 10.1016/j.bmcl.2014.04.001
CHEMBL3288133 118718 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 496 10 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CCC 10.1016/j.bmcl.2014.04.001
45485963 203871 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567561 203871 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24752561 69605 2 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 5 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784215 69605 2 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 461 5 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752421 69614 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 529 5 1 6 4.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784223 69614 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 529 5 1 6 4.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44452951 104530 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 549 10 4 10 2.0 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC2CC2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL271643 104530 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 549 10 4 10 2.0 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC2CC2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485939 203929 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567883 203929 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485899 204523 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571583 204523 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
44457290 17117 0 None -288 2 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 892 16 8 21 -1.6 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162168 17117 0 None -288 2 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 892 16 8 21 -1.6 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
45485959 203988 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 14 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568211 203988 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 14 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
23642329 69594 2 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784204 69594 2 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45270323 202026 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551020 202026 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650882 209724 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 357 4 0 9 1.0 Cc1c(OCc2nnnn2C)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62928 209724 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 357 4 0 9 1.0 Cc1c(OCc2nnnn2C)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
45271984 201867 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549724 201867 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45273789 202686 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL559126 202686 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45267750 202706 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559340 202706 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
16739158 17113 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 578 6 4 10 2.6 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162164 17113 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 578 6 4 10 2.6 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
15983055 98863 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 510 7 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C(F)(F)F)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419483 98863 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 510 7 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C(F)(F)F)c3)C2)nc1C 10.1021/jm400820m
54580044 69629 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 396 4 1 6 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NC3CCCCO3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784241 69629 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 396 4 1 6 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NC3CCCCO3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44453131 162242 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 509 8 4 10 0.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL403928 162242 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 509 8 4 10 0.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
11503687 98104 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402273 98104 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
2746550 69583 5 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784193 69583 5 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485919 203569 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCOCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565542 203569 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCOCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485852 204203 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 612 16 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569617 204203 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 612 16 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485861 204243 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 13 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569781 204243 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 13 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485909 204292 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CC(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570053 204292 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CC(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270295 201550 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 625 14 2 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538171 201550 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 625 14 2 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54579996 69599 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784209 69599 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54583975 69618 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784227 69618 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650875 209987 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 386 5 0 6 3.2 Cc1c(OCCN2CCCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64383 209987 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 386 5 0 6 3.2 Cc1c(OCCN2CCCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
4742794 210074 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 399 6 0 7 1.9 C=Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64734 210074 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 399 6 0 7 1.9 C=Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44457324 17124 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 993 18 6 22 1.4 Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4OC(Cc5ccccc5)O[C@@H]34)[C@H]3OC(Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
CHEMBL1162178 17124 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 993 18 6 22 1.4 Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4OC(Cc5ccccc5)O[C@@H]34)[C@H]3OC(Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
11561748 98875 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419496 98875 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
45268594 202342 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 574 11 2 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL554782 202342 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 574 11 2 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24801573 17138 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 466 6 6 10 0.2 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm701348d
CHEMBL1162195 17138 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 466 6 6 10 0.2 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O 10.1021/jm701348d
24752422 69582 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784192 69582 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
11641496 98061 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 478 4 1 8 2.5 COC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402147 98061 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 478 4 1 8 2.5 COC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68911008 98092 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 6 2 7 2.6 CCOC(=O)c1cnc(N2CCC(NC(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402261 98092 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 466 6 2 7 2.6 CCOC(=O)c1cnc(N2CCC(NC(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15983546 98880 2 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419501 98880 2 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
24752271 69606 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 495 5 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784216 69606 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 495 5 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44457249 17107 0 None -12 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1018 18 6 21 2.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@@H]3OC(/C=C/c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162158 17107 0 None -12 2 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1018 18 6 21 2.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@@H]3OC(/C=C/c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
45273819 201932 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL550278 201932 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270314 201924 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL550206 201924 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
11569565 98095 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402264 98095 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
1746 8823 1 None -251 2 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 812 14 7 19 -1.7 O=c1ccn(c(=O)[nH]1)[C@@H]1O[C@@H]([C@@H]2[C@H]1OC(O2)Cc1ccccc1)COP(=O)(OP(=O)(OP(=O)(OC[C@@H]1O[C@@H]([C@H]([C@H]1O)O)n1ccc(=O)[nH]c1=O)O)O)O 10.1021/jm701348d
44457307 8823 1 None -251 2 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 812 14 7 19 -1.7 O=c1ccn(c(=O)[nH]1)[C@@H]1O[C@@H]([C@@H]2[C@H]1OC(O2)Cc1ccccc1)COP(=O)(OP(=O)(OP(=O)(OC[C@@H]1O[C@@H]([C@H]([C@H]1O)O)n1ccc(=O)[nH]c1=O)O)O)O 10.1021/jm701348d
CHEMBL1162174 8823 1 None -251 2 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 812 14 7 19 -1.7 O=c1ccn(c(=O)[nH]1)[C@@H]1O[C@@H]([C@@H]2[C@H]1OC(O2)Cc1ccccc1)COP(=O)(OP(=O)(OP(=O)(OC[C@@H]1O[C@@H]([C@H]([C@H]1O)O)n1ccc(=O)[nH]c1=O)O)O)O 10.1021/jm701348d
24752270 69607 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784217 69607 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485888 203740 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 582 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566520 203740 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 582 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44304081 172498 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 373 5 0 7 1.3 CN1CCN(CCOc2ccc3c(=O)cc(N4CCOCC4)oc3c2)CC1 10.1021/jm00066a012
CHEMBL424596 172498 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 373 5 0 7 1.3 CN1CCN(CCOc2ccc3c(=O)cc(N4CCOCC4)oc3c2)CC1 10.1021/jm00066a012
16739093 17127 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 560 8 4 10 2.3 O=C(Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21)NC1CCCC1 10.1021/jm701348d
CHEMBL1162182 17127 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 560 8 4 10 2.3 O=C(Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21)NC1CCCC1 10.1021/jm701348d
23649325 7329 56 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasmaAntagonist activity at P2Y12 receptor in human platelet rich plasma
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmc.2022.116614
7360 7329 56 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasmaAntagonist activity at P2Y12 receptor in human platelet rich plasma
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmc.2022.116614
CHEMBL2419490 7329 56 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasmaAntagonist activity at P2Y12 receptor in human platelet rich plasma
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmc.2022.116614
45485862 204257 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569910 204257 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485905 204300 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570150 204300 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45269465 203033 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 554 12 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561810 203033 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 554 12 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
11677907 98058 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402144 98058 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
45485956 204345 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 13 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570386 204345 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 13 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
71740352 98100 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 404 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=S)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402269 98100 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 404 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=S)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485894 204232 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569742 204232 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
54580995 69590 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784200 69590 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15983672 98870 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419491 98870 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
11663657 98077 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402246 98077 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11656053 98084 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402253 98084 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68914580 98087 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 438 6 2 7 1.8 CCOC(=O)c1cnc(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402256 98087 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 438 6 2 7 1.8 CCOC(=O)c1cnc(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751712 69603 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784213 69603 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44452947 161966 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 526 9 3 10 2.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL402401 161966 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 526 9 3 10 2.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485863 204244 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569815 204244 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270294 202107 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 541 12 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551619 202107 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 541 12 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54584163 69330 1 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 354 4 1 5 2.6 CCOC(=O)c1ccc(N2CCN(C(=O)Nc3ccccc3)CC2)nc1 10.1016/j.bmcl.2011.03.088
CHEMBL1782538 69330 1 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 354 4 1 5 2.6 CCOC(=O)c1ccc(N2CCN(C(=O)Nc3ccccc3)CC2)nc1 10.1016/j.bmcl.2011.03.088
11519648 98075 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402244 98075 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
1765 10589 98 None 1 8 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
4184 10589 98 None 1 8 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
9871419 10589 98 None 1 8 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
CHEMBL398435 10589 98 None 1 8 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
DB08816 10589 98 None 1 8 Human 7.4 pIC50 = 7.4 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1039/D1MD00128K
45485962 203808 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567133 203808 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44631970 201628 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539733 201628 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267722 202879 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560882 202879 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44452898 101858 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2ccccc2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL255350 101858 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2ccccc2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485935 203829 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567271 203829 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139236 204346 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570387 204346 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45273782 202287 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553654 202287 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650862 208208 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 352 4 0 6 2.9 Cc1c(OCc2cccnc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60481 208208 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 352 4 0 6 2.9 Cc1c(OCc2cccnc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650876 209155 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 373 5 1 7 1.2 Cc1c(OCCN2CCNCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL61062 209155 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 373 5 1 7 1.2 Cc1c(OCCN2CCNCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
4742793 209727 1 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 6 0 7 1.8 CCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62939 209727 1 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 6 0 7 1.8 CCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650873 210173 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 374 5 0 7 1.6 Cc1c(OCCN2CCOCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL65466 210173 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 374 5 0 7 1.6 Cc1c(OCCN2CCOCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650872 210328 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 358 5 0 6 2.4 Cc1c(OCCN2CCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL66594 210328 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 358 5 0 6 2.4 Cc1c(OCCN2CCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
11595497 209926 6 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 351 4 0 5 3.5 Cc1c(OCc2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64162 209926 6 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 351 4 0 5 3.5 Cc1c(OCc2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
16739094 17129 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 520 8 4 10 1.3 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162184 17129 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 520 8 4 10 1.3 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
45485889 203767 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 14 2 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OCC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566745 203767 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 610 14 2 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OCC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45268642 202397 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 645 15 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556142 202397 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 645 15 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650856 107801 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 275 2 0 5 1.9 COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL294535 107801 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 275 2 0 5 1.9 COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
15650888 210337 1 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 387 4 0 5 4.4 O=c1cc(N2CCOCC2)oc2cc(OCc3cccc4ccccc34)ccc12 10.1021/jm00066a012
CHEMBL66647 210337 1 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 387 4 0 5 4.4 O=c1cc(N2CCOCC2)oc2cc(OCc3cccc4ccccc34)ccc12 10.1021/jm00066a012
44610519 118711 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 504 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288126 118711 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 504 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1016/j.bmcl.2014.04.001
24751850 69595 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784205 69595 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45272861 202260 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552971 202260 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650874 210252 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 390 5 0 7 2.4 Cc1c(OCCN2CCSCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL66027 210252 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 390 5 0 7 2.4 Cc1c(OCCN2CCSCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
15650867 109066 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 408 7 0 6 3.8 CCN(CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C)c1ccccc1 10.1021/jm00066a012
CHEMBL303366 109066 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 408 7 0 6 3.8 CCN(CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C)c1ccccc1 10.1021/jm00066a012
15650864 208098 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 379 5 0 6 3.2 Cc1c(OCC(=O)c2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60420 208098 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 379 5 0 6 3.2 Cc1c(OCC(=O)c2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44453009 161995 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 577 11 3 11 2.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC2CC2C(=O)OCC)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL402592 161995 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 577 11 3 11 2.5 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC2CC2C(=O)OCC)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485851 204211 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 597 13 2 9 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCO3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569681 204211 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 597 13 2 9 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCO3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45272036 202365 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL555342 202365 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650858 207375 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 381 5 0 6 3.5 COc1ccccc1COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL59922 207375 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 381 5 0 6 3.5 COc1ccccc1COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
24752419 69609 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784219 69609 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751576 69623 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 5 1 5 4.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784232 69623 2 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 5 1 5 4.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45270296 202108 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551620 202108 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24799834 17135 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 461 6 3 10 1.2 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162190 17135 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 461 6 3 10 1.2 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(/C=C/c3ccccc3)O[C@H]21 10.1021/jm701348d
122192512 130587 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 445 7 5 12 0.9 CCCSc1nc(N/N=C/c2cccc(O)c2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1039/D1MD00128K
CHEMBL3623467 130587 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometryInhibition of P2Y12 receptor in human platelet assessed as reduction in ADP-induced VASP phosphorylation by flow cytometry
ChEMBL 445 7 5 12 0.9 CCCSc1nc(N/N=C/c2cccc(O)c2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1039/D1MD00128K
24751710 69621 2 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784230 69621 2 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54583974 69600 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 424 4 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784210 69600 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 424 4 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44457292 17118 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 914 16 5 19 1.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@H]34)[C@@H]3OC(Cc4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162169 17118 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 914 16 5 19 1.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(Cc5ccccc5)O[C@H]34)[C@@H]3OC(Cc4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
11497605 98078 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402247 98078 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11691323 98085 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 470 5 1 7 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402254 98085 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 470 5 1 7 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15650857 207208 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 381 5 0 6 3.5 COc1ccc(COc2ccc3c(=O)cc(N4CCOCC4)oc3c2C)cc1 10.1021/jm00066a012
CHEMBL59822 207208 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 381 5 0 6 3.5 COc1ccc(COc2ccc3c(=O)cc(N4CCOCC4)oc3c2C)cc1 10.1021/jm00066a012
44452736 102940 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 451 6 3 9 1.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL260602 102940 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 451 6 3 9 1.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
44457401 17139 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 993 18 6 22 1.4 Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4O[C@@H](Cc5ccccc5)O[C@@H]34)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
CHEMBL1162196 17139 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 993 18 6 22 1.4 Nc1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]3O[C@H](n4ccc(=O)[nH]c4=O)[C@H]4O[C@@H](Cc5ccccc5)O[C@@H]34)[C@H]3O[C@@H](Cc4ccccc4)O[C@H]32)c(=O)n1 10.1021/jm701348d
44453109 162034 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 545 8 3 10 2.7 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)c2ccco2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL402800 162034 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 545 8 3 10 2.7 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNC(=O)c2ccco2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45485957 204336 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570295 204336 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485920 204524 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571584 204524 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24750874 69616 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 529 6 1 6 4.9 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3nc(C(F)(F)F)c(C(=O)OCC)cc3C#N)CC2)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784225 69616 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 529 6 1 6 4.9 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3nc(C(F)(F)F)c(C(=O)OCC)cc3C#N)CC2)c1 10.1016/j.bmcl.2011.03.088
45485864 203765 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566720 203765 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44453032 104619 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 494 8 3 9 2.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL272113 104619 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 494 8 3 9 2.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
54579997 69622 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 432 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784231 69622 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 432 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15650871 210102 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 372 5 0 6 2.8 Cc1c(OCCN2CCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL64863 210102 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 372 5 0 6 2.8 Cc1c(OCCN2CCCCC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
24752558 98071 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 481 6 1 7 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3cccs3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402156 98071 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 481 6 1 7 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3cccs3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
45485915 204302 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570152 204302 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485912 204293 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570060 204293 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
44453132 104801 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 509 9 4 10 1.4 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL272975 104801 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 509 9 4 10 1.4 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CNCC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
24801414 17110 0 None 263 2 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 648 10 5 12 2.9 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]2O[C@@H](Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162161 17110 0 None 263 2 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 648 10 5 12 2.9 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@H]2O[C@@H](Cc3ccccc3)O[C@H]21 10.1021/jm701348d
45485901 204299 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCNCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570149 204299 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCNCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
44457251 17108 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1278 22 8 25 6.9 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(NC(=O)Nc5ccccc5)ncnc43)[C@@H]3O[C@H](Cc4ccccc4)O[C@H]23)[C@@H]2O[C@H](Cc3ccccc3)O[C@@H]21 10.1021/jm701348d
CHEMBL1162159 17108 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1278 22 8 25 6.9 O=C(Nc1ccccc1)Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(NC(=O)Nc5ccccc5)ncnc43)[C@@H]3O[C@H](Cc4ccccc4)O[C@H]23)[C@@H]2O[C@H](Cc3ccccc3)O[C@@H]21 10.1021/jm701348d
16739123 17130 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 576 12 4 10 2.9 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162185 17130 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 576 12 4 10 2.9 CCCCCCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(Cc3ccccc3)O[C@H]21 10.1021/jm701348d
11627571 98065 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 506 5 1 8 3.2 CC(C)OC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402150 98065 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 506 5 1 8 3.2 CC(C)OC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485908 204291 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570045 204291 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
71740353 98101 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 416 4 1 6 2.6 CCOC(=O)c1cnc(N2CCN(C(=O)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402270 98101 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 416 4 1 6 2.6 CCOC(=O)c1cnc(N2CCN(C(=O)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
45485942 204306 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570156 204306 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
15650887 210025 1 None - 1 Human 4.3 pIC50 = 4.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 338 4 0 6 2.6 O=c1cc(N2CCOCC2)oc2cc(OCc3ccccn3)ccc12 10.1021/jm00066a012
CHEMBL64555 210025 1 None - 1 Human 4.3 pIC50 = 4.3 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 338 4 0 6 2.6 O=c1cc(N2CCOCC2)oc2cc(OCc3ccccn3)ccc12 10.1021/jm00066a012
15982393 98097 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402266 98097 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
45272869 202261 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552972 202261 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54579995 69585 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C#N)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784195 69585 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C#N)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44457249 17107 0 None -12 2 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1018 18 6 21 2.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@@H]3OC(/C=C/c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162158 17107 0 None -12 2 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1018 18 6 21 2.0 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@@H]3OC(/C=C/c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
45485932 203937 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567915 203937 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 677 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45267721 203501 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564981 203501 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44608149 118714 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288129 118714 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
68911155 98091 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402260 98091 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
24799835 17132 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 459 4 3 10 0.6 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
CHEMBL1162187 17132 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 459 4 3 10 0.6 Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2OC(C#Cc3ccccc3)O[C@H]21 10.1021/jm701348d
45272054 201671 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 635 11 3 8 3.5 O=C(O)CC[C@H](NC(=O)c1cc(N2CCC(O)CC2)cc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CCCC2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540736 201671 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 635 11 3 8 3.5 O=C(O)CC[C@H](NC(=O)c1cc(N2CCC(O)CC2)cc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CCCC2)CC1 10.1016/j.bmcl.2009.06.075
69224988 98871 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419492 98871 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
68911027 98060 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 5 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC3CN(C(=O)NS(=O)(=O)c4ccccc4)CC3C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402146 98060 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 483 5 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC3CN(C(=O)NS(=O)(=O)c4ccccc4)CC3C2)nc1C 10.1016/j.ejmech.2013.04.007
44452952 161847 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 647 13 4 11 2.4 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN(CC2CC2C(=O)O)CC2CC2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL401780 161847 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 647 13 4 11 2.4 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN(CC2CC2C(=O)O)CC2CC2C(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
24750561 69625 1 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 6 1 5 4.7 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3ncc(C(=O)OCC)cc3Cl)CC2)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784234 69625 1 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 470 6 1 5 4.7 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3ncc(C(=O)OCC)cc3Cl)CC2)c1 10.1016/j.bmcl.2011.03.088
45267728 202985 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561484 202985 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650859 108982 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 301 4 0 5 2.5 C=CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL302875 108982 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 301 4 0 5 2.5 C=CCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
68556579 118713 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 482 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288128 118713 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 482 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
15650886 107413 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 347 4 0 7 1.8 COC(=O)COc1ccc2c(=O)c(C)c(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL292047 107413 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 347 4 0 7 1.8 COC(=O)COc1ccc2c(=O)c(C)c(N3CCOCC3)oc2c1C 10.1021/jm00066a012
44452878 103852 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2cccc(C(=O)O)c2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL267283 103852 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 586 10 3 10 3.6 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2cccc(C(=O)O)c2)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45273811 203276 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 552 13 2 7 3.4 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563429 203276 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 552 13 2 7 3.4 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485933 204304 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570154 204304 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45271092 203223 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563041 203223 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485886 204261 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569914 204261 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485950 204328 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570263 204328 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24750876 69613 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 491 6 1 7 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784222 69613 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 491 6 1 7 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45273818 201627 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 623 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539732 201627 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 623 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54580993 69573 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784178 69573 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
15983670 98864 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419484 98864 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
45485903 204297 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(C)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570108 204297 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(C)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
15650860 209624 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 4 0 5 4.7 Cc1c(OCc2ccc3ccccc3c2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62470 209624 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 401 4 0 5 4.7 Cc1c(OCc2ccc3ccccc3c2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44457294 17119 0 None -125 2 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 938 16 8 25 0.2 Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@@H]3OC(Cc4ccccc4)O[C@H]23)[C@H](O)[C@@H]1O 10.1021/jm701348d
CHEMBL1162170 17119 0 None -125 2 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 938 16 8 25 0.2 Nc1ncnc2c1ncn2[C@H]1O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@@H]3OC(Cc4ccccc4)O[C@H]23)[C@H](O)[C@@H]1O 10.1021/jm701348d
45485914 204294 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 649 12 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570064 204294 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 649 12 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44452921 102038 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 480 7 3 9 2.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL256251 102038 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 480 7 3 9 2.2 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CC(=O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
2746549 69326 13 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL1782534 69326 13 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
2746549 69326 13 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1782534 69326 13 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45485946 204554 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571812 204554 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
68913220 98059 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 509 5 1 9 2.5 CCOC(=O)c1cc(C#N)c(N2C[C@@H]3C[C@H]2CN3C(=O)NS(=O)(=O)c2ccc(Cl)s2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402145 98059 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 509 5 1 9 2.5 CCOC(=O)c1cc(C#N)c(N2C[C@@H]3C[C@H]2CN3C(=O)NS(=O)(=O)c2ccc(Cl)s2)nc1C 10.1016/j.ejmech.2013.04.007
45485953 204344 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570385 204344 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
15650898 209629 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 415 7 0 7 2.2 CCCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL62500 209629 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 415 7 0 7 2.2 CCCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
11569565 98095 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL2402264 98095 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) by GTPgammaS binding assay
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.bmcl.2016.04.030
24751577 69617 2 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784226 69617 2 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45485856 204253 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCCN3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569889 204253 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCCN3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
15650868 207352 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 319 5 0 6 2.0 COCCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL59911 207352 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 319 5 0 6 2.0 COCCOc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
68911120 98869 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 6 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419489 98869 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 456 6 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1021/jm400820m
45272902 202494 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 468 9 2 7 1.7 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL557062 202494 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 468 9 2 7 1.7 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485898 203955 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568059 203955 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
73294137 98868 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 8 2 9 1.0 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(CO)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419488 98868 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 8 2 9 1.0 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(CO)cc3)C2)nc1C 10.1021/jm400820m
45485922 203847 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567416 203847 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45267707 202748 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559689 202748 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270288 202051 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551217 202051 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44457338 17126 0 None -1 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1056 20 10 25 -0.4 CNc1ccccc1C(=O)O[C@H]1[C@@H](O)[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2OC(=O)c2ccccc2NC)O[C@@H]1n1ccc(=O)[nH]c1=O 10.1021/jm701348d
CHEMBL1162181 17126 0 None -1 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 1056 20 10 25 -0.4 CNc1ccccc1C(=O)O[C@H]1[C@@H](O)[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2OC(=O)c2ccccc2NC)O[C@@H]1n1ccc(=O)[nH]c1=O 10.1021/jm701348d
25165435 118717 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 484 9 1 8 2.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1OC 10.1016/j.bmcl.2014.04.001
CHEMBL3288132 118717 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 484 9 1 8 2.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1OC 10.1016/j.bmcl.2014.04.001
54581027 69626 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 487 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H]3C[C@H]3c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784235 69626 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 487 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H]3C[C@H]3c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
45269483 201572 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 603 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538645 201572 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 603 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45272881 201640 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539983 201640 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267738 203134 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562485 203134 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271162 202089 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551484 202089 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485921 203797 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567050 203797 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485929 204303 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570153 204303 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45273820 201629 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539734 201629 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
68913141 98089 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402258 98089 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
45485918 203753 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566599 203753 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45269472 203118 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562405 203118 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45485849 204208 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569679 204208 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
90644280 118716 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 504 9 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C(F)F 10.1016/j.bmcl.2014.04.001
CHEMBL3288131 118716 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 504 9 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C(F)F 10.1016/j.bmcl.2014.04.001
68911205 98878 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419499 98878 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
15650883 170052 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 419 5 0 9 2.5 Cc1c(OCc2nnnn2-c2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL418660 170052 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 419 5 0 9 2.5 Cc1c(OCc2nnnn2-c2ccccc2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
44241562 203211 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in CHO FlpIn cells assessed as reduction n 2-methylthio-ADP mediated inhibition of forskolin-induced cAMP response element-directed luciferase expression by bright-glo assayAntagonist activity at human recombinant P2Y12 receptor expressed in CHO FlpIn cells assessed as reduction n 2-methylthio-ADP mediated inhibition of forskolin-induced cAMP response element-directed luciferase expression by bright-glo assay
ChEMBL 340 6 2 8 1.2 Cc1ccc(S(=O)(=O)Oc2cc(N)nc(SCCN)n2)cc1 10.1016/j.bmc.2009.04.061
CHEMBL562982 203211 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in CHO FlpIn cells assessed as reduction n 2-methylthio-ADP mediated inhibition of forskolin-induced cAMP response element-directed luciferase expression by bright-glo assayAntagonist activity at human recombinant P2Y12 receptor expressed in CHO FlpIn cells assessed as reduction n 2-methylthio-ADP mediated inhibition of forskolin-induced cAMP response element-directed luciferase expression by bright-glo assay
ChEMBL 340 6 2 8 1.2 Cc1ccc(S(=O)(=O)Oc2cc(N)nc(SCCN)n2)cc1 10.1016/j.bmc.2009.04.061
45485936 203833 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567280 203833 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485897 203918 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567840 203918 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
24829943 202693 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559259 202693 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45268619 202285 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 573 11 3 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553572 202285 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 573 11 3 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15983301 98090 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402259 98090 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
44457262 17111 0 None -2 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 966 16 6 21 1.3 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(c5ccccc5)O[C@H]34)[C@@H]3OC(c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162162 17111 0 None -2 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 966 16 6 21 1.3 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(c5ccccc5)O[C@H]34)[C@@H]3OC(c4ccccc4)O[C@@H]32)c(=O)[nH]1 10.1021/jm701348d
24750557 69588 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 497 4 1 6 4.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784198 69588 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 497 4 1 6 4.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
11697626 98879 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 428 6 1 8 1.4 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419500 98879 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 428 6 1 8 1.4 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1021/jm400820m
24751851 69597 2 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784207 69597 2 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
4742792 207407 10 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 387 5 0 7 1.6 Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL59941 207407 10 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 387 5 0 7 1.6 Cc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
45271128 201707 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 580 11 4 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL541742 201707 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 580 11 4 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
54580185 69333 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.7 CC(C)OC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782542 69333 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 1 5 3.7 CC(C)OC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
45485931 203644 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565974 203644 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 679 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
54585098 69332 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 374 3 1 5 2.9 COC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782541 69332 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 374 3 1 5 2.9 COC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
44457247 17106 0 None -85 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 904 16 8 21 -1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162157 17106 0 None -85 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 904 16 8 21 -1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
45485855 204252 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569884 204252 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485917 204277 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 12 2 10 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569995 204277 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 12 2 10 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44457247 17106 0 None -85 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 904 16 8 21 -1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
CHEMBL1162157 17106 0 None -85 2 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as inhibition of ADP-induced human platelet aggregation by washed platelet assay
ChEMBL 904 16 8 21 -1.1 O=c1ccn([C@H]2O[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@@H]4OC(/C=C/c5ccccc5)O[C@H]34)[C@H](O)[C@@H]2O)c(=O)[nH]1 10.1021/jm701348d
11627317 98067 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 490 6 1 7 3.7 CCCC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402152 98067 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 490 6 1 7 3.7 CCCC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15650897 207594 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 413 7 0 7 2.0 C=CCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
CHEMBL60083 207594 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 413 7 0 7 2.0 C=CCc1c(OCCN2CCN(C)CC2)ccc2c(=O)cc(N3CCOCC3)oc12 10.1021/jm00066a012
11706351 98079 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402248 98079 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
45142449 203109 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562344 203109 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
15650863 207810 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 333 4 0 7 1.5 COC(=O)COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
CHEMBL60240 207810 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
In vitro inhibitory activity against ADP-induced human platelet aggregationIn vitro inhibitory activity against ADP-induced human platelet aggregation
ChEMBL 333 4 0 7 1.5 COC(=O)COc1ccc2c(=O)cc(N3CCOCC3)oc2c1C 10.1021/jm00066a012
90644281 118715 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 486 9 1 7 3.3 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CF 10.1016/j.bmcl.2014.04.001
CHEMBL3288130 118715 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of ADP-induced [35S]GTPgammaS binding after 45 mins by scintillation counting analysis
ChEMBL 486 9 1 7 3.3 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CF 10.1016/j.bmcl.2014.04.001
45485958 203902 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567740 203902 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485904 204298 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570128 204298 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485860 204240 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569771 204240 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometryAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced platelet aggregation by light transmission aggregometry
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45268641 201617 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 579 11 3 8 2.3 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539661 201617 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 579 11 3 8 2.3 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24752559 69581 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C#N)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784191 69581 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C#N)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751297 69589 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 6 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784199 69589 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 475 6 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751711 69596 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784206 69596 2 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
11699570 98080 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402249 98080 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
54580994 69574 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 0 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)N(C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784184 69574 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assayAntagonist activity at human recombinant P2Y12 receptor expressed in platelet cell membrane by [35S]GTPgammaS binding assay
ChEMBL 402 4 0 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)N(C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24829780 203244 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563183 203244 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
68910943 98876 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
CHEMBL2419497 98876 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assayAntagonist activity at P2Y12 receptor (unknown origin) expressed in CHO cell membrane by [35S]GTPgammaS binding assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
11684524 98083 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402252 98083 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751017 98102 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 432 4 1 6 2.7 CCOC(=O)c1cnc(N2CCN(C(=S)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402271 98102 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysisAntagonist activity at P2Y12 receptor (unknown origin) assessed as inhibition of GTPgammaS binding after 1 hr by scintillation counting analysis
ChEMBL 432 4 1 6 2.7 CCOC(=O)c1cnc(N2CCN(C(=S)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
44452977 102336 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 542 10 4 11 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC(O)CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
CHEMBL257651 102336 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assayAntagonist activity at P2Y12 receptor assessed as platelet aggregation by washed platelet assay
ChEMBL 542 10 4 11 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](CSCC(O)CO)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21 10.1016/j.bmcl.2008.01.038
45272880 202262 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552973 202262 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric methodAntagonist activity at human P2Y12 receptor assessed as inhibition of ADP-induced platelet-rich plasma aggregation by turbidimetric method
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44583582 9978 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
5904 9978 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
59448166 9978 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
CHEMBL1207916 9978 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
CHEMBL455536 9978 3 None - 1 Human 9.8 pKd = 9.8 Functional
Competitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assayCompetitive antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as forskolin/ 2-methylthio-ADP-induced cAMP production preincubated for 10 mins followed 2-methylthio-ADP addition measured after 3.5 hrs by luciferase reporter gene assay
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/acs.jmedchem.7b00030
44583582 9978 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
5904 9978 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
59448166 9978 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
CHEMBL1207916 9978 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
CHEMBL455536 9978 3 None - 1 Human 9.8 pA2 = 9.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19690189
1765 10589 98 None -2 8 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
4184 10589 98 None -2 8 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
9871419 10589 98 None -2 8 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
CHEMBL398435 10589 98 None -2 8 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
DB08816 10589 98 None -2 8 Rat 8.3 pIC50 = 8.3 Functional
NoneNone
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
1776 7574 38 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
5006 7574 38 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
9854012 7574 38 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
CHEMBL334966 7574 38 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
DB06441 7574 38 None -2 4 Human 8.1 pIC50 = 8.1 Functional
cAMP accumulation in HORK3-expressing cellscAMP accumulation in HORK3-expressing cells
Drug Central 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O None
10340 7904 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonism of ADP-induced platelet aggregation in human platelet-rich plasma.Antagonism of ADP-induced platelet aggregation in human platelet-rich plasma.
Guide to Pharmacology 468 5 1 8 2.2 N#Cc1cc2C(=O)OCc2nc1N1CCC(CC1)(C)C(=O)NS(=O)(=O)Cc1ccc(cc1)C 30843696
137553172 7904 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonism of ADP-induced platelet aggregation in human platelet-rich plasma.Antagonism of ADP-induced platelet aggregation in human platelet-rich plasma.
Guide to Pharmacology 468 5 1 8 2.2 N#Cc1cc2C(=O)OCc2nc1N1CCC(CC1)(C)C(=O)NS(=O)(=O)Cc1ccc(cc1)C 30843696
1764 6864 0 None -1 2 Human 5.4 pIC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 393 5 5 11 -1.1 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(O)O 11502873
189762 6864 0 None -1 2 Human 5.4 pIC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 393 5 5 11 -1.1 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(O)O 11502873
CHEMBL606240 6864 0 None -1 2 Human 5.4 pIC50 = 5.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 393 5 5 11 -1.1 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(O)O 11502873
1732 7238 0 None -5 4 Human 6.0 pIC50 = 6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 832 14 6 29 -5.0 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2cnc3c2ncnc3N)[O-])[O-])[O-])[O-])O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 12815166
25243905 7238 0 None -5 4 Human 6.0 pIC50 = 6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 832 14 6 29 -5.0 O[C@@H]1[C@@H](COP(=O)(OP(=O)(OP(=O)(OP(=O)(OC[C@H]2O[C@H]([C@@H]([C@@H]2O)O)n2cnc3c2ncnc3N)[O-])[O-])[O-])[O-])O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 12815166
16741348 7544 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 558 10 3 8 2.0 CCOC(=O)N1CCN(CC1)C(=O)C(NC(=O)c1cc(OC(C(=O)O)(C)C)c2c(n1)cc(cc2)C)CCC(=O)O 18539312
1766 7544 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 558 10 3 8 2.0 CCOC(=O)N1CCN(CC1)C(=O)C(NC(=O)c1cc(OC(C(=O)O)(C)C)c2c(n1)cc(cc2)C)CCC(=O)O 18539312
139031067 7896 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 900 14 10 24 0.1 O[C@H]1C(COP(=O)(OP(=O)(C(P(=O)(OP(=O)(OC[C@H]2O[C@H](C([C@H]2O)O)n2cnc3c2ncnc3N)S)O)Cl)O)S)O[C@H]([C@H]1O)n1cnc2c1ncnc2N 23083103
6148 7896 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 900 14 10 24 0.1 O[C@H]1C(COP(=O)(OP(=O)(C(P(=O)(OP(=O)(OC[C@H]2O[C@H](C([C@H]2O)O)n2cnc3c2ncnc3N)S)O)Cl)O)S)O[C@H]([C@H]1O)n1cnc2c1ncnc2N 23083103
73755176 7896 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 900 14 10 24 0.1 O[C@H]1C(COP(=O)(OP(=O)(C(P(=O)(OP(=O)(OC[C@H]2O[C@H](C([C@H]2O)O)n2cnc3c2ncnc3N)S)O)Cl)O)S)O[C@H]([C@H]1O)n1cnc2c1ncnc2N 23083103
3384 7261 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7582510
3384 7261 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7858849
5311009 7261 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7582510
5311009 7261 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7858849
CHEMBL1160359 7261 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7582510
CHEMBL1160359 7261 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 615 11 7 14 0.6 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(F)F)O)O 7858849
1776 7574 38 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
5006 7574 38 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
9854012 7574 38 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
CHEMBL334966 7574 38 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
DB06441 7574 38 None -2 4 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 11502873
121990 6863 15 None -2 5 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11502873
1710 6863 15 None -2 5 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11502873
1763 6863 15 None -2 5 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11502873
CHEMBL435402 6863 15 None -2 5 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11502873
1755 7077 17 None 32 6 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11502873
5310996 7077 17 None 32 6 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11502873
CHEMBL335206 7077 17 None 32 6 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 443 6 6 12 -1.6 O[C@@H]1[C@@H](COP(=O)(OP(=S)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11502873
1776 7574 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
5006 7574 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
9854012 7574 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
CHEMBL334966 7574 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
DB06441 7574 38 None -2 4 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 12213051
10405534 10042 0 None - 1 Human 5.2 pIC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 349 5 2 4 2.9 OC(=O)/C=C\1/CN(CCC1S)C(c1ccccc1F)C(=O)C1CC1 16268477
1771 10042 0 None - 1 Human 5.2 pIC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 349 5 2 4 2.9 OC(=O)/C=C\1/CN(CCC1S)C(c1ccccc1F)C(=O)C1CC1 16268477
CHEMBL3526431 10042 0 None - 1 Human 5.2 pIC50 None 5.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 349 5 2 4 2.9 OC(=O)/C=C\1/CN(CCC1S)C(c1ccccc1F)C(=O)C1CC1 16268477
1769 8824 0 None - 1 Human 6.3 pIC50 None 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 633 10 4 12 2.6 O=C(c1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@@H](O2)Cc1ccccc1)COP(=O)(OP(=O)(O)O)O 18232657
91827342 8824 0 None - 1 Human 6.3 pIC50 None 6.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 633 10 4 12 2.6 O=C(c1ccccc1)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@@H](O2)Cc1ccccc1)COP(=O)(OP(=O)(O)O)O 18232657
16681707 7546 7 None - 1 Human 7.0 pIC50 None 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 18539312
1767 7546 7 None - 1 Human 7.0 pIC50 None 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 18539312
CHEMBL2172275 7546 7 None - 1 Human 7.0 pIC50 None 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 18539312
11273179 10074 5 None - 1 Human 8.0 pIC50 None 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 18232657
1770 10074 5 None - 1 Human 8.0 pIC50 None 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 18232657
CHEMBL1162175 10074 5 None - 1 Human 8.0 pIC50 None 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 18232657
DB05553 10074 5 None - 1 Human 8.0 pIC50 None 8.0 Functional
UnclassifiedUnclassified
Guide to Pharmacology 532 8 4 10 1.8 CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]([C@@H]2[C@H]1O[C@H](O2)/C=C/c1ccccc1)COP(=O)(O)O 18232657
1765 10589 98 None 1 8 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974
4184 10589 98 None 1 8 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974
9871419 10589 98 None 1 8 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974
CHEMBL398435 10589 98 None 1 8 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974
DB08816 10589 98 None 1 8 Human 8.6 pKB = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 25186974




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
44443919 101191 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Antagonist activity at human P2Y12 by aggregation assayAntagonist activity at human P2Y12 by aggregation assay
ChEMBL 553 14 6 13 0.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.5b01972
CHEMBL251024 101191 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Antagonist activity at human P2Y12 by aggregation assayAntagonist activity at human P2Y12 by aggregation assay
ChEMBL 553 14 6 13 0.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.5b01972
1776 7574 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
5006 7574 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
9854012 7574 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
CHEMBL334966 7574 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
DB06441 7574 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
1776 7574 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 (unknown origin)Antagonist activity at P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/acs.jmedchem.5b01972
5006 7574 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 (unknown origin)Antagonist activity at P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/acs.jmedchem.5b01972
9854012 7574 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 (unknown origin)Antagonist activity at P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/acs.jmedchem.5b01972
CHEMBL334966 7574 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 (unknown origin)Antagonist activity at P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/acs.jmedchem.5b01972
DB06441 7574 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Antagonist activity at P2Y12 (unknown origin)Antagonist activity at P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1021/acs.jmedchem.5b01972
1776 7574 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
5006 7574 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
9854012 7574 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
CHEMBL334966 7574 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
DB06441 7574 38 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2022.128837
44443921 175533 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human P2Y12 by aggregation assayAntagonist activity at human P2Y12 by aggregation assay
ChEMBL 551 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.5b01972
CHEMBL437204 175533 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Antagonist activity at human P2Y12 by aggregation assayAntagonist activity at human P2Y12 by aggregation assay
ChEMBL 551 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.5b01972
10557443 16997 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 783 13 7 14 3.1 O=P(O)(OC[C@H]1O[C@@H](n2cnc3c(NCC(F)(F)F)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O 10.1016/j.bmcl.2016.04.030
CHEMBL1160364 16997 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 783 13 7 14 3.1 O=P(O)(OC[C@H]1O[C@@H](n2cnc3c(NCC(F)(F)F)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O 10.1016/j.bmcl.2016.04.030
66575818 120846 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326907 120846 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
44554515 118708 0 None - 0 Human 9.0 pIC50 = 9 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 118708 0 None - 0 Human 9.0 pIC50 = 9 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
49764561 196915 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 601 12 2 9 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)sc2N2CC[C@H](OC)C2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5173489 196915 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 601 12 2 9 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)sc2N2CC[C@H](OC)C2)CC1 10.1016/j.ejmech.2021.113924
49764180 197316 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 524 9 3 7 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5179719 197316 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 524 9 3 7 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
46931928 197614 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 600 10 3 7 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](Cc2ccc(P(=O)(O)O)cc2)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5184268 197614 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 600 10 3 7 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](Cc2ccc(P(=O)(O)O)cc2)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
49763085 198213 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 622 10 3 9 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2nc(-c3ccccc3)sc2N2CCN(C)CC2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5192953 198213 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 622 10 3 9 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2nc(-c3ccccc3)sc2N2CCN(C)CC2)CC1 10.1016/j.ejmech.2021.113924
49764183 198370 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 572 8 3 7 2.3 CCOC(=O)N1CCN(C(=O)[C@H](Cc2ccc(P(=O)(O)O)cc2)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5195237 198370 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 572 8 3 7 2.3 CCOC(=O)N1CCN(C(=O)[C@H](Cc2ccc(P(=O)(O)O)cc2)NC(=O)c2csc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
49763087 198894 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 609 13 3 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2nc(-c3ccccc3)sc2N(C)CCCC)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5203416 198894 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 609 13 3 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2nc(-c3ccccc3)sc2N(C)CCCC)CC1 10.1016/j.ejmech.2021.113924
15983053 98865 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419485 98865 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
66854978 198061 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 784 14 3 11 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CCNS(=O)(=O)C(F)(F)F)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5190693 198061 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 784 14 3 11 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CCNS(=O)(=O)C(F)(F)F)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
87180479 199139 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 719 16 3 10 1.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC(F)F)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5207212 199139 0 None - 0 Human 8.0 pIC50 = 8 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 719 16 3 10 1.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC(F)F)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
1765 10589 98 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
4184 10589 98 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
9871419 10589 98 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
CHEMBL398435 10589 98 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
DB08816 10589 98 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2022.128837
44443917 101157 0 None - 0 Human 7.0 pIC50 = 7 Binding
Antagonist activity at human P2Y12 by aggregation assayAntagonist activity at human P2Y12 by aggregation assay
ChEMBL 552 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1ncn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.5b01972
CHEMBL250832 101157 0 None - 0 Human 7.0 pIC50 = 7 Binding
Antagonist activity at human P2Y12 by aggregation assayAntagonist activity at human P2Y12 by aggregation assay
ChEMBL 552 14 6 12 0.8 CCCCNc1nc(SCCC)nc2c1ncn2[C@@H]1O[C@H](/C=C/C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](O)[C@H]1O 10.1021/acs.jmedchem.5b01972
118711090 120628 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 608 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325652 120628 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 608 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67460312 120398 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322621 120398 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118711072 120610 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325634 120610 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711074 120612 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 11 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325636 120612 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 11 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711077 120615 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325639 120615 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711079 120617 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325641 120617 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711087 120625 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325649 120625 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711091 120629 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCNC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325653 120629 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCNC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576450 120672 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 526 8 2 7 4.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325781 120672 0 None - 0 Rat 6.0 pIC50 = 6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 526 8 2 7 4.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54581027 69626 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 487 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H]3C[C@H]3c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784235 69626 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 487 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H]3C[C@H]3c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
54580044 69629 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 396 4 1 6 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NC3CCCCO3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784241 69629 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 396 4 1 6 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NC3CCCCO3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
68600063 133440 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 645 11 2 8 3.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCCC3c3ccccc3)c3ccccc3n2)CC1 nan
CHEMBL3652613 133440 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 645 11 2 8 3.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCCC3c3ccccc3)c3ccccc3n2)CC1 nan
118711172 120670 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)NC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325779 120670 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)NC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
127039360 143919 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1048 20 10 26 3.1 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
127040666 143919 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1048 20 10 26 3.1 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3745863 143919 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1048 20 10 26 3.1 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747870 143919 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1048 20 10 26 3.1 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
25165435 118717 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 484 9 1 8 2.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1OC 10.1016/j.bmcl.2014.04.001
CHEMBL3288132 118717 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 484 9 1 8 2.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1OC 10.1016/j.bmcl.2014.04.001
44608149 118714 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288129 118714 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 502 8 1 7 3.8 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
118711093 120631 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CNCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325655 120631 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CNCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
23649325 7329 56 None - 1 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
7360 7329 56 None - 1 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
CHEMBL2419490 7329 56 None - 1 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
24968874 98874 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
CHEMBL2419495 98874 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
118711190 120694 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325802 120694 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711191 120695 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325803 120695 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576530 120696 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325804 120696 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
67460624 120410 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 551 9 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccsc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322632 120410 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 551 9 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccsc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
71607689 110989 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 480 7 3 9 3.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098247 110989 0 None - 0 Rat 7.0 pIC50 = 7.0 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 480 7 3 9 3.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
15983055 98863 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 510 7 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C(F)(F)F)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419483 98863 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 510 7 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C(F)(F)F)c3)C2)nc1C 10.1021/jm400820m
24751997 69602 2 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc4ccccc34)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784212 69602 2 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc4ccccc34)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL54256 201727 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 664 7 2 14 1.5 CS(=O)(=O)c1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(S(C)(=O)=O)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
118711084 120622 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 9 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325646 120622 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 9 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711086 120624 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325648 120624 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711088 120626 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325650 120626 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711176 120675 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 608 9 1 7 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325784 120675 0 None - 0 Rat 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 608 9 1 7 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711181 120682 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325791 120682 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
11684524 98083 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402252 98083 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
11561528 98098 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402267 98098 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24752129 69584 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784194 69584 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751577 69617 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784226 69617 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
145968628 171909 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 515 9 3 8 0.2 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)NCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227647 171909 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 515 9 3 8 0.2 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)NCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
145971167 171931 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)[C@@H](C)C1 10.1016/j.bmcl.2018.03.090
CHEMBL4227969 171931 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)[C@@H](C)C1 10.1016/j.bmcl.2018.03.090
145967502 171968 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 430 6 2 7 0.6 CCOC(=O)N1CCN(C(=O)[C@H](CO)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228684 171968 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 430 6 2 7 0.6 CCOC(=O)N1CCN(C(=O)[C@H](CO)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
44610519 118711 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 504 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288126 118711 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 504 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1016/j.bmcl.2014.04.001
68556579 118713 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 482 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288128 118713 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 482 8 1 7 3.4 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
118711089 120627 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325651 120627 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
127038951 143928 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1026 16 10 26 2.1 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46240906 143928 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1026 16 10 26 2.1 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3746312 143928 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1026 16 10 26 2.1 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747879 143928 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1026 16 10 26 2.1 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
71607634 110982 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 538 10 5 12 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098239 110982 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 538 10 5 12 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
118711083 120621 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325645 120621 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
90644280 118716 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 504 9 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C(F)F 10.1016/j.bmcl.2014.04.001
CHEMBL3288131 118716 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 504 9 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C(F)F 10.1016/j.bmcl.2014.04.001
118711091 120629 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCNC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325653 120629 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCNC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711184 120686 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Br)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325795 120686 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Br)c(C)cc34)cc2)c1C 10.1021/jm500588w
68600322 133438 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 708 11 2 9 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O[C@H](C)C(=O)N3CCC[C@H]3C(=O)N3CCCCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652611 133438 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 708 11 2 9 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O[C@H](C)C(=O)N3CCC[C@H]3C(=O)N3CCCCC3)c3ccc(C)cc3n2)CC1 nan
15983175 98866 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419486 98866 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
118711180 120679 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 634 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5ccc(F)cc5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325788 120679 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 634 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5ccc(F)cc5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576220 120697 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 120697 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
11684912 98076 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402245 98076 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11706351 98079 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402248 98079 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
68911120 98869 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 6 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419489 98869 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 6 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1021/jm400820m
118711179 120678 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 1 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325787 120678 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 1 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
15983175 98866 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419486 98866 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 460 7 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)C2)nc1C 10.1021/jm400820m
24751575 69601 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 456 4 1 5 4.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784211 69601 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 456 4 1 5 4.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
22185065 171857 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 426 8 1 5 2.2 CCCCCC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4226930 171857 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 426 8 1 5 2.2 CCCCCC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
71740352 98100 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 404 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=S)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402269 98100 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 404 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=S)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711096 120634 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 582 11 1 7 5.6 CCCCN1CCN(C(=O)Cn2cc(C(=O)Nc3ccc(-n4ncc(C(=O)CCC)c4C)cc3)c3cc(C)ccc32)CC1 10.1021/jm500588w
CHEMBL3325658 120634 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 582 11 1 7 5.6 CCCCN1CCN(C(=O)Cn2cc(C(=O)Nc3ccc(-n4ncc(C(=O)CCC)c4C)cc3)c3cc(C)ccc32)CC1 10.1021/jm500588w
67463039 120391 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 574 11 3 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322614 120391 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 574 11 3 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118711074 120612 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 11 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325636 120612 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 11 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607553 110983 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn(C3[C@H](O)[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098240 110983 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn(C3[C@H](O)[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
44554515 118708 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 118708 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
2741913 120840 5 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 412 5 2 5 5.0 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)c1C 10.1021/jm500588w
CHEMBL3326901 120840 5 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 412 5 2 5 5.0 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)c1C 10.1021/jm500588w
67460741 120408 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 562 9 2 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccc[n+]([O-])c3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322630 120408 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 562 9 2 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccc[n+]([O-])c3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
16681707 7546 7 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human P2Y12Antagonist activity at human P2Y12
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/acs.jmedchem.5b01972
1767 7546 7 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human P2Y12Antagonist activity at human P2Y12
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/acs.jmedchem.5b01972
CHEMBL2172275 7546 7 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human P2Y12Antagonist activity at human P2Y12
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/acs.jmedchem.5b01972
16681707 7546 7 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
1767 7546 7 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
CHEMBL2172275 7546 7 None - 1 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
66575821 120719 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2cnc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cn2)c1C 10.1021/jm500588w
CHEMBL3325892 120719 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2cnc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cn2)c1C 10.1021/jm500588w
24752558 98071 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 481 6 1 7 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3cccs3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402156 98071 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 481 6 1 7 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3cccs3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
118711969 120841 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 480 10 3 7 4.6 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
CHEMBL3326902 120841 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 480 10 3 7 4.6 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
25175044 133430 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 655 12 2 10 1.7 CCOC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc2cc(C)ccc12 nan
CHEMBL3652603 133430 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 655 12 2 10 1.7 CCOC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc2cc(C)ccc12 nan
24985991 198555 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of 2-MeS[3H]-ADP from P2Y12 (unknown origin) expressed in HEK293 cells preincubated for 5 mins followed by 2-MeS[3H]-ADP addition and measured after 30 mins by Topcount beta counter analysisDisplacement of 2-MeS[3H]-ADP from P2Y12 (unknown origin) expressed in HEK293 cells preincubated for 5 mins followed by 2-MeS[3H]-ADP addition and measured after 30 mins by Topcount beta counter analysis
ChEMBL 456 7 4 10 2.1 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3CC[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2021.113924
CHEMBL5197988 198555 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of 2-MeS[3H]-ADP from P2Y12 (unknown origin) expressed in HEK293 cells preincubated for 5 mins followed by 2-MeS[3H]-ADP addition and measured after 30 mins by Topcount beta counter analysisDisplacement of 2-MeS[3H]-ADP from P2Y12 (unknown origin) expressed in HEK293 cells preincubated for 5 mins followed by 2-MeS[3H]-ADP addition and measured after 30 mins by Topcount beta counter analysis
ChEMBL 456 7 4 10 2.1 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3CC[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2021.113924
127041005 143924 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1152 14 10 24 1.3 Nc1nc(I)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
46240702 143924 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1152 14 10 24 1.3 Nc1nc(I)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746901 143924 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1152 14 10 24 1.3 Nc1nc(I)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747875 143924 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1152 14 10 24 1.3 Nc1nc(I)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(I)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
118711185 120687 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325796 120687 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(C)cc34)cc2)c1C 10.1021/jm500588w
71607634 110982 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 538 10 5 12 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098239 110982 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 538 10 5 12 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
118711077 120615 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325639 120615 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
23649325 7329 56 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 7329 56 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 7329 56 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
127040347 143917 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.3 CCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46241743 143917 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.3 CCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747704 143917 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.3 CCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747869 143917 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.3 CCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
11504760 98066 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 534 7 1 8 3.9 CC(C)CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402151 98066 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 534 7 1 8 3.9 CC(C)CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
11712235 98096 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 457 5 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402265 98096 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 457 5 1 8 1.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
44610468 118712 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 500 9 1 8 3.5 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288127 118712 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 500 9 1 8 3.5 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
118711090 120628 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 608 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325652 120628 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 608 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711092 120630 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCN(C)C5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325654 120630 0 None - 0 Rat 5.9 pIC50 = 5.9 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCN(C)C5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
46241019 143913 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 928 16 10 27 -1.0 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3745979 143913 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 928 16 10 27 -1.0 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747865 143913 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 928 16 10 27 -1.0 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
24751999 69591 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1784201 69591 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751999 69591 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784201 69591 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751995 69592 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784202 69592 2 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
145968144 171877 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)[C@@H](C)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227196 171877 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)[C@@H](C)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711187 120689 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 544 8 1 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325798 120689 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 544 8 1 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(F)cc34)cc2)c1C 10.1021/jm500588w
12000767 120384 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 576 11 3 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NS(=O)(=O)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322597 120384 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 576 11 3 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NS(=O)(=O)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118711193 120699 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 532 6 1 7 4.0 CC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325807 120699 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 532 6 1 7 4.0 CC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
71264539 110990 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 552 11 5 12 1.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(O)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098249 110990 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 552 11 5 12 1.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(O)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
15983672 98870 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419491 98870 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
118711177 120676 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 596 8 2 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@@H](O)CN5C[C@@H]4C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325785 120676 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 596 8 2 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@@H](O)CN5C[C@@H]4C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576296 120693 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325801 120693 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118710245 120428 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322650 120428 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
74220534 120720 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.5 CCCC(=O)c1cnn([C@H]2CC[C@H](NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
CHEMBL3325893 120720 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.5 CCCC(=O)c1cnn([C@H]2CC[C@H](NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
11532836 98103 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402272 98103 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
145987950 171990 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 458 7 2 7 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228996 171990 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 458 7 2 7 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711071 120609 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCNC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325633 120609 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCNC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711249 120725 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 603 9 2 8 3.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(N)=O)c2)c1C 10.1021/jm500588w
CHEMBL3325898 120725 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 603 9 2 8 3.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(N)=O)c2)c1C 10.1021/jm500588w
145970219 171904 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 480 7 2 7 1.6 CCOC(=O)N1CCN(C(=O)[C@H](Cc2cnc[nH]2)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227595 171904 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 480 7 2 7 1.6 CCOC(=O)N1CCN(C(=O)[C@H](Cc2cnc[nH]2)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
145969360 171974 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 442 6 1 6 2.3 CCOC(=O)N1CCN(C(=O)[C@@H](NC(=O)c2cc(OC)c3ccccc3n2)C(C)C)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228736 171974 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 442 6 1 6 2.3 CCOC(=O)N1CCN(C(=O)[C@@H](NC(=O)c2cc(OC)c3ccccc3n2)C(C)C)CC1 10.1016/j.bmcl.2018.03.090
118711064 120603 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325625 120603 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607662 110980 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 487 10 4 12 1.1 CCCSc1nc(N[C@@H]2C[C@H]2c2cccnc2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098236 110980 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 487 10 4 12 1.1 CCCSc1nc(N[C@@H]2C[C@H]2c2cccnc2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
44762396 120839 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 407 7 1 6 3.6 CCOC(=O)c1c(C)nn(-c2ccc(C(=O)NCc3ccccc3OC)cc2)c1C 10.1021/jm500588w
CHEMBL3326900 120839 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 407 7 1 6 3.6 CCOC(=O)c1c(C)nn(-c2ccc(C(=O)NCc3ccccc3OC)cc2)c1C 10.1021/jm500588w
59534140 120420 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 10 2 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322642 120420 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 10 2 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11706351 98079 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402248 98079 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
71607589 110978 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 526 10 4 12 2.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(Cl)s2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098234 110978 0 None - 0 Rat 6.8 pIC50 = 6.8 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 526 10 4 12 2.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(Cl)s2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
11993787 98873 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 512 8 1 8 3.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C(C)C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419494 98873 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 512 8 1 8 3.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C(C)C)cc3)CC2)nc1C 10.1021/jm400820m
24751708 69620 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784229 69620 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711064 120603 0 None - 0 Rat 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325625 120603 0 None - 0 Rat 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67463112 120388 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 526 11 3 8 2.2 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)n1 10.1016/j.bmcl.2014.06.070
CHEMBL3322611 120388 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 526 11 3 8 2.2 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)n1 10.1016/j.bmcl.2014.06.070
71607592 110981 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098238 110981 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
71607664 110986 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098243 110986 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
44762396 120839 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 407 7 1 6 3.6 CCOC(=O)c1c(C)nn(-c2ccc(C(=O)NCc3ccccc3OC)cc2)c1C 10.1021/jm500588w
CHEMBL3326900 120839 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 407 7 1 6 3.6 CCOC(=O)c1c(C)nn(-c2ccc(C(=O)NCc3ccccc3OC)cc2)c1C 10.1021/jm500588w
67460401 120392 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 528 11 4 9 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322615 120392 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 528 11 4 9 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68600802 133433 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 680 11 2 9 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652606 133433 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 680 11 2 9 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCC3)c3ccc(C)cc3n2)CC1 nan
15983546 98880 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419501 98880 2 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
66575899 120718 3 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1021/jm500588w
CHEMBL3325891 120718 3 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1021/jm500588w
118711970 120842 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 478 11 3 6 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)Nc3cc(C)ccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
CHEMBL3326903 120842 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 478 11 3 6 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)Nc3cc(C)ccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
66575899 120718 3 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1016/j.bmcl.2022.128837
CHEMBL3325891 120718 3 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1016/j.bmcl.2022.128837
44296486 195720 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 492 9 2 9 4.1 CCOc1ccc2nc(NC(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)sc2c1 10.1016/s0960-894x(01)00313-4
CHEMBL50806 195720 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 492 9 2 9 4.1 CCOc1ccc2nc(NC(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)sc2c1 10.1016/s0960-894x(01)00313-4
CHEMBL540200 201648 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 596 9 2 12 3.4 CCOc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
CHEMBL540200 201648 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Antagonist activity at human P2Y12Antagonist activity at human P2Y12
ChEMBL 596 9 2 12 3.4 CCOc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)=C(O)N12 10.1021/acs.jmedchem.5b01972
11684912 98076 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402245 98076 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
23642329 69594 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784204 69594 2 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711075 120613 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 551 11 2 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCn4ccnc4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325637 120613 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 551 11 2 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCn4ccnc4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711098 120637 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 580 10 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325661 120637 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 580 10 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711184 120686 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Br)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325795 120686 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Br)c(C)cc34)cc2)c1C 10.1021/jm500588w
24752560 69578 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3OC)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784188 69578 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3OC)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751711 69596 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784206 69596 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751709 69619 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784228 69619 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
145967823 171736 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)C[C@@H]1C 10.1016/j.bmcl.2018.03.090
CHEMBL4225138 171736 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)C[C@@H]1C 10.1016/j.bmcl.2018.03.090
71607553 110983 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn(C3[C@H](O)[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098240 110983 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn(C3[C@H](O)[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
67462688 120390 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 560 10 3 8 3.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(Nc3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322613 120390 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 560 10 3 8 3.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(Nc3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
12002005 120401 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 588 10 3 8 2.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322624 120401 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 588 10 3 8 2.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
1776 7574 38 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
5006 7574 38 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
9854012 7574 38 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
CHEMBL334966 7574 38 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
DB06441 7574 38 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.ejmech.2015.10.055
11561528 98098 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402267 98098 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 452 5 1 7 2.1 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL300240 108594 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 652 9 2 14 3.0 CCOC(=O)c1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(C(=O)OCC)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
118711076 120614 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 542 11 2 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC(C)CN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325638 120614 0 None - 0 Rat 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 542 11 2 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC(C)CN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66575818 120846 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326907 120846 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
69224555 98867 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419487 98867 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
24751572 69329 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 432 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Br)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782537 69329 2 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 432 4 1 5 3.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Br)c1 10.1016/j.bmcl.2011.03.088
24752269 69575 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784185 69575 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752559 69581 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C#N)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784191 69581 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C#N)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
10292521 171754 6 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 369 4 1 4 1.9 CCOC(=O)N1CCN(C(=O)CNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4225415 171754 6 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 369 4 1 4 1.9 CCOC(=O)N1CCN(C(=O)CNC(=O)c2ccc3ccccc3c2)CC1 10.1016/j.bmcl.2018.03.090
22184925 171923 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 460 6 1 5 2.5 CCc1ccc(C(=O)N2CCN(C(=O)CNC(=O)c3cc(OC)c4ccccc4n3)CC2)cc1 10.1016/j.bmcl.2018.03.090
CHEMBL4227910 171923 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 460 6 1 5 2.5 CCc1ccc(C(=O)N2CCN(C(=O)CNC(=O)c3cc(OC)c4ccccc4n3)CC2)cc1 10.1016/j.bmcl.2018.03.090
6918456 21287 110 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 373 5 0 5 3.9 CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2 10.1016/j.bmcl.2022.128837
CHEMBL1201772 21287 110 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 373 5 0 5 3.9 CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2 10.1016/j.bmcl.2022.128837
DB06209 21287 110 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 373 5 0 5 3.9 CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2 10.1016/j.bmcl.2022.128837
118711973 120845 0 None - 0 Rat 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326906 120845 0 None - 0 Rat 4.8 pIC50 = 4.8 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
145970653 171872 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 458 7 2 7 1.1 CCOC(=O)N1CCN(C(=O)[C@@H](CC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227170 171872 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 458 7 2 7 1.1 CCOC(=O)N1CCN(C(=O)[C@@H](CC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
71607633 110979 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 507 10 4 13 1.5 CCCSc1nc(N[C@@H]2C[C@H]2c2scnc2C)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098235 110979 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 507 10 4 13 1.5 CCCSc1nc(N[C@@H]2C[C@H]2c2scnc2C)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
11569565 98095 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402264 98095 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
118711174 120673 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 572 10 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCF)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325782 120673 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 572 10 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCF)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711175 120674 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 590 10 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325783 120674 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 590 10 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
11503160 98088 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402257 98088 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
11503687 98104 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402273 98104 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68913927 98093 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402262 98093 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
24750723 69587 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 515 4 1 6 4.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784197 69587 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 515 4 1 6 4.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24750557 69588 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 497 4 1 6 4.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784198 69588 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 497 4 1 6 4.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
145967657 171842 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 504 9 2 8 1.5 CCOC(=O)N1CCN(C(=O)[C@@H](CSCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4226648 171842 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 504 9 2 8 1.5 CCOC(=O)N1CCN(C(=O)[C@@H](CSCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
24752128 69577 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784187 69577 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C(C)C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24750719 69627 2 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 394 4 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784238 69627 2 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 394 4 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
145970872 171847 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)[C@H](C)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4226722 171847 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)[C@H](C)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
15983670 98864 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419484 98864 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
118711073 120611 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 11 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325635 120611 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 11 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607666 110988 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 460 7 3 9 2.8 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C=C[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098246 110988 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 460 7 3 9 2.8 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C=C[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
67459391 120393 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 556 12 4 9 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCC(=O)O)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322616 120393 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 556 12 4 9 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCC(=O)O)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24786234 146525 0 None - 1 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by microplate reader analysisAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by microplate reader analysis
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2016.04.030
CHEMBL3798413 146525 0 None - 1 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by microplate reader analysisAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by microplate reader analysis
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2016.04.030
1776 7574 38 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
5006 7574 38 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
9854012 7574 38 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
CHEMBL334966 7574 38 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
DB06441 7574 38 None - 0 Human 8.7 pIC50 = 8.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced aggregation preincubated for 5 mins followed by ADP addition by turbidimetric analysis
ChEMBL 775 15 7 15 2.9 CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmc.2014.12.034
24786234 146525 0 None - 1 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptor by beta-counter analysisDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor by beta-counter analysis
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2016.04.030
CHEMBL3798413 146525 0 None - 1 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptor by beta-counter analysisDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor by beta-counter analysis
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2016.04.030
1756 7251 10 None - 1 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
5310954 7251 10 None - 1 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
CHEMBL336292 7251 10 None - 1 Human 8.6 pIC50 = 8.6 Binding
Antagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric methodAntagonist activity at P2Y12 receptor in human platelets assessed as inhibition of ADP-induced platelet aggregation by turbidimetric method
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2016.04.030
87416471 198448 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 720 11 1 11 4.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CP2(=O)OCc3cccc(C)c3O2)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5196387 198448 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 720 11 1 11 4.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CP2(=O)OCc3cccc(C)c3O2)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
73603967 120721 5 None - 0 Rat 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 567 8 1 8 3.5 CCCC(=O)c1cnn(C2CCN(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
CHEMBL3325894 120721 5 None - 0 Rat 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 567 8 1 8 3.5 CCCC(=O)c1cnn(C2CCN(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
15982393 98097 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402266 98097 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
66576297 120636 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 584 11 1 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325660 120636 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 584 11 1 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711190 120694 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325802 120694 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576530 120696 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325804 120696 0 None - 0 Rat 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 120697 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 120697 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
11620159 98877 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419498 98877 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
11697626 98879 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 428 6 1 8 1.4 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419500 98879 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 428 6 1 8 1.4 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1021/jm400820m
145970444 171927 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 488 9 2 8 0.7 CCOC(=O)N1CCN(C(=O)[C@H](COCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227949 171927 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 488 9 2 8 0.7 CCOC(=O)N1CCN(C(=O)[C@H](COCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711185 120687 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325796 120687 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(C)cc34)cc2)c1C 10.1021/jm500588w
90644282 118707 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 494 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288122 118707 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 494 8 1 7 3.6 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
118711972 120844 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326905 120844 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67462328 120396 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 552 9 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322619 120396 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 552 9 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67461716 120405 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 541 10 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322628 120405 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 541 10 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
12001755 120419 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 9 3 9 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322641 120419 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 9 3 9 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68913927 98093 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402262 98093 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 505 6 2 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
127039361 143920 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1156 20 10 26 4.2 Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
127039919 143920 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1156 20 10 26 4.2 Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746192 143920 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1156 20 10 26 4.2 Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747871 143920 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1156 20 10 26 4.2 Nc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(SCCC(F)(F)F)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
11699088 98062 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 506 6 1 8 3.2 CCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402148 98062 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 506 6 1 8 3.2 CCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24752130 69580 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784190 69580 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
145969883 171721 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 457 7 2 7 0.5 CCOC(=O)N1CCN(C(=O)[C@H](CC(N)=O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4224920 171721 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 457 7 2 7 0.5 CCOC(=O)N1CCN(C(=O)[C@H](CC(N)=O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
54697995 201503 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 508 4 2 9 2.6 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccccc3s2)S(=O)(=O)N=C2Sc3ccccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL53491 201503 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 508 4 2 9 2.6 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccccc3s2)S(=O)(=O)N=C2Sc3ccccc3N12 10.1016/s0960-894x(01)00313-4
145986354 172015 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 0 6 1.6 CCOC(=O)N1CCN(C(=O)CN(C)C(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4229217 172015 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 0 6 1.6 CCOC(=O)N1CCN(C(=O)CN(C)C(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
12002012 120424 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 527 11 3 8 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322646 120424 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 527 11 3 8 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67464394 120400 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 594 10 3 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)C3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322623 120400 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 594 10 3 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)C3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
23649325 7329 56 None - 1 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 7329 56 None - 1 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 7329 56 None - 1 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
66576377 120680 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325789 120680 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
71607631 110984 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098241 110984 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
127039316 143916 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 992 16 10 26 1.5 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46196450 143916 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 992 16 10 26 1.5 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747385 143916 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 992 16 10 26 1.5 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747868 143916 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 992 16 10 26 1.5 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
69223141 98860 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 8 1 8 1.6 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CCc3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419480 98860 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 8 1 8 1.6 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CCc3ccccc3)C2)nc1C 10.1021/jm400820m
118711067 120607 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325629 120607 0 None - 0 Rat 5.7 pIC50 = 5.7 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
44296002 21559 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 638 8 4 8 5.1 CC(C(O)C(O)[C@@H](C)C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
CHEMBL1206713 21559 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 638 8 4 8 5.1 CC(C(O)C(O)[C@@H](C)C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
CHEMBL299307 21559 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 638 8 4 8 5.1 CC(C(O)C(O)[C@@H](C)C1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
168274164 197188 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 624 8 4 8 4.7 C[C@H]([C@@H](O)[C@H](O)[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
CHEMBL5177774 197188 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 624 8 4 8 4.7 C[C@H]([C@@H](O)[C@H](O)[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
CHEMBL301991 108833 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 536 5 2 10 3.3 Cc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(C)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
145969318 171915 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 472 8 2 7 1.5 CCOC(=O)N1CCN(C(=O)[C@@H](CCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227756 171915 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 472 8 2 7 1.5 CCOC(=O)N1CCN(C(=O)[C@@H](CCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
67463698 120414 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 582 10 4 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N[C@H]3CC[C@H](O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322636 120414 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 582 10 4 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N[C@H]3CC[C@H](O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
44554515 118708 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 118708 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
118710244 120427 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 539 10 3 8 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322649 120427 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 539 10 3 8 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11570029 98081 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 529 5 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402250 98081 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 529 5 1 8 2.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
73294137 98868 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 472 8 2 9 1.0 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(CO)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419488 98868 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 472 8 2 9 1.0 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(CO)cc3)C2)nc1C 10.1021/jm400820m
118711183 120685 0 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 551 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C#N)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325794 120685 0 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 551 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C#N)cc34)cc2)c1C 10.1021/jm500588w
24751438 69576 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784186 69576 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24751300 69586 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 483 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784196 69586 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 483 4 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
11451 9985 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Nc1c2C(=O)c3ccccc3C(=O)c2c(cc1S(=O)(=O)O)Nc1ccc(cc1)Sc1ccc(c(c1)C)C 10.1021/acs.jmedchem.7b00030
132574707 9985 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Nc1c2C(=O)c3ccccc3C(=O)c2c(cc1S(=O)(=O)O)Nc1ccc(cc1)Sc1ccc(c(c1)C)C 10.1021/acs.jmedchem.7b00030
CHEMBL4116316 9985 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Nc1c2C(=O)c3ccccc3C(=O)c2c(cc1S(=O)(=O)O)Nc1ccc(cc1)Sc1ccc(c(c1)C)C 10.1021/acs.jmedchem.7b00030
118711972 120844 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326905 120844 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
68911027 98060 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 5 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC3CN(C(=O)NS(=O)(=O)c4ccccc4)CC3C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402146 98060 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 5 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC3CN(C(=O)NS(=O)(=O)c4ccccc4)CC3C2)nc1C 10.1016/j.ejmech.2013.04.007
24751850 69595 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784205 69595 2 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3cccc(C)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15983546 98880 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419501 98880 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 442 7 1 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1021/jm400820m
127040000 143914 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 27 0.9 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46241331 143914 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 27 0.9 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3746558 143914 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 27 0.9 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747866 143914 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 27 0.9 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)OP(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
73345971 98074 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 414 5 1 5 3.4 C=C(NC(=O)N1CCN(c2ncc(C(=O)OCC)cc2Cl)CC1)c1ccccc1 10.1016/j.ejmech.2013.04.007
CHEMBL2402243 98074 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 414 5 1 5 3.4 C=C(NC(=O)N1CCN(c2ncc(C(=O)OCC)cc2Cl)CC1)c1ccccc1 10.1016/j.ejmech.2013.04.007
24751017 98102 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 432 4 1 6 2.7 CCOC(=O)c1cnc(N2CCN(C(=S)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402271 98102 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 432 4 1 6 2.7 CCOC(=O)c1cnc(N2CCN(C(=S)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751581 69292 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 5 1 5 2.9 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782078 69292 2 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 5 1 5 2.9 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54580185 69333 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.7 CC(C)OC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782542 69333 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.7 CC(C)OC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
60606 68334 73 None - 1 Human 5.6 pIC50 = 5.6 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 10.1016/j.bmcl.2022.128837
CHEMBL1771 68334 73 None - 1 Human 5.6 pIC50 = 5.6 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 10.1016/j.bmcl.2022.128837
DB00758 68334 73 None - 1 Human 5.6 pIC50 = 5.6 Binding
Inhibition of P2Y12 (unknown origin)Inhibition of P2Y12 (unknown origin)
ChEMBL 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 10.1016/j.bmcl.2022.128837
137630000 167809 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c(C)c1 10.1021/acs.jmedchem.7b00030
CHEMBL4087247 167809 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c(C)c1 10.1021/acs.jmedchem.7b00030
CHEMBL4116405 167809 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c(C)c1 10.1021/acs.jmedchem.7b00030
67460268 120421 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 10 3 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N[C@@H]3CCOC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322643 120421 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 10 3 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N[C@@H]3CCOC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11627571 98065 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 506 5 1 8 3.2 CC(C)OC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402150 98065 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 506 5 1 8 3.2 CC(C)OC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
145970953 171956 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 471 8 2 7 0.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(N)=O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228415 171956 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 471 8 2 7 0.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(N)=O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711972 120844 0 None - 0 Rat 4.6 pIC50 = 4.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326905 120844 0 None - 0 Rat 4.6 pIC50 = 4.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 486 10 2 6 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67461519 120395 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 597 12 3 10 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322618 120395 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 597 12 3 10 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68911155 98091 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402260 98091 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
66576450 120672 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 526 8 2 7 4.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325781 120672 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 526 8 2 7 4.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
11526078 98082 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402251 98082 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
145987961 172019 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 471 9 2 7 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCCCN)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4229257 172019 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 471 9 2 7 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCCCN)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711249 120725 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 603 9 2 8 3.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(N)=O)c2)c1C 10.1021/jm500588w
CHEMBL3325898 120725 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 603 9 2 8 3.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(N)=O)c2)c1C 10.1021/jm500588w
12000848 120385 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 624 11 3 9 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NS(=O)(=O)c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322598 120385 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 624 11 3 9 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NS(=O)(=O)c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68911155 98091 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402260 98091 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 6 2 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
66576298 120597 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325452 120597 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711102 120642 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325666 120642 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67459575 120399 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 549 9 2 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-n3cc(C)cn3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322622 120399 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 549 9 2 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-n3cc(C)cn3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
145971125 171856 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 486 9 2 7 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4226913 171856 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 486 9 2 7 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711187 120689 0 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 544 8 1 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325798 120689 0 None - 0 Rat 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 544 8 1 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(F)cc34)cc2)c1C 10.1021/jm500588w
24968874 98874 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
CHEMBL2419495 98874 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 506 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3F)CC2)nc1C 10.1021/jm400820m
54580993 69573 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784178 69573 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 489 5 1 6 4.6 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
54580995 69590 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784200 69590 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54583975 69618 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784227 69618 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 420 5 1 5 3.1 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3cccc(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711065 120604 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)c(C)c34)cc2)c1C 10.1021/jm500588w
CHEMBL3325626 120604 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)c(C)c34)cc2)c1C 10.1021/jm500588w
66575821 120719 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2cnc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cn2)c1C 10.1021/jm500588w
CHEMBL3325892 120719 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2cnc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cn2)c1C 10.1021/jm500588w
67464143 120394 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 555 12 3 9 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322617 120394 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 555 12 3 9 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67461890 120413 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 542 12 4 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322635 120413 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 542 12 4 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68598655 133436 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 736 14 2 10 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OCC(C)C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652609 133436 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 736 14 2 10 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OCC(C)C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
118711173 120671 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)N(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325780 120671 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)N(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607589 110978 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 526 10 4 12 2.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(Cl)s2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098234 110978 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 526 10 4 12 2.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(Cl)s2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
15983053 98865 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419485 98865 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 476 7 1 8 2.2 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(Cl)cc3)C2)nc1C 10.1021/jm400820m
68556549 118706 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 482 8 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C(C)c3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288121 118706 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 482 8 1 7 3.7 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C(C)c3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
118711098 120637 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 580 10 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325661 120637 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 580 10 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
16681707 7546 7 None - 1 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
1767 7546 7 None - 1 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
CHEMBL2172275 7546 7 None - 1 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1016/j.bmcl.2016.04.030
71607631 110984 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098241 110984 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 496 7 4 10 1.9 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
15983672 98870 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419491 98870 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 488 7 1 8 2.4 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(F)cc3)CC2)nc1C 10.1021/jm400820m
69224054 98872 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419493 98872 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
68913220 98059 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 509 5 1 9 2.5 CCOC(=O)c1cc(C#N)c(N2C[C@@H]3C[C@H]2CN3C(=O)NS(=O)(=O)c2ccc(Cl)s2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402145 98059 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 509 5 1 9 2.5 CCOC(=O)c1cc(C#N)c(N2C[C@@H]3C[C@H]2CN3C(=O)NS(=O)(=O)c2ccc(Cl)s2)nc1C 10.1016/j.ejmech.2013.04.007
118710243 120423 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 609 11 2 9 2.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3CN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322645 120423 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 609 11 2 9 2.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3CN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
137630586 167866 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(C)c(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c1 10.1021/acs.jmedchem.7b00030
CHEMBL4081274 167866 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(C)c(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c1 10.1021/acs.jmedchem.7b00030
CHEMBL4116838 167866 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 530 5 3 7 5.8 Cc1ccc(C)c(Sc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2)c1 10.1021/acs.jmedchem.7b00030
25022583 133443 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 676 10 2 8 2.5 Cc1ccc2c(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)cc(C(=O)NCC(=O)N3CCN(C(=O)OCCC(F)(F)F)CC3)nc2c1 nan
CHEMBL3652616 133443 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 676 10 2 8 2.5 Cc1ccc2c(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)cc(C(=O)NCC(=O)N3CCN(C(=O)OCCC(F)(F)F)CC3)nc2c1 nan
25022583 133443 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 676 10 2 8 2.5 Cc1ccc2c(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)cc(C(=O)NCC(=O)N3CCN(C(=O)OCCC(F)(F)F)CC3)nc2c1 10.1016/j.ejmech.2021.113924
CHEMBL3652616 133443 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 676 10 2 8 2.5 Cc1ccc2c(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)cc(C(=O)NCC(=O)N3CCN(C(=O)OCCC(F)(F)F)CC3)nc2c1 10.1016/j.ejmech.2021.113924
59534139 120430 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 596 12 2 9 2.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322652 120430 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 596 12 2 9 2.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
44464779 120431 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322653 120431 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
42629406 197949 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 617 10 3 9 1.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5188874 197949 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 617 10 3 9 1.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
69224988 98871 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419492 98871 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
25110832 196742 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 511 6 2 4 4.6 Cc1[nH]c(-c2ccccc2)c(/C=C/C(=O)O)c1C(=O)C(=O)N1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5170672 196742 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 511 6 2 4 4.6 Cc1[nH]c(-c2ccccc2)c(/C=C/C(=O)O)c1C(=O)C(=O)N1CCN(c2cccc(C(F)(F)F)c2)CC1 10.1016/j.ejmech.2021.113924
66576297 120636 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 584 11 1 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325660 120636 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 584 11 1 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576451 120681 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325790 120681 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711191 120695 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325803 120695 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 120697 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 120697 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576448 127351 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325630 127351 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545653 127351 0 None - 0 Rat 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
66576296 120693 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325801 120693 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711190 120694 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325802 120694 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 2 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576530 120696 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325804 120696 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 641 10 1 9 5.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5cc(C)on5)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 120697 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 120697 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
11503687 98104 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402273 98104 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 5 1 7 2.4 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711974 120847 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 1 6 4.8 CCCC(=O)c1cnn(-c2ccc(N(C)C(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326908 120847 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 1 6 4.8 CCCC(=O)c1cnn(-c2ccc(N(C)C(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
68911088 98056 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402142 98056 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11677907 98058 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402144 98058 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
118711067 120607 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325629 120607 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
66576375 127352 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325631 127352 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545654 127352 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
12001296 120409 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 575 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccc(OC)cc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322631 120409 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 575 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccc(OC)cc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
46241233 143915 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 26 -0.3 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3746620 143915 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 26 -0.3 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747867 143915 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 960 16 10 26 -0.3 CSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(O)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
2746550 69583 5 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784193 69583 5 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
127040676 143921 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1104 24 10 26 4.7 CCCCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
46240598 143921 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1104 24 10 26 4.7 CCCCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3746188 143921 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1104 24 10 26 4.7 CCCCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
CHEMBL3747872 143921 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1104 24 10 26 4.7 CCCCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]4O[C@@H](n5cnc6c(N)nc(SCCCCC)nc65)[C@H](O)[C@@H]4O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.ejmech.2015.10.055
24751297 69589 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 6 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784199 69589 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 6 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
22916 21497 22 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
CHEMBL1206272 21497 22 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
CHEMBL256057 21497 22 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
71607687 110992 0 None - 0 Rat 4.5 pIC50 = 4.5 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 542 10 3 10 3.3 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098251 110992 0 None - 0 Rat 4.5 pIC50 = 4.5 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 542 10 3 10 3.3 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
15983670 98864 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
CHEMBL2419484 98864 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3cccc(C)c3)C2)nc1C 10.1021/jm400820m
11547134 199306 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to P2Y12 (unknown origin)Binding affinity to P2Y12 (unknown origin)
ChEMBL 461 4 1 7 2.9 Cc1cnc(-c2cnc(N3CCN(C(=O)NS(=O)(=O)c4ccccc4)CC3)c(Cl)c2)o1 10.1016/j.ejmech.2021.113924
CHEMBL5209548 199306 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Binding affinity to P2Y12 (unknown origin)Binding affinity to P2Y12 (unknown origin)
ChEMBL 461 4 1 7 2.9 Cc1cnc(-c2cnc(N3CCN(C(=O)NS(=O)(=O)c4ccccc4)CC3)c(Cl)c2)o1 10.1016/j.ejmech.2021.113924
2746549 69326 13 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1782534 69326 13 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752420 69612 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784221 69612 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
1765 10589 98 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
4184 10589 98 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
9871419 10589 98 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
CHEMBL398435 10589 98 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
DB08816 10589 98 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometryInhibition of P2Y12 in human platelet rich plasma assessed as reduction in ADP-induced platelet aggregation pre-incubated before ADP addition and measured after 10 mins by Bruker spectrophotometry
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmc.2017.07.045
23649325 7329 56 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 7329 56 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 7329 56 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
23649325 7329 56 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
7360 7329 56 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
CHEMBL2419490 7329 56 None - 1 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1021/jm400820m
24751579 69593 2 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3OC)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784203 69593 2 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 418 5 1 6 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3OC)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
15982393 98097 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402266 98097 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 471 6 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
118711094 120632 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CN(C)CC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325656 120632 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CN(C)CC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607689 110989 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 480 7 3 9 3.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098247 110989 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 480 7 3 9 3.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](F)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
2746549 69326 13 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL1782534 69326 13 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 447 4 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
24752131 69615 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784224 69615 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
118711247 120722 0 None - 0 Rat 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 561 8 0 8 4.8 CCCC(=O)c1cnn(-c2ccc(OC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325895 120722 0 None - 0 Rat 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 561 8 0 8 4.8 CCCC(=O)c1cnn(-c2ccc(OC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711192 120698 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 546 7 1 7 4.4 CCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325806 120698 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 546 7 1 7 4.4 CCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711182 120684 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325793 120684 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
168293684 198971 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 502 8 2 6 2.7 CCOC(=O)N1CCN(C(=O)[C@@H](CCC(=O)O)NC(=O)c2cc(Cl)cc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5204363 198971 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 502 8 2 6 2.7 CCOC(=O)N1CCN(C(=O)[C@@H](CCC(=O)O)NC(=O)c2cc(Cl)cc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
127040999 143923 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1056 14 10 24 1.6 Nc1nc(Br)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Br)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
46240799 143923 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1056 14 10 24 1.6 Nc1nc(Br)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Br)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746598 143923 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1056 14 10 24 1.6 Nc1nc(Br)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Br)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747874 143923 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1056 14 10 24 1.6 Nc1nc(Br)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Br)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
12001662 120426 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 527 9 3 8 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)O)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322648 120426 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 527 9 3 8 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)O)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
71607632 110985 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098242 110985 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
118711066 120606 0 None - 0 Rat 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325628 120606 0 None - 0 Rat 5.5 pIC50 = 5.5 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54732977 108554 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 576 4 2 9 4.0 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc(Cl)cc3s2)S(=O)(=O)N=C2Sc3cc(Cl)ccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL299983 108554 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 576 4 2 9 4.0 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc(Cl)cc3s2)S(=O)(=O)N=C2Sc3cc(Cl)ccc3N12 10.1016/s0960-894x(01)00313-4
54732982 108663 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 598 6 2 13 2.5 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc([N+](=O)[O-])cc3s2)S(=O)(=O)N=C2Sc3cc([N+](=O)[O-])ccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL300750 108663 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 598 6 2 13 2.5 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc([N+](=O)[O-])cc3s2)S(=O)(=O)N=C2Sc3cc([N+](=O)[O-])ccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL5288399 201201 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Antagonist activity at P2Y12 receptor in human blood platelets assessed as inhibition of ADP-induced platelet aggregation compound preincubated with blood for 5 mins prior to ADP addition by electrode aggregometry assayAntagonist activity at P2Y12 receptor in human blood platelets assessed as inhibition of ADP-induced platelet aggregation compound preincubated with blood for 5 mins prior to ADP addition by electrode aggregometry assay
ChEMBL 572 10 4 4 7.0 O=C(CCCCCCCC(=O)Nc1ccc2[nH]c3ccccc3c(=O)c2c1)Nc1ccc2[nH]c3ccccc3c(=O)c2c1 10.1039/d2md00285j
137630492 167856 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 517 6 3 8 4.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(SCc3cccnc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
CHEMBL4090874 167856 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 517 6 3 8 4.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(SCc3cccnc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
CHEMBL4116755 167856 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 517 6 3 8 4.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(SCc3cccnc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.7b00030
67460935 120404 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 525 8 2 7 2.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322627 120404 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 525 8 2 7 2.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11691323 98085 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 470 5 1 7 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402254 98085 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 470 5 1 7 2.3 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(F)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711186 120688 0 None - 0 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325797 120688 0 None - 0 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
54732979 195185 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 544 4 2 9 2.9 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc(F)cc3s2)S(=O)(=O)N=C2Sc3cc(F)ccc3N12 10.1016/s0960-894x(01)00313-4
CHEMBL50192 195185 0 None - 0 Human 4.4 pIC50 = 4.4 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 544 4 2 9 2.9 O=C1/C(=C(\O)CS(=O)(=O)Nc2nc3ccc(F)cc3s2)S(=O)(=O)N=C2Sc3cc(F)ccc3N12 10.1016/s0960-894x(01)00313-4
66919972 196861 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 643 13 3 11 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CC(C(=O)O)C(=O)O)NC(=O)c2cc(OC3(C(=O)OCC)CCC3)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5172707 196861 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting methodDisplacement of [33P]2MeSADP from human P2Y12 expressed in CHO cell membranes preincubated for 15 mins followed by [33P]2MeSADP addition and measured after 20 mins by microbeta scintillation counting method
ChEMBL 643 13 3 11 1.3 CCOC(=O)N1CCN(C(=O)[C@H](CC(C(=O)O)C(=O)O)NC(=O)c2cc(OC3(C(=O)OCC)CCC3)n(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
11519648 98075 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402244 98075 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
24751712 69603 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784213 69603 2 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 438 4 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc4ccccc4c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
68916097 98068 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
CHEMBL2402153 98068 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
68911205 98878 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419499 98878 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
68911205 98878 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419499 98878 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 496 6 1 9 2.9 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1021/jm400820m
66576448 127351 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325630 127351 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545653 127351 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
118710245 120428 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322650 120428 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68597944 133441 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 680 13 3 9 2.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652614 133441 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 680 13 3 9 2.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
68601276 133446 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 666 12 3 9 1.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652619 133446 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 666 12 3 9 1.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
44554515 118708 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 118708 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
44464779 120431 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322653 120431 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11569565 98095 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL2402264 98095 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL540200 201648 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Compound was evaluated for its ability to inhibit human Purinergic receptor P2Y12 expressed in Xenopus oocyteCompound was evaluated for its ability to inhibit human Purinergic receptor P2Y12 expressed in Xenopus oocyte
ChEMBL 596 9 2 12 3.4 CCOc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(OCC)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
74220534 120720 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.5 CCCC(=O)c1cnn([C@H]2CC[C@H](NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
CHEMBL3325893 120720 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.5 CCCC(=O)c1cnn([C@H]2CC[C@H](NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
67462098 120425 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 567 9 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C3CCC(O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322647 120425 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 567 9 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C3CCC(O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
66576298 120597 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325452 120597 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711083 120621 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325645 120621 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711093 120631 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CNCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325655 120631 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 552 8 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CNCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711097 120635 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 570 10 2 8 3.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325659 120635 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 570 10 2 8 3.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711101 120640 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C(C)C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325664 120640 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C(C)C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711102 120642 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325666 120642 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711172 120670 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)NC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325779 120670 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)NC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711174 120673 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 572 10 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCF)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325782 120673 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 572 10 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCF)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711180 120679 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 634 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5ccc(F)cc5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325788 120679 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 634 10 1 7 6.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(Cc5ccc(F)cc5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711181 120682 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325791 120682 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
66576610 120683 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325792 120683 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
66576296 120693 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325801 120693 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 11 1 8 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCOC)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 120697 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 120697 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576221 120723 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 585 8 1 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C#N)c2)c1C 10.1021/jm500588w
CHEMBL3325896 120723 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 585 8 1 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C#N)c2)c1C 10.1021/jm500588w
66575819 120605 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325627 120605 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
66576377 120680 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325789 120680 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
118711191 120695 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325803 120695 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 631 10 1 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(=O)N(C)C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711073 120611 0 None - 0 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 11 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325635 120611 0 None - 0 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 11 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN4CCCC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711973 120845 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326906 120845 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
44554515 118708 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 118708 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
118711097 120635 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 570 10 2 8 3.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325659 120635 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 570 10 2 8 3.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CCO)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607665 110991 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 554 11 4 11 2.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098250 110991 0 None - 0 Rat 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 554 11 4 11 2.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
118711066 120606 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325628 120606 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54584163 69330 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 354 4 1 5 2.6 CCOC(=O)c1ccc(N2CCN(C(=O)Nc3ccccc3)CC2)nc1 10.1016/j.bmcl.2011.03.088
CHEMBL1782538 69330 1 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 354 4 1 5 2.6 CCOC(=O)c1ccc(N2CCN(C(=O)Nc3ccccc3)CC2)nc1 10.1016/j.bmcl.2011.03.088
1765 10589 98 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
4184 10589 98 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
9871419 10589 98 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
CHEMBL398435 10589 98 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
DB08816 10589 98 None - 1 Rat 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm500588w
11569565 98095 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402264 98095 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 497 5 1 9 2.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
68916097 98068 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
CHEMBL2402153 98068 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 488 5 1 7 3.3 O=C(c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1)C1CC1 10.1016/j.ejmech.2013.04.007
CHEMBL5279963 200823 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human blood platelets assessed as inhibition of ADP-induced platelet aggregation compound preincubated with blood for 5 mins prior to ADP addition by electrode aggregometry assayAntagonist activity at P2Y12 receptor in human blood platelets assessed as inhibition of ADP-induced platelet aggregation compound preincubated with blood for 5 mins prior to ADP addition by electrode aggregometry assay
ChEMBL 597 9 3 10 4.6 CCOC(=O)c1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4c(-c5ccccc5)noc4C)cn3C)cn2C)cn1C 10.1039/d2md00285j
12001028 120306 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 10 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3321766 120306 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 568 10 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118710246 120429 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@@H]3C[C@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322651 120429 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 11 2 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@@H]3C[C@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11663657 98077 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402246 98077 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 525 5 1 8 2.7 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
68914580 98087 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 438 6 2 7 1.8 CCOC(=O)c1cnc(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402256 98087 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 438 6 2 7 1.8 CCOC(=O)c1cnc(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24750876 69613 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 491 6 1 7 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784222 69613 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 491 6 1 7 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
145970029 171953 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)C[C@H]1C 10.1016/j.bmcl.2018.03.090
CHEMBL4228398 171953 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)C[C@H]1C 10.1016/j.bmcl.2018.03.090
23649325 7329 56 None - 1 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 7329 56 None - 1 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 7329 56 None - 1 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 secondsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 10 seconds
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
118711099 120638 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 9 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325662 120638 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 9 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
15983301 98090 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402259 98090 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
68916926 146469 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 491 6 1 9 3.1 CCc1cnc(-c2cc(C#N)c(N3CC(C(=O)NS(=O)(=O)c4ccc(Cl)s4)C3)nc2C)o1 10.1016/j.bmcl.2016.04.030
CHEMBL3798029 146469 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 491 6 1 9 3.1 CCc1cnc(-c2cc(C#N)c(N3CC(C(=O)NS(=O)(=O)c4ccc(Cl)s4)C3)nc2C)o1 10.1016/j.bmcl.2016.04.030
2741913 120840 5 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 412 5 2 5 5.0 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)c1C 10.1021/jm500588w
CHEMBL3326901 120840 5 None - 0 Human 5.4 pIC50 = 5.4 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 412 5 2 5 5.0 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccc(Cl)cc3)cc2)c1C 10.1021/jm500588w
145967859 171791 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)[C@H](C)C1 10.1016/j.bmcl.2018.03.090
CHEMBL4225935 171791 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 5 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)[C@H](C)C1 10.1016/j.bmcl.2018.03.090
118711086 120624 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325648 120624 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
70922234 120641 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325665 120641 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118710241 120397 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 567 9 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322620 120397 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 567 9 2 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67459247 120418 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 3 9 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322640 120418 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 3 9 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
66575819 120605 0 None - 0 Rat 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325627 120605 0 None - 0 Rat 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
54579997 69622 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 432 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784231 69622 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 432 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(OC)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711078 120616 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C4CCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325640 120616 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C4CCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711971 120843 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 486 9 2 6 5.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)n3cc(CCCC(=O)O)c4ccc(C)cc43)cc2)c1C 10.1021/jm500588w
CHEMBL3326904 120843 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 486 9 2 6 5.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)n3cc(CCCC(=O)O)c4ccc(C)cc43)cc2)c1C 10.1021/jm500588w
53233471 69611 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL1784220 69611 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
53233471 69611 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784220 69611 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(F)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
66576451 120681 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325790 120681 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711181 120682 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325791 120682 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 618 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Br)cc34)cc2)c1C 10.1021/jm500588w
66576221 120723 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 585 8 1 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C#N)c2)c1C 10.1021/jm500588w
CHEMBL3325896 120723 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 585 8 1 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C#N)c2)c1C 10.1021/jm500588w
71607632 110985 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098242 110985 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
11561748 98875 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419496 98875 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
44296000 21563 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 702 10 3 9 5.9 CC(CC[C@@H](C)C1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
CHEMBL1206719 21563 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 702 10 3 9 5.9 CC(CC[C@@H](C)C1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
CHEMBL299895 21563 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligandBinding affinity against Purinergic receptor P2Y12 using [3H]2-methylthio-ADP as radioligand
ChEMBL 702 10 3 9 5.9 CC(CC[C@@H](C)C1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@@]3(C)CC[C@]12C)C(C)(C)C 10.1016/s0960-894x(03)00260-9
24752421 69614 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 529 5 1 6 4.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784223 69614 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 529 5 1 6 4.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
118711247 120722 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 561 8 0 8 4.8 CCCC(=O)c1cnn(-c2ccc(OC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325895 120722 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 561 8 0 8 4.8 CCCC(=O)c1cnn(-c2ccc(OC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
168283736 199682 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 688 10 3 9 5.5 C[C@H](CC[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
CHEMBL5183695 199682 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 688 10 3 9 5.5 C[C@H](CC[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
CHEMBL5222086 199682 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 (unknown origin)Displacement of [3H]2MeSADP from P2Y12 (unknown origin)
ChEMBL 688 10 3 9 5.5 C[C@H](CC[C@@H](C)C(C)(C)C)[C@H]1CC[C@H]2[C@@H]3C[C@H](OS(=O)(=O)O)[C@H]4C[C@@H](OS(=O)(=O)O)[C@H](OS(=O)(=O)O)C[C@]4(C)[C@H]3CC[C@]12C 10.1016/j.ejmech.2021.113924
68911008 98092 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 6 2 7 2.6 CCOC(=O)c1cnc(N2CCC(NC(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402261 98092 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 466 6 2 7 2.6 CCOC(=O)c1cnc(N2CCC(NC(=O)NS(=O)(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
71607665 110991 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 554 11 4 11 2.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098250 110991 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 554 11 4 11 2.4 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCC(F)CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
24752557 69579 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784189 69579 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 481 4 1 6 4.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(Cl)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
68598694 133439 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 694 13 3 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O[C@H](C)C(=O)N3CCC[C@H]3C(=O)NCC3CC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652612 133439 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 694 13 3 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O[C@H](C)C(=O)N3CCC[C@H]3C(=O)NCC3CC3)c3ccc(C)cc3n2)CC1 nan
68599106 133442 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 708 13 2 10 2.3 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652615 133442 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 708 13 2 10 2.3 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
68599934 133444 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 622 11 2 8 2.1 CCCCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccccc3n2)CC1 nan
CHEMBL3652617 133444 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 622 11 2 8 2.1 CCCCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccccc3n2)CC1 nan
1765 10589 98 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
4184 10589 98 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
9871419 10589 98 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
CHEMBL398435 10589 98 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
DB08816 10589 98 None - 1 Human 8.3 pIC50 = 8.3 Binding
Antagonist activity at P2Y12 receptor (unknown origin)Antagonist activity at P2Y12 receptor (unknown origin)
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2016.04.030
66575819 120605 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325627 120605 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
127047545 146354 2 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1016/j.bmcl.2016.04.030
CHEMBL3797316 146354 2 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [3H]-2-Mes-ADP from human P2Y12 receptorDisplacement of [3H]-2-Mes-ADP from human P2Y12 receptor
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1016/j.bmcl.2016.04.030
66576610 120683 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325792 120683 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
16066663 84923 38 None - 1 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]2MeSADP from human P2Y12 preincubated for 5 mins followed by [3H]2MeSADP addition and measured after 15 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 preincubated for 5 mins followed by [3H]2MeSADP addition and measured after 15 mins by scintillation counting method
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1016/j.ejmech.2021.113924
CHEMBL2103828 84923 38 None - 1 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]2MeSADP from human P2Y12 preincubated for 5 mins followed by [3H]2MeSADP addition and measured after 15 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 preincubated for 5 mins followed by [3H]2MeSADP addition and measured after 15 mins by scintillation counting method
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1016/j.ejmech.2021.113924
118711085 120623 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325647 120623 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711089 120627 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325651 120627 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 2 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCCC4CN)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711175 120674 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325783 120674 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 590 10 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711177 120676 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 596 8 2 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@@H](O)CN5C[C@@H]4C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325785 120676 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 596 8 2 8 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@@H](O)CN5C[C@@H]4C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711178 120677 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 538 8 2 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325786 120677 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 538 8 2 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576377 120680 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325789 120680 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 556 9 1 8 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(OC)cc34)cc2)c1C 10.1021/jm500588w
66576375 127352 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325631 127352 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545654 127352 0 None - 0 Rat 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
66576298 120597 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325452 120597 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 560 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576451 120681 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325790 120681 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 578 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(F)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711182 120684 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325793 120684 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576220 120697 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 120697 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576448 127351 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325630 127351 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545653 127351 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
66576375 127352 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325631 127352 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3545654 127352 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
1765 10589 98 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
4184 10589 98 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
9871419 10589 98 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
CHEMBL398435 10589 98 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
DB08816 10589 98 None - 1 Human 6.3 pIC50 = 6.3 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2013.11.055
11561748 98875 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419496 98875 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 463 6 1 8 2.6 CCOC(=O)c1cnc(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)c(Cl)c1 10.1021/jm400820m
24752271 69606 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 495 5 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784216 69606 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 495 5 1 6 3.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
24752270 69607 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784217 69607 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3C)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
1765 10589 98 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
4184 10589 98 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
9871419 10589 98 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
CHEMBL398435 10589 98 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
DB08816 10589 98 None - 1 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysisAntagonist activity at P2Y12 in human whole blood assessed as suppression of ADP-induced decrease in PGE1-induced VASP phosphorylation measured after 10 mins by immunostaining based flow cytometric analysis
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/acs.jmedchem.0c01524
67460979 120403 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 511 9 2 7 2.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322626 120403 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 511 9 2 7 2.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
67463220 120417 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 3 9 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322639 120417 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 554 9 3 9 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11656053 98084 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402253 98084 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
22184858 171778 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 428 7 1 6 2.1 CCCOc1cc(C(=O)NCC(=O)N2CCN(C(=O)OCC)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
CHEMBL4225733 171778 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 428 7 1 6 2.1 CCCOc1cc(C(=O)NCC(=O)N2CCN(C(=O)OCC)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
12001567 120406 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 546 9 2 8 2.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccncc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322629 120406 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 546 9 2 8 2.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccncc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
12001030 120412 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 566 10 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CN3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322634 120412 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 566 10 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CN3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
118711188 120690 0 None - 0 Rat 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)ccc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325799 120690 0 None - 0 Rat 5.3 pIC50 = 5.3 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 1 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)ccc34)cc2)c1C 10.1021/jm500588w
54583974 69600 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 424 4 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784210 69600 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 424 4 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(F)c(F)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711250 120726 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 602 7 0 8 4.6 CCCC(=O)c1cnn(-c2ccc3c(c2)OCCN3C(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)c1C 10.1021/jm500588w
CHEMBL3325899 120726 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 602 7 0 8 4.6 CCCC(=O)c1cnn(-c2ccc3c(c2)OCCN3C(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)c1C 10.1021/jm500588w
67462183 120415 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 542 11 4 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322637 120415 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 542 11 4 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)CO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
11627317 98067 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 490 6 1 7 3.7 CCCC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402152 98067 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 490 6 1 7 3.7 CCCC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
54584960 69628 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784240 69628 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 6 1 6 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3cccs3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
54585885 69604 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 6 1 5 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784214 69604 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 6 1 5 3.0 CCOC(=O)c1cnc(N2CCN(C(=O)NCCc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711194 120700 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 614 8 1 7 5.3 Cc1c(C(=O)CCC(F)(F)F)cnn1-c1ccc(NC(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)cc1 10.1021/jm500588w
CHEMBL3325808 120700 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 614 8 1 7 5.3 Cc1c(C(=O)CCC(F)(F)F)cnn1-c1ccc(NC(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)cc1 10.1021/jm500588w
24752561 69605 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 5 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784215 69605 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 461 5 1 6 3.2 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3ccccc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
68910943 98876 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
CHEMBL2419497 98876 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
67462816 120402 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 509 9 2 7 2.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C3CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322625 120402 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 509 9 2 7 2.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C3CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24750874 69616 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 529 6 1 6 4.9 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3nc(C(F)(F)F)c(C(=O)OCC)cc3C#N)CC2)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784225 69616 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 529 6 1 6 4.9 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3nc(C(F)(F)F)c(C(=O)OCC)cc3C#N)CC2)c1 10.1016/j.bmcl.2011.03.088
118711189 120692 0 None - 0 Rat 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 569 9 2 8 3.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(N)=O)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325800 120692 0 None - 0 Rat 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 569 9 2 8 3.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(N)=O)cc34)cc2)c1C 10.1021/jm500588w
69224555 98867 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
CHEMBL2419487 98867 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)C2)nc1C 10.1021/jm400820m
68911289 98086 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of human P2Y12Inhibition of human P2Y12
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/acs.jmedchem.1c01571
CHEMBL2402255 98086 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of human P2Y12Inhibition of human P2Y12
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/acs.jmedchem.1c01571
CHEMBL5206028 98086 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of human P2Y12Inhibition of human P2Y12
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/acs.jmedchem.1c01571
68911289 98086 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402255 98086 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL5206028 98086 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
66575899 120718 3 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1021/jm500588w
CHEMBL3325891 120718 3 None - 0 Rat 7.2 pIC50 = 7.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 562 8 1 9 3.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)nn2)c1C 10.1021/jm500588w
68910943 98876 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.bmcl.2016.04.030
CHEMBL2419497 98876 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity to P2Y12 receptor (unknown origin)Binding affinity to P2Y12 receptor (unknown origin)
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.bmcl.2016.04.030
137630841 167892 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 424 3 4 7 3.0 Cc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1O 10.1021/acs.jmedchem.7b00030
CHEMBL4069492 167892 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 424 3 4 7 3.0 Cc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1O 10.1021/acs.jmedchem.7b00030
CHEMBL4117118 167892 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount methodAntagonist activity at human P2Y12 receptor expressed in CHO cells assessed as inhibition of 2-MeSADP-induced beta-arrestin translocation preincubated for 30 mins followed by 2-MeSADP addition measured after 90 mins by luminescence-based topcount method
ChEMBL 424 3 4 7 3.0 Cc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1O 10.1021/acs.jmedchem.7b00030
118711081 120619 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325643 120619 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711182 120684 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325793 120684 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 574 8 1 7 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(C)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
118711192 120698 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 546 7 1 7 4.4 CCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325806 120698 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 546 7 1 7 4.4 CCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
24751998 69598 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1784208 69598 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
24751851 69597 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784207 69597 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 422 4 1 5 3.9 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(Cl)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
24751998 69598 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784208 69598 2 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 1 5 3.6 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711070 120608 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 526 9 3 7 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N[C@H]4CCNC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325632 120608 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 526 9 3 7 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N[C@H]4CCNC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711075 120613 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 551 11 2 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCn4ccnc4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325637 120613 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 551 11 2 8 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCn4ccnc4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
11949423 199154 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 582 11 2 9 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL5207480 199154 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 582 11 2 9 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
24750561 69625 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 470 6 1 5 4.7 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3ncc(C(=O)OCC)cc3Cl)CC2)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784234 69625 1 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 470 6 1 5 4.7 C=C(C)c1cccc(C(C)(C)NC(=O)N2CCN(c3ncc(C(=O)OCC)cc3Cl)CC2)c1 10.1016/j.bmcl.2011.03.088
11503160 98088 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402257 98088 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 443 6 2 8 1.3 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
68918061 98057 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402143 98057 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
71607663 110987 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098244 110987 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in human platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 540 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](OCCO)[C@@H]3F)c2n1 10.1016/j.bmcl.2013.11.055
11677907 98058 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402144 98058 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 511 5 1 9 2.8 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2C)nc1C 10.1016/j.ejmech.2013.04.007
46233355 207328 0 None - 1 Human 7.2 pIC50 = 7.2 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 545 9 2 7 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL598998 207328 0 None - 1 Human 7.2 pIC50 = 7.2 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 545 9 2 7 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
44554515 118708 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL3288123 118708 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 526 9 1 8 4.0 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)C3(c4ccccc4)CC3)CC2)nc1SC 10.1016/j.bmcl.2014.04.001
CHEMBL5280208 200836 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity at P2Y12 receptor in human blood platelets assessed as inhibition of ADP-induced platelet aggregation compound preincubated with blood for 5 mins prior to ADP addition by electrode aggregometry assayAntagonist activity at P2Y12 receptor in human blood platelets assessed as inhibition of ADP-induced platelet aggregation compound preincubated with blood for 5 mins prior to ADP addition by electrode aggregometry assay
ChEMBL 502 5 4 4 5.0 O=C(CCC(=O)Nc1ccc2[nH]c3ccccc3c(=O)c2c1)Nc1ccc2[nH]c3ccccc3c(=O)c2c1 10.1039/d2md00285j
68601482 133432 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 702 12 3 9 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3cc(F)c(F)cc3n2)CC1 nan
CHEMBL3652605 133432 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 702 12 3 9 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3cc(F)c(F)cc3n2)CC1 nan
118711087 120625 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325649 120625 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71607592 110981 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098238 110981 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 494 7 5 11 1.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
11641496 98061 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 478 4 1 8 2.5 COC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402147 98061 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 478 4 1 8 2.5 COC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711095 120633 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325657 120633 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711176 120675 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 608 9 1 7 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325784 120675 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 608 9 1 7 5.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC(F)(F)F)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
71740819 98070 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 491 5 1 7 3.5 CCOC(=O)c1ccc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402155 98070 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 491 5 1 7 3.5 CCOC(=O)c1ccc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
54579996 69599 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784209 69599 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 430 5 1 5 4.4 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccc(C(C)C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
68600085 133431 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 694 12 3 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC(F)(F)F)c3ccccc3n2)CC1 nan
CHEMBL3652604 133431 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 694 12 3 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC(F)(F)F)c3ccccc3n2)CC1 nan
15983052 98862 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3C)C2)nc1C 10.1021/jm400820m
CHEMBL2419482 98862 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 456 7 1 8 1.8 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)Cc3ccccc3C)C2)nc1C 10.1021/jm400820m
68910943 98876 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
CHEMBL2419497 98876 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 468 6 1 9 2.1 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1021/jm400820m
11699570 98080 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402249 98080 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
68842714 98099 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 460 7 2 6 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2CCC(=O)O)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402268 98099 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 460 7 2 6 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2CCC(=O)O)c(Cl)c1 10.1016/j.ejmech.2013.04.007
54579995 69585 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C#N)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784195 69585 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 472 4 1 7 3.4 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3ccc(C#N)cc3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
11497605 98078 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402247 98078 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
10294407 171887 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 400 5 1 6 1.3 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227347 171887 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 400 5 1 6 1.3 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
69224054 98872 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419493 98872 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 484 7 1 8 2.6 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(C)cc3)CC2)nc1C 10.1021/jm400820m
66576220 120697 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 120697 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
73603967 120721 5 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 567 8 1 8 3.5 CCCC(=O)c1cnn(C2CCN(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
CHEMBL3325894 120721 5 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 567 8 1 8 3.5 CCCC(=O)c1cnn(C2CCN(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)CC2)c1C 10.1021/jm500588w
118711973 120845 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326906 120845 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 9 2 6 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CCC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711179 120678 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 1 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325787 120678 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 552 8 1 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711094 120632 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CN(C)CC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325656 120632 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CN(C)CC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711100 120639 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325663 120639 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 8 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
70922234 120641 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325665 120641 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCNC(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711193 120699 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 532 6 1 7 4.0 CC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325807 120699 0 None - 0 Rat 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 532 6 1 7 4.0 CC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
66576610 120683 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325792 120683 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 594 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C(F)(F)F)cc34)cc2)c1C 10.1021/jm500588w
44555026 118719 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 468 8 1 7 3.1 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
CHEMBL3288134 118719 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 468 8 1 7 3.1 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.bmcl.2014.04.001
68600647 133435 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 762 14 2 10 3.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OCC2CCCC2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652608 133435 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 762 14 2 10 3.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OCC2CCCC2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
118711079 120617 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325641 120617 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 2 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711082 120620 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325644 120620 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
24937181 204228 0 None - 1 Human 7.2 pIC50 = 7.2 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
CHEMBL569732 204228 0 None - 1 Human 7.2 pIC50 = 7.2 Binding
Displacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting methodDisplacement of tritium-labeled 2MeSADP from human P2Y12 expressed in CHO cells measured after 2 hrs by scintillation counting method
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.ejmech.2021.113924
118711088 120626 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325650 120626 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
12001479 120411 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 535 9 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3cn[nH]c3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322633 120411 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 535 9 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3cn[nH]c3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
127038949 143927 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.5 CNc1nc(SC)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(NC)nc(SC)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
46241636 143927 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.5 CNc1nc(SC)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(NC)nc(SC)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746852 143927 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.5 CNc1nc(SC)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(NC)nc(SC)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747878 143927 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 1020 18 10 26 2.5 CNc1nc(SC)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(NC)nc(SC)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
11620159 98877 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
CHEMBL2419498 98877 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assayAntagonist activity at human P2Y12 receptor assessed as inhibition of fibrinogen-induced platelet aggregation by washed platelet assay
ChEMBL 491 6 1 8 3.3 CCOC(=O)c1cnc(N2CCC(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1021/jm400820m
118711248 120724 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 604 9 2 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(=O)O)c2)c1C 10.1021/jm500588w
CHEMBL3325897 120724 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 604 9 2 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(=O)O)c2)c1C 10.1021/jm500588w
24752419 69609 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784219 69609 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 475 5 1 6 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(C)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
118711100 120639 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325663 120639 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCCC5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711183 120685 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 551 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C#N)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325794 120685 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 551 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(C#N)cc34)cc2)c1C 10.1021/jm500588w
118710242 120422 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 9 3 9 0.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322644 120422 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 553 9 3 9 0.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24752422 69582 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784192 69582 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 477 5 1 7 3.5 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)Nc3cccc(OC)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
44296487 108811 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 284 1 1 6 1.7 COc1cccc2c1N1C(O)=CS(=O)(=O)N=C1S2 10.1016/s0960-894x(01)00313-4
CHEMBL301805 108811 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 284 1 1 6 1.7 COc1cccc2c1N1C(O)=CS(=O)(=O)N=C1S2 10.1016/s0960-894x(01)00313-4
24751576 69623 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 470 5 1 5 4.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784232 69623 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 470 5 1 5 4.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(Cl)c(Cl)c3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
11519648 98075 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402244 98075 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 551 5 1 9 3.1 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
15983301 98090 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402259 98090 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 457 7 2 8 1.5 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)Cc3ccccc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
145969559 171933 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 529 7 2 6 3.4 CCOC(=O)N1CCN(C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228020 171933 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 529 7 2 6 3.4 CCOC(=O)N1CCN(C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
68599474 133445 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 732 14 3 11 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652618 133445 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 732 14 3 11 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
66576220 120697 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325805 120697 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 629 8 1 8 4.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN5CCN(C)C(=O)C5C4)c4ccc(Cl)cc34)cc2)c1C 10.1021/jm500588w
127047545 146354 2 None - 0 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1016/j.bmcl.2016.04.030
CHEMBL3797316 146354 2 None - 0 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysisAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation measured for 5 mins by light transmission analysis
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1016/j.bmcl.2016.04.030
127047545 146354 2 None - 0 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at human P2Y12Antagonist activity at human P2Y12
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1021/acs.jmedchem.5b01972
CHEMBL3797316 146354 2 None - 0 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at human P2Y12Antagonist activity at human P2Y12
ChEMBL 558 10 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(C)(C)C(=O)O)c3ccc(C)cc3n2)CC1 10.1021/acs.jmedchem.5b01972
118711969 120841 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 480 10 3 7 4.6 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
CHEMBL3326902 120841 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 480 10 3 7 4.6 CCOC(=O)c1c(C)nn(-c2ccc(NC(=O)Nc3ccccc3OCCCC(=O)O)cc2)c1C 10.1021/jm500588w
CHEMBL53599 201519 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12Ability to displace [3H]2-MeS-ADP from human Purinergic receptor P2Y12
ChEMBL 568 7 2 12 2.7 COc1ccc2c(c1)SC1=NS(=O)(=O)C(C(=O)CS(=O)(=O)Nc3nc4ccc(OC)cc4s3)=C(O)N12 10.1016/s0960-894x(01)00313-4
118711070 120608 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 526 9 3 7 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N[C@H]4CCNC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325632 120608 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 526 9 3 7 4.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N[C@H]4CCNC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711078 120616 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C4CCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325640 120616 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C4CCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711082 120620 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325644 120620 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 540 8 2 7 4.6 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711099 120638 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 9 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325662 120638 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 566 9 1 7 5.0 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C5CC5)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711173 120671 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)N(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325780 120671 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 568 8 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC(C)N(C)C(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711067 120607 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325629 120607 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 499 8 1 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)C)c4cc(C)c(C)cc34)cc2)c1C 10.1021/jm500588w
11699570 98080 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402249 98080 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 545 5 1 8 3.0 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)CC2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
90644281 118715 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 486 9 1 7 3.3 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CF 10.1016/j.bmcl.2014.04.001
CHEMBL3288130 118715 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysisAntagonist activity P2Y12 receptor in human blood assessed as inhibition of ADP-induced platelet aggregation measured as residual platelet count after 5 mins by flow cytometric analysis
ChEMBL 486 9 1 7 3.3 CCCC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1CF 10.1016/j.bmcl.2014.04.001
118711194 120700 0 None - 0 Rat 5.1 pIC50 = 5.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 614 8 1 7 5.3 Cc1c(C(=O)CCC(F)(F)F)cnn1-c1ccc(NC(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)cc1 10.1021/jm500588w
CHEMBL3325808 120700 0 None - 0 Rat 5.1 pIC50 = 5.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 614 8 1 7 5.3 Cc1c(C(=O)CCC(F)(F)F)cnn1-c1ccc(NC(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)cc1 10.1021/jm500588w
118711101 120640 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C(C)C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325664 120640 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 568 9 1 7 5.2 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C(C)C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
24752711 69608 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
CHEMBL1784218 69608 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 479 5 1 6 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NCc3cccc(F)c3)CC2)nc1C(F)(F)F 10.1016/j.bmcl.2011.03.088
68598525 133434 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 679 12 3 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(N)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
CHEMBL3652607 133434 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 679 12 3 9 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(N)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3ccc(C)cc3n2)CC1 nan
118711064 120603 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325625 120603 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 2 6 5.1 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3c(C)n(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711080 120618 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 582 10 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325642 120618 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 582 10 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
22184814 171751 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 6 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4225388 171751 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 414 6 1 6 1.7 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
71607666 110988 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 460 7 3 9 2.8 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C=C[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
CHEMBL3098246 110988 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assayAntagonist activity at P2Y12 receptor in rat platelet-rich plasma assessed as inhibition of ADP-induced platelet aggregation incubated for 5 mins prior to ADP-challenge by light transmission-based assay
ChEMBL 460 7 3 9 2.8 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C=C[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2013.11.055
68913141 98089 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402258 98089 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
118711178 120677 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 538 8 2 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325786 120677 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 538 8 2 7 4.3 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4C[C@@H]5C[C@H]4CN5)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
145967492 171958 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 472 8 2 7 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4228420 171958 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 472 8 2 7 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
145986356 172016 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 419 4 1 4 2.5 CCOC(=O)N1CCN(C(=O)CNC(=O)C=C2c3ccccc3-c3ccccc32)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4229219 172016 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 419 4 1 4 2.5 CCOC(=O)N1CCN(C(=O)CNC(=O)C=C2c3ccccc3-c3ccccc32)CC1 10.1016/j.bmcl.2018.03.090
145970199 171868 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 490 7 1 6 2.9 CCOC(=O)N1CCN(C(=O)[C@H](Cc2ccccc2)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
CHEMBL4227070 171868 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 490 7 1 6 2.9 CCOC(=O)N1CCN(C(=O)[C@H](Cc2ccccc2)NC(=O)c2cc(OC)c3ccccc3n2)CC1 10.1016/j.bmcl.2018.03.090
118711085 120623 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325647 120623 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(N(C)C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
11684524 98083 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402252 98083 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 486 5 1 7 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccccc3Cl)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
15982392 98094 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 485 7 2 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402263 98094 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 485 7 2 8 2.2 CCOC(=O)c1cc(C#N)c(N2CCC(NC(=O)NS(=O)(=O)Cc3ccccc3)CC2)nc1C 10.1016/j.ejmech.2013.04.007
118711076 120614 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 542 11 2 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC(C)CN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325638 120614 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 542 11 2 7 4.7 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NC(C)CN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54586076 69328 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782536 69328 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
69224603 98861 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 448 7 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CC3CCCCC3)C2)nc1C 10.1021/jm400820m
CHEMBL2419481 98861 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) expressed in CHO cell membrane after 1 hr by scintillation counting analysis
ChEMBL 448 7 1 8 1.9 CCOC(=O)c1cc(C#N)c(N2CC(C(=O)NS(=O)(=O)CC3CCCCC3)C2)nc1C 10.1021/jm400820m
118711092 120630 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCN(C)C5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325654 120630 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 566 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CC5CCN(C)C5C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
54586076 69328 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1782536 69328 2 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 388 4 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
22184796 171951 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 418 5 1 5 2.6 COc1cc(C(=O)NCC(=O)N2CCN(c3cccc(C)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
CHEMBL4228342 171951 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 418 5 1 5 2.6 COc1cc(C(=O)NCC(=O)N2CCN(c3cccc(C)c3)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
23649325 7329 56 None - 1 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 7329 56 None - 1 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 7329 56 None - 1 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysisAntagonist activity P2Y12 receptor in human washed platelets assessed as inhibition of ADP-induced platelet aggregation after 5 to 90 mins by spectrophotometric analysis
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
68598844 133437 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 684 11 3 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3cc(F)c(C)cc3n2)CC1 nan
CHEMBL3652610 133437 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.Binding Assay: The ability of a test compound to bind to the P2Y12 receptor was evaluated in a recombinant cell membrane binding assay. In this competitive binding assay, the test compound competed against a radiolabeled agonist for binding to the P2Y12 receptor, expressed on the cell membrane. Inhibition of binding of the labeled material was measured and correlated to the amount and potency of the test compound. This binding assay is a modification of the procedure described by Takasaki, J. et. al, Mol. Pharmacol., 2001, Vol. 60, pg. 432.
ChEMBL 684 11 3 9 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)c3cc(F)c(C)cc3n2)CC1 nan
23649325 7329 56 None - 1 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
7360 7329 56 None - 1 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
CHEMBL2419490 7329 56 None - 1 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 minsDisplacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 60 mins
ChEMBL 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 10.1016/j.bmcl.2014.04.001
118710247 120432 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322654 120432 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 581 13 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc([C@H]3C[C@H]3COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
68911289 98086 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402255 98086 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL5206028 98086 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 483 6 2 9 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)s3)C2)nc1C 10.1016/j.ejmech.2013.04.007
11526078 98082 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402251 98082 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 492 5 1 8 2.8 CCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711080 120618 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 582 10 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325642 120618 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 582 10 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CC4CCCN(C)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711095 120633 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325657 120633 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 554 9 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(CC)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711096 120634 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 582 11 1 7 5.6 CCCCN1CCN(C(=O)Cn2cc(C(=O)Nc3ccc(-n4ncc(C(=O)CCC)c4C)cc3)c3cc(C)ccc32)CC1 10.1021/jm500588w
CHEMBL3325658 120634 0 None - 0 Rat 6.1 pIC50 = 6.1 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 582 11 1 7 5.6 CCCCN1CCN(C(=O)Cn2cc(C(=O)Nc3ccc(-n4ncc(C(=O)CCC)c4C)cc3)c3cc(C)ccc32)CC1 10.1021/jm500588w
69224988 98871 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
CHEMBL2419492 98871 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assayAntagonist activity at P2Y12 receptor in human whole blood assessed as inhibition of ADP-induced platelet aggregation after 5 mins by residual platelet count assay
ChEMBL 500 8 1 9 2.3 CCOC(=O)c1cc(C#N)c(N2CCC(C(=O)NS(=O)(=O)Cc3ccc(OC)cc3)CC2)nc1C 10.1021/jm400820m
22185105 171916 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 427 4 2 5 1.6 COc1cc(C(=O)NCC(=O)N2CCN(C(=O)NC(C)(C)C)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
CHEMBL4227774 171916 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting methodDisplacement of [3H]2MeSADP from P2Y12 receptor in human platelets after 60 mins by TopCount scintillation counting method
ChEMBL 427 4 2 5 1.6 COc1cc(C(=O)NCC(=O)N2CCN(C(=O)NC(C)(C)C)CC2)nc2ccccc12 10.1016/j.bmcl.2018.03.090
118711072 120610 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325634 120610 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)NCCN(C)C)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
24751574 69327 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.ejmech.2013.04.007
CHEMBL1782535 69327 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.ejmech.2013.04.007
24751574 69327 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782535 69327 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 379 4 1 6 2.5 CCOC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(C#N)c1 10.1016/j.bmcl.2011.03.088
118711066 120606 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325628 120606 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 472 8 1 7 4.9 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)OC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711250 120726 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 602 7 0 8 4.6 CCCC(=O)c1cnn(-c2ccc3c(c2)OCCN3C(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)c1C 10.1021/jm500588w
CHEMBL3325899 120726 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 602 7 0 8 4.6 CCCC(=O)c1cnn(-c2ccc3c(c2)OCCN3C(=O)c2cn(CC(=O)N3CCN(C)CC3)c3ccc(Cl)cc23)c1C 10.1021/jm500588w
127040997 143922 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 968 14 10 24 1.4 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
46240803 143922 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 968 14 10 24 1.4 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3746502 143922 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 968 14 10 24 1.4 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
CHEMBL3747873 143922 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Antagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysisAntagonist activity at human platelet P2Y12 receptor assessed as inhibition of ADP-mediated decrease in intra-platelet phosphorylated VASP by FLUO-4 staining based flow cytometric analysis
ChEMBL 968 14 10 24 1.4 Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(S)OP(=O)(O)C(Cl)P(=O)(O)OP(=O)(S)OC[C@H]2O[C@@H](n3cnc4c(N)nc(Cl)nc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O 10.1016/j.ejmech.2015.10.055
71740705 98069 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 526 6 1 8 2.9 CCCS(=O)(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402154 98069 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 526 6 1 8 2.9 CCCS(=O)(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
68913141 98089 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
CHEMBL2402258 98089 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Antagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregationAntagonist activity at P2Y12 receptor in human washed platelets assessed as inhibition of fibrinogen-induced aggregation
ChEMBL 477 6 2 8 2.0 CCOC(=O)c1cc(C#N)c(N2CC(NC(=O)NS(=O)(=O)c3ccc(Cl)cc3)C2)nc1C 10.1016/j.ejmech.2013.04.007
118711071 120609 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCNC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325633 120609 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 528 11 2 7 4.4 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N(C)CCNC)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
118711084 120622 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 9 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325646 120622 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 540 9 2 7 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCC(NC)C4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
68911088 98056 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
CHEMBL2402142 98056 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 623 8 2 10 3.3 CCOC(=O)c1cc(C#N)c(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)C(CCC(=O)O)C2)nc1C(F)(F)F 10.1016/j.ejmech.2013.04.007
11706300 98063 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 520 7 1 8 3.6 CCCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402149 98063 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 520 7 1 8 3.6 CCCCOC(=O)c1cnc(N2CCN(C(=O)NS(=O)(=O)c3ccc(Cl)s3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
118711081 120619 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325643 120619 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 554 8 1 7 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCCN(C)CC4)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67459556 120389 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 526 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322612 120389 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 526 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24751996 69624 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784233 69624 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.5 CCOC(=O)c1cnc(N2CCN(C(=O)N[C@@H](C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711248 120724 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 9 2 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(=O)O)c2)c1C 10.1021/jm500588w
CHEMBL3325897 120724 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 604 9 2 8 4.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4ccc(Cl)cc34)c(C(=O)O)c2)c1C 10.1021/jm500588w
54580994 69574 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 0 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)N(C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784184 69574 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 402 4 0 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)N(C)c3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
12000684 120416 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 556 12 3 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
CHEMBL3322638 120416 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 556 12 3 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(C)COC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2014.06.070
24751710 69621 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1784230 69621 2 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 416 5 1 5 3.3 CCOC(=O)c1cnc(N2CCN(C(=O)NCc3ccc(C)cc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
66575818 120846 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3326907 120846 0 None - 0 Rat 5.0 pIC50 = 5.0 Binding
Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationAntagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregation
ChEMBL 458 8 2 6 4.8 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)O)c4ccc(C)cc34)cc2)c1C 10.1021/jm500588w
67463976 120386 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 525 11 2 7 2.8 CCCCc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)n1 10.1016/j.bmcl.2014.06.070
CHEMBL3322599 120386 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting methodDisplacement of [3H]-2-methyl-thio-adenosine 5'-diphosphate from human recombinant P2Y12 expressed in CHO cell membranes by scintillation counting method
ChEMBL 525 11 2 7 2.8 CCCCc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)n1 10.1016/j.bmcl.2014.06.070
54585098 69332 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 374 3 1 5 2.9 COC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
CHEMBL1782541 69332 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation countingDisplacement of [125I]-AZ11931285 from human recombinant P2Y12 receptor expressed in platelet cell membrane after 1 hr by scintillation counting
ChEMBL 374 3 1 5 2.9 COC(=O)c1cnc(N2CCN(C(=O)Nc3ccccc3)CC2)c(Cl)c1 10.1016/j.bmcl.2011.03.088
118711186 120688 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 594 8 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
CHEMBL3325797 120688 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysisDisplacement of [33P]2MeS-ADP from P2Y12 receptor (unknown origin) transfected in CHO cells after 30 mins by scintillation counting analysis
ChEMBL 594 8 1 7 5.5 CCCC(=O)c1cnn(-c2ccc(NC(=O)c3cn(CC(=O)N4CCN(C)CC4)c4cc(Cl)c(Cl)cc34)cc2)c1C 10.1021/jm500588w
71740353 98101 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 416 4 1 6 2.6 CCOC(=O)c1cnc(N2CCN(C(=O)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
CHEMBL2402270 98101 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysisDisplacement of [125I]-AZ11931285 from P2Y12 receptor (unknown origin) after 1 hr by scintillation counting analysis
ChEMBL 416 4 1 6 2.6 CCOC(=O)c1cnc(N2CCN(C(=O)NC(=O)c3ccccc3)CC2)c(Cl)c1 10.1016/j.ejmech.2013.04.007
1756 7251 10 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nMBinding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nM
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2005.08.104
5310954 7251 10 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nMBinding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nM
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2005.08.104
CHEMBL336292 7251 10 None - 1 Human 8.3 pKd = 8.3 Binding
Binding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nMBinding affinity to P2Y12 receptor expressed in human platelets from 0.047 to 50 nM
ChEMBL 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 10.1016/j.bmcl.2005.08.104
168296904 199769 0 None - 1 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constantDisplacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constant
ChEMBL 501 9 6 13 -0.2 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2022.128837
CHEMBL5199350 199769 0 None - 1 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constantDisplacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constant
ChEMBL 501 9 6 13 -0.2 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2022.128837
CHEMBL5222620 199769 0 None - 1 Human 8.2 pKd = 8.2 Binding
Displacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constantDisplacement of [3H]PSB-0413 from P2Y12 in human platelets assessed as dissociation constant
ChEMBL 501 9 6 13 -0.2 CCCSc1nc(N)c2ncn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2022.128837
20690446 101194 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 470 8 4 10 2.1 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](C(=O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL251041 101194 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 470 8 4 10 2.1 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](C(=O)O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
58334279 197443 0 None - 1 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-2MesADP from human P2Y12 in HEK cell membrane assessed as inhibition constant incubated for 1 hr by scintillation counter methodDisplacement of [3H]-2MesADP from human P2Y12 in HEK cell membrane assessed as inhibition constant incubated for 1 hr by scintillation counter method
ChEMBL 430 6 0 8 3.6 CCCc1cc2c(N3CCn4c(nnc4C(F)(F)F)C3)nc(OCCF)nc2s1 10.1016/j.bmcl.2022.128837
CHEMBL5181634 197443 0 None - 1 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-2MesADP from human P2Y12 in HEK cell membrane assessed as inhibition constant incubated for 1 hr by scintillation counter methodDisplacement of [3H]-2MesADP from human P2Y12 in HEK cell membrane assessed as inhibition constant incubated for 1 hr by scintillation counter method
ChEMBL 430 6 0 8 3.6 CCCc1cc2c(N3CCn4c(nnc4C(F)(F)F)C3)nc(OCCF)nc2s1 10.1016/j.bmcl.2022.128837
45485957 204336 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570295 204336 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485932 203937 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567915 203937 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485963 203871 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567561 203871 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232890 207710 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601696 207710 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485958 203902 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567740 203902 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485931 203644 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565974 203644 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44443939 100981 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 576 10 4 11 2.6 OCCO[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccc(F)c(F)c4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL249790 100981 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 576 10 4 11 2.6 OCCO[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccc(F)c(F)c4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
46232949 207680 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 13 3 8 2.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(N)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601489 207680 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 13 3 8 2.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(N)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485966 203622 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 15 3 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565836 203622 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 15 3 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485957 204336 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL570295 204336 0 None - 1 Human 9.2 pKi = 9.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 3 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485898 203955 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568059 203955 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485962 203808 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567133 203808 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485943 203896 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCO)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567709 203896 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCO)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485959 203988 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 14 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568211 203988 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 14 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232887 207709 0 None - 1 Human 9.1 pKi = 9.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601695 207709 0 None - 1 Human 9.1 pKi = 9.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
44129060 89100 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 15 3 10 2.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172149 89100 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 15 3 10 2.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45485961 203784 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 13 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566913 203784 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 677 13 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485965 203551 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565409 203551 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 14 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)NC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485968 204526 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571599 204526 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232894 207712 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601698 207712 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485952 204332 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570275 204332 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485886 204261 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569914 204261 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141136 204139 0 None - 1 Human 9.0 pKi = 9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 15 2 7 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL569097 204139 0 None - 1 Human 9.0 pKi = 9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 15 2 7 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142217 207706 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL601692 207706 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142217 207706 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601692 207706 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232896 207743 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 14 2 8 3.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601903 207743 0 None - 1 Human 9.0 pKi = 9.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 14 2 8 3.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485889 203767 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 14 2 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OCC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566745 203767 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 14 2 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OCC)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485922 203847 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567416 203847 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485884 203997 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568250 203997 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485849 204208 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569679 204208 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485850 204210 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569680 204210 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 585 15 2 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485904 204298 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570128 204298 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232899 207745 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601905 207745 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485917 204277 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 12 2 10 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569995 204277 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 12 2 10 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485955 204334 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 12 2 9 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570289 204334 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 12 2 9 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139405 206153 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 14 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590950 206153 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 14 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139408 207557 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 695 15 2 9 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600575 207557 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 695 15 2 9 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485938 204305 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 12 2 9 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570155 204305 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 12 2 9 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233241 205320 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 683 15 2 10 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578094 205320 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 683 15 2 10 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233234 206265 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 721 14 4 9 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591712 206265 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 721 14 4 9 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232943 207676 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601485 207676 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485915 204302 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570152 204302 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139236 204346 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570387 204346 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44129137 89081 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 733 15 3 12 1.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172129 89081 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 733 15 3 12 1.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46233325 205368 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578522 205368 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141983 205951 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589519 205951 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140552 206412 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)CC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592850 206412 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)CC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141342 207673 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL601478 207673 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141983 205951 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589519 205951 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232879 205983 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 15 3 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589804 205983 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 15 3 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45141342 207673 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601478 207673 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
20690429 103813 1 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 469 8 4 10 1.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](C(N)=O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL266922 103813 1 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 469 8 4 10 1.5 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](C(N)=O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
45485969 203546 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 705 14 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565363 203546 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 705 14 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485914 204294 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 649 12 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570064 204294 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 649 12 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140751 206135 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 12 2 8 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590749 206135 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 12 2 8 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233243 206341 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 722 14 3 10 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592410 206341 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 722 14 3 10 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140554 206343 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 11 2 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592441 206343 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 11 2 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232911 206020 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590008 206020 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232950 206041 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(=O)NC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590146 206041 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(=O)NC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232942 206056 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590260 206056 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 13 2 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232940 207674 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 15 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601483 207674 0 None - 1 Human 8.8 pKi = 8.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 15 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45140553 206418 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C3CCOC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592883 206418 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C3CCOC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233242 205364 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 682 15 3 10 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578507 205364 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 682 15 3 10 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142216 205924 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 650 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589335 205924 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 650 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142216 205924 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589335 205924 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
1765 10589 98 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
4184 10589 98 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
9871419 10589 98 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
CHEMBL398435 10589 98 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
DB08816 10589 98 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1016/j.bmcl.2007.07.057
44443935 160654 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 442 7 4 10 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL398295 160654 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 442 7 4 10 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](O)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
45485944 203576 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCO)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565573 203576 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 15 3 10 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCO)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
11950687 203732 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 558 8 3 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566438 203732 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 558 8 3 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45272861 202260 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552971 202260 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270323 202026 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL551020 202026 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141135 205318 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 13 2 8 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578076 205318 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 13 2 8 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139404 206376 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 12 2 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592650 206376 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 12 2 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139592 207197 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 12 3 7 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598161 207197 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 12 3 7 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142222 207532 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 705 13 2 8 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600370 207532 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 705 13 2 8 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141980 207910 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 678 13 2 9 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603145 207910 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 678 13 2 9 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232921 206050 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 691 12 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590254 206050 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 691 12 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232930 207641 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CN4CCCC4=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601274 207641 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CN4CCCC4=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485950 204328 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570263 204328 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
21130371 21659 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 408 3 3 6 3.3 Cc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
CHEMBL1207842 21659 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 408 3 3 6 3.3 Cc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
CHEMBL445413 21659 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 408 3 3 6 3.3 Cc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
106250 21688 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
106250 21688 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208092 21688 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1208092 21688 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496030 21688 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL496030 21688 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
25125169 21689 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 487 5 4 9 3.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208096 21689 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 487 5 4 9 3.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496229 21689 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 487 5 4 9 3.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
25123834 21717 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208284 21717 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL522725 21717 0 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 410 3 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
3018777 67024 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 424 4 3 7 3.0 COc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
CHEMBL1671995 67024 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 424 4 3 7 3.0 COc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
CHEMBL1741070 67024 6 None - 1 Human 5.0 pKi = 5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 424 4 3 7 3.0 COc1cccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1021/jm1012193
44129368 89136 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172270 89136 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44129451 89091 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 609 10 2 9 0.9 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172139 89091 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 609 10 2 9 0.9 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45485887 203705 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCOCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566309 203705 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCOCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485897 203918 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567840 203918 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485930 203973 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNCC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568128 203973 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNCC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485928 204222 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569722 204222 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CNC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
24937181 204228 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569732 204228 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 596 12 3 9 2.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485856 204253 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCCN3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569889 204253 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCCN3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45271154 202449 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556522 202449 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45269438 202780 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560009 202780 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271154 202449 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL556522 202449 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45269438 202780 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL560009 202780 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 11 2 6 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233330 205264 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 15 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577630 205264 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 15 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142218 205975 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 16 3 8 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589719 205975 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 16 3 8 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139770 205977 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 14 3 7 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589737 205977 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 14 3 7 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140934 206291 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 12 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591991 206291 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 12 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233240 206340 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592409 206340 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139585 206360 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 610 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592535 206360 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 610 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139767 206416 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCCN3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592881 206416 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCCN3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139951 206994 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 526 11 3 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596750 206994 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 526 11 3 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140164 207916 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)C3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603151 207916 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)C3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232882 206013 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590001 206013 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232927 207639 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601272 207639 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(N4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
66855175 89090 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 623 10 2 9 1.3 CCOC(=O)N1CCN(C(=O)[C@H](C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172138 89090 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 623 10 2 9 1.3 CCOC(=O)N1CCN(C(=O)[C@H](C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45140745 207411 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 551 9 2 7 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599422 207411 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 551 9 2 7 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
24829943 202693 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559259 202693 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24829943 202693 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL559259 202693 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 4 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45267707 202748 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559689 202748 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233356 207329 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 8 2 7 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598999 207329 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 8 2 7 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485848 204166 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 571 14 2 9 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569319 204166 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 571 14 2 9 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485863 204244 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569815 204244 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485912 204293 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570060 204293 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485946 204554 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571812 204554 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45267751 201667 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540672 201667 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267751 201667 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL540672 201667 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141347 205321 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 691 12 2 8 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578102 205321 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 691 12 2 8 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139407 205907 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 695 16 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589216 205907 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 695 16 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140754 206150 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 17 3 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCNCC(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590874 206150 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 17 3 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCNCC(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141343 207228 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 14 3 7 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598387 207228 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 14 3 7 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232920 207666 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 693 14 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601447 207666 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 693 14 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232884 207707 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 15 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601693 207707 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 15 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232895 207713 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601699 207713 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45142448 208461 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 526 11 2 7 2.8 CCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL606209 208461 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 526 11 2 7 2.8 CCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
11950159 203894 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 515 8 2 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567702 203894 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 515 8 2 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
16120270 21716 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2cc(Cl)ccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208282 21716 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2cc(Cl)ccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL522053 21716 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2cc(Cl)ccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45485864 203765 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566720 203765 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
3711684 21719 8 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208290 21719 8 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL524284 21719 8 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 472 4 4 7 3.4 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45139955 207911 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 13 3 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603146 207911 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 13 3 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232904 205965 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 638 14 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCO)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589597 205965 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 638 14 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCO)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232933 206054 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590258 206054 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45487796 203734 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 418 3 0 6 4.7 CCc1cc2c(N3CCN(C(=O)Oc4cccc5ccccc45)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566447 203734 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 418 3 0 6 4.7 CCc1cc2c(N3CCN(C(=O)Oc4cccc5ccccc45)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
66854575 89096 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 713 13 3 9 1.9 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)c2ccccc2)CC1 10.1021/jm300771j
CHEMBL2172145 89096 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 713 13 3 9 1.9 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)c2ccccc2)CC1 10.1021/jm300771j
46233389 207229 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 485 8 2 4 4.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cccc(-c4ccccc4)c3)CC2)c1 10.1021/jm901518t
CHEMBL598388 207229 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 485 8 2 4 4.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cccc(-c4ccccc4)c3)CC2)c1 10.1021/jm901518t
46233222 207083 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597380 207083 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44126037 7895 2 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 10.1021/jm300771j
5905 7895 2 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 10.1021/jm300771j
CHEMBL2172277 7895 2 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 10.1021/jm300771j
45485907 204285 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570020 204285 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45273819 201932 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL550278 201932 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45268593 203391 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 14 2 6 4.4 CCCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564150 203391 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 14 2 6 4.4 CCCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
1765 10589 98 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
4184 10589 98 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
9871419 10589 98 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
CHEMBL398435 10589 98 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
DB08816 10589 98 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1021/jm300771j
45273819 201932 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL550278 201932 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45268593 203391 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 14 2 6 4.4 CCCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL564150 203391 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 14 2 6 4.4 CCCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140361 206253 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 598 16 2 8 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591619 206253 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 598 16 2 8 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45487821 203897 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 532 8 3 7 3.0 CCc1cc2c(N3CCN(C(=O)Cc4ccc(F)c(F)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567715 203897 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 532 8 3 7 3.0 CCc1cc2c(N3CCN(C(=O)Cc4ccc(F)c(F)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45267728 202985 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL561484 202985 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233388 205955 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 561 9 2 4 5.6 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)CC2)c1 10.1021/jm901518t
CHEMBL589528 205955 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 561 9 2 4 5.6 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)CC2)c1 10.1021/jm901518t
46233630 207333 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 536 10 1 6 3.8 CCCCC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599006 207333 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 536 10 1 6 3.8 CCCCC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45273798 202467 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 11 3 8 1.8 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556723 202467 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 11 3 8 1.8 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270318 201947 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 12 2 7 3.6 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL550415 201947 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 12 2 7 3.6 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45485861 204243 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569781 204243 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44631970 201628 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539733 201628 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271162 202089 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551484 202089 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45268642 202397 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 645 15 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556142 202397 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 645 15 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44631970 201628 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL539733 201628 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45273820 201629 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL539734 201629 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141581 205986 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589817 205986 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140155 207403 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 10 2 6 2.8 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CC2)CC1 10.1021/jm901518t
CHEMBL599399 207403 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 10 2 6 2.8 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CC2)CC1 10.1021/jm901518t
24829442 208032 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 9 2 6 3.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603866 208032 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 9 2 6 3.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44631970 201628 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL539733 201628 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45273820 201629 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL539734 201629 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232902 205921 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589298 205921 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45270274 202537 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 562 9 2 5 5.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)n3)CC2)c1 10.1021/jm901518t
CHEMBL557553 202537 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 562 9 2 5 5.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)n3)CC2)c1 10.1021/jm901518t
13991590 164145 49 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 492 7 6 9 3.9 O=C(/C=C/c1ccc(O)c2oc(-c3ccc(O)c(O)c3)cc12)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O 10.1016/j.ejmech.2021.113924
CHEMBL4077922 164145 49 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 492 7 6 9 3.9 O=C(/C=C/c1ccc(O)c2oc(-c3ccc(O)c(O)c3)cc12)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O 10.1016/j.ejmech.2021.113924
45269482 201571 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 10 3 8 2.5 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538644 201571 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 10 3 8 2.5 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267738 203134 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562485 203134 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267738 203134 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL562485 203134 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 528 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485858 204101 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 13 3 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568824 204101 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 610 13 3 9 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232923 206023 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@@H](O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590039 206023 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@@H](O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232916 207777 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602110 207777 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45487809 203731 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 559 8 3 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cn4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566437 203731 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 559 8 3 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cn4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45271977 201801 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 396 6 1 6 1.5 CCC(=O)ON1CCN(C(=O)CNC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549307 201801 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 396 6 1 6 1.5 CCC(=O)ON1CCN(C(=O)CNC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233386 207370 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 396 5 1 5 1.8 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599202 207370 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 396 5 1 5 1.8 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45487841 203582 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 487 7 2 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL565618 203582 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 487 7 2 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCO)nc2s1 10.1016/j.bmcl.2009.08.059
45485882 204259 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 13 2 8 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC3CCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569912 204259 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 13 2 8 4.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC3CCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141770 206128 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590742 206128 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232931 206028 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(C(N)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590087 206028 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(C(N)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
25863 67036 56 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)c(Nc3nc(Cl)nc(Cl)n3)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1672104 67036 56 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)c(Nc3nc(Cl)nc(Cl)n3)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1741102 67036 56 None - 1 Human 4.8 pKi = 4.8 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)c(Nc3nc(Cl)nc(Cl)n3)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
11950328 204057 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 488 7 3 7 2.5 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568567 204057 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 488 7 3 7 2.5 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
66856100 89087 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 651 12 2 9 2.1 CCC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC)CC1 10.1021/jm300771j
CHEMBL2172135 89087 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 651 12 2 9 2.1 CCC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC)CC1 10.1021/jm300771j
71455298 89116 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 598 11 2 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCCC3=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172166 89116 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 598 11 2 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCCC3=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
11950328 204057 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 488 7 3 7 2.5 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568567 204057 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 488 7 3 7 2.5 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45272880 202262 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552973 202262 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45272036 202365 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL555342 202365 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271155 202419 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556330 202419 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45272880 202262 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL552973 202262 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 11 2 8 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272036 202365 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL555342 202365 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 2 8 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45271155 202419 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL556330 202419 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140162 206252 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 3 8 2.9 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591593 206252 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 3 8 2.9 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139945 206989 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 550 10 2 6 3.3 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCCC(F)(F)F)CC1 10.1021/jm901518t
CHEMBL596732 206989 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 550 10 2 6 3.3 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCCC(F)(F)F)CC1 10.1021/jm901518t
45139953 207801 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL602294 207801 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232922 206051 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@H](O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590255 206051 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC[C@H](O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
66854919 89082 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 652 12 3 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCN)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172130 89082 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 652 12 3 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCN)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487838 204088 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 608 5 0 7 5.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCN(C(=O)C(F)(F)F)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568772 204088 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 608 5 0 7 5.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCN(C(=O)C(F)(F)F)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
66854714 89089 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 651 11 2 9 2.0 CCOC(=O)N1CCN(C(=O)[C@@H](NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C(C)C)CC1 10.1021/jm300771j
CHEMBL2172137 89089 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 651 11 2 9 2.0 CCOC(=O)N1CCN(C(=O)[C@@H](NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C(C)C)CC1 10.1021/jm300771j
45485854 204255 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCN(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569908 204255 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCCN(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
25123180 21606 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 485 5 4 7 4.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1207384 21606 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 485 5 4 7 4.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL401859 21606 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 485 5 4 7 4.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
46233668 207024 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 8 1 6 4.0 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)c2ccccc2)CC1 10.1021/jm901518t
CHEMBL596962 207024 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 8 1 6 4.0 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)c2ccccc2)CC1 10.1021/jm901518t
45272035 201868 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 12 2 8 2.4 COCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL549727 201868 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 12 2 8 2.4 COCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OC(C)C)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45485893 203535 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCC3CCNC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565249 203535 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCC3CCNC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485857 204256 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 13 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569909 204256 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 13 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
11670815 203979 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 517 8 3 8 3.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC[C@@H](O)CO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568148 203979 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 517 8 3 8 3.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC[C@@H](O)CO)nc2s1 10.1016/j.bmcl.2009.08.059
66856844 89107 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 14 3 10 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172156 89107 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 14 3 10 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NCC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45141776 206422 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 705 13 2 8 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592887 206422 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 705 13 2 8 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
9953334 101161 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 409 9 4 10 0.7 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](C(N)=O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL250848 101161 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 409 9 4 10 0.7 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](C(N)=O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
45271128 201707 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 11 4 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL541742 201707 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 580 11 4 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
25125168 21690 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
25125168 21690 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208098 21690 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1208098 21690 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496401 21690 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL496401 21690 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 556 5 4 10 4.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45487813 203862 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 542 10 3 9 2.6 CCc1cc2c(N3CCN(C(=O)COc4cccc(OC)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567502 203862 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 542 10 3 9 2.6 CCc1cc2c(N3CCN(C(=O)COc4cccc(OC)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
44128982 89093 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 16 4 10 2.0 CCCCOC(=O)N1CCC(NC(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C1 10.1021/jm300771j
CHEMBL2172142 89093 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 16 4 10 2.0 CCCCOC(=O)N1CCC(NC(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C1 10.1021/jm300771j
45140353 207119 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 530 9 2 6 3.2 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm901518t
CHEMBL597563 207119 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 530 9 2 6 3.2 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm901518t
87791 21697 10 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c(S(=O)(=O)O)c1 10.1021/jm9003297
CHEMBL1208117 21697 10 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c(S(=O)(=O)O)c1 10.1021/jm9003297
CHEMBL498229 21697 10 None - 1 Human 4.7 pKi = 4.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c(S(=O)(=O)O)c1 10.1021/jm9003297
45485900 204296 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570093 204296 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485949 204326 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570256 204326 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485953 204344 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570385 204344 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140551 206410 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 11 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592825 206410 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 11 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
24786234 146525 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-2-MeS-ADP from human P2Y12 assessed as inhibition constant incubated for 30 minsDisplacement of [3H]-2-MeS-ADP from human P2Y12 assessed as inhibition constant incubated for 30 mins
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1021/acs.jmedchem.5b01972
CHEMBL3798413 146525 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-2-MeS-ADP from human P2Y12 assessed as inhibition constant incubated for 30 minsDisplacement of [3H]-2-MeS-ADP from human P2Y12 assessed as inhibition constant incubated for 30 mins
ChEMBL 494 8 4 12 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](c4nnn[nH]4)[C@@H](O)[C@H]3O)c2n1 10.1021/acs.jmedchem.5b01972
46232951 206000 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(=O)NCC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589901 206000 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(C(=O)NCC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232945 207677 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 595 13 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601486 207677 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 595 13 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485936 203833 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567280 203833 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485910 204301 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 706 14 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570151 204301 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 706 14 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141579 206040 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 15 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590140 206040 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 15 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140938 206176 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 14 2 7 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591048 206176 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 14 2 7 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140748 206419 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592884 206419 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44631974 207746 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 12 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601906 207746 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 12 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485859 204239 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569764 204239 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485929 204303 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570153 204303 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 15 3 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485911 204287 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570028 204287 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 653 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233229 205214 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 707 12 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577236 205214 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 707 12 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140932 206381 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C3CCOC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592678 206381 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C3CCOC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233329 205440 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 14 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579330 205440 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 14 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141981 205959 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CO)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589554 205959 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CO)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139771 207912 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 2 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603147 207912 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 2 7 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140928 208112 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL604288 208112 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485888 203740 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 582 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566520 203740 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 582 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485956 204345 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 13 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570386 204345 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 13 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141986 205117 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL576331 205117 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141134 205294 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 2 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577844 205294 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 12 2 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139769 206367 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592577 206367 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232944 206046 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590194 206046 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
9823796 160816 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 426 7 3 9 2.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3CC[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL398434 160816 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 426 7 3 9 2.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3CC[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
45485908 204291 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570045 204291 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45142445 206130 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590744 206130 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139772 206132 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 13 2 7 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590746 206132 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 13 2 7 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142223 207555 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 15 2 9 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600573 207555 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 15 2 9 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140365 207915 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 16 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603150 207915 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 16 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232893 206016 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 12 2 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590004 206016 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 12 2 8 3.1 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232941 207675 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 15 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601484 207675 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 15 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485896 203558 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565470 203558 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 2 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485933 204304 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570154 204304 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233233 205319 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 666 13 3 8 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NC(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578080 205319 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 666 13 3 8 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NC(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141128 206086 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(NC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590418 206086 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(NC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485935 203829 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567271 203829 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 665 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485855 204252 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569884 204252 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 654 16 2 10 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN3CCOCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233327 205405 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 12 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578899 205405 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 12 2 9 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140558 206161 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 3 7 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590990 206161 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 3 7 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140165 207917 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 621 12 2 7 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603152 207917 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 621 12 2 7 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232883 205989 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589824 205989 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232900 207747 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 13 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601907 207747 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 13 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232917 207778 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 14 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602111 207778 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 14 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485918 203753 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566599 203753 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCOCC4)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485906 204273 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569988 204273 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 666 12 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
66855197 89139 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172273 89139 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45269472 203118 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL562405 203118 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141582 205353 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578335 205353 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140160 207332 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 3 7 3.3 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599005 207332 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 3 7 3.3 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
66856952 89086 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 14 3 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCCCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172134 89086 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 14 3 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCCCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487850 203775 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 554 6 1 7 4.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCCC(C(N)=O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566874 203775 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 554 6 1 7 4.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCCC(C(N)=O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
45272846 202433 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 3 8 1.6 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556446 202433 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 3 8 1.6 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
66856999 89088 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 665 12 2 9 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CC(C)C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172136 89088 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 665 12 2 9 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CC(C)C)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45272902 202494 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 468 9 2 7 1.7 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL557062 202494 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 468 9 2 7 1.7 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
24830601 207433 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 468 8 2 6 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599605 207433 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 468 8 2 6 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25128138 21704 0 None - 1 Human 7.7 pKi = 7.7 Binding
Antagonist activity at human P2Y12 assessed as inhibition constantAntagonist activity at human P2Y12 assessed as inhibition constant
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.5b01972
CHEMBL1208159 21704 0 None - 1 Human 7.7 pKi = 7.7 Binding
Antagonist activity at human P2Y12 assessed as inhibition constantAntagonist activity at human P2Y12 assessed as inhibition constant
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.5b01972
CHEMBL502519 21704 0 None - 1 Human 7.7 pKi = 7.7 Binding
Antagonist activity at human P2Y12 assessed as inhibition constantAntagonist activity at human P2Y12 assessed as inhibition constant
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/acs.jmedchem.5b01972
44610760 204089 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 583 7 2 8 3.2 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3[C@H](C(N)=O)CC[C@@H]3C(N)=O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568774 204089 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 583 7 2 8 3.2 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3[C@H](C(N)=O)CC[C@@H]3C(N)=O)nc2s1 10.1016/j.bmcl.2009.08.059
45269472 203118 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562405 203118 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 3 8 2.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
25128138 21704 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208159 21704 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL502519 21704 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 529 6 5 8 4.5 Nc1c(C(=O)O)cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
46232936 207643 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.0 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(CO)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601276 207643 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.0 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(CO)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
39073052 203760 2 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 332 4 0 5 2.9 CCc1cc2c(N3CCN(C(=O)CC(C)C)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566661 203760 2 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 332 4 0 5 2.9 CCc1cc2c(N3CCN(C(=O)CC(C)C)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
67204 21715 14 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1S(=O)(=O)O 10.1021/jm9003297
CHEMBL1208280 21715 14 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1S(=O)(=O)O 10.1021/jm9003297
CHEMBL521709 21715 14 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)ccc1S(=O)(=O)O 10.1021/jm9003297
45487790 205761 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 526 10 3 8 3.0 CCc1cc2c(N3CCN(C(=O)CCOc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585306 205761 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 526 10 3 8 3.0 CCc1cc2c(N3CCN(C(=O)CCOc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45270294 202107 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551619 202107 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44129522 89111 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 12 2 10 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172160 89111 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 12 2 10 1.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45485881 204258 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 625 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SCC(F)(F)F)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569911 204258 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 625 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SCC(F)(F)F)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485901 204299 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCNCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570149 204299 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 595 12 3 9 2.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCNCC3)n2)CC1 10.1016/j.bmcl.2009.09.017
66855285 89115 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 723 16 4 10 2.4 CCCCOC(=O)NC1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172165 89115 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 723 16 4 10 2.4 CCCCOC(=O)NC1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45141772 205904 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589198 205904 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141982 206131 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 16 2 8 4.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590745 206131 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 16 2 8 4.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140936 206200 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 17 2 7 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCN(CC)CC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591226 206200 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 17 2 7 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCN(CC)CC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232915 206004 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 12 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589930 206004 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 12 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232925 206052 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(COC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590256 206052 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(COC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45487789 203936 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 496 8 3 7 2.7 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567913 203936 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 496 8 3 7 2.7 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
16066663 84923 38 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1016/j.bmcl.2022.128837
CHEMBL2103828 84923 38 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1016/j.bmcl.2022.128837
45269461 202973 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 539 11 2 7 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561406 202973 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 539 11 2 7 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
16066663 84923 38 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1021/jm300771j
CHEMBL2103828 84923 38 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 523 5 4 8 3.1 CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F 10.1021/jm300771j
44128901 89079 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 730 14 3 11 0.2 CCOC(=O)N1CCN(C(=O)[C@H](CCNS(C)(=O)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172127 89079 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 730 14 3 11 0.2 CCOC(=O)N1CCN(C(=O)[C@H](CCNS(C)(=O)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44129058 89084 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 653 12 3 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172132 89084 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 653 12 3 10 0.7 CCOC(=O)N1CCN(C(=O)[C@H](CCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487789 203936 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 496 8 3 7 2.7 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567913 203936 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 496 8 3 7 2.7 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
66854417 89109 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 13 3 10 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC(C(=O)NC4CCC4)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172158 89109 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 13 3 10 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC(C(=O)NC4CCC4)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
6689 21686 16 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc1S(=O)(=O)O 10.1021/jm9003297
CHEMBL1208089 21686 16 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc1S(=O)(=O)O 10.1021/jm9003297
CHEMBL495834 21686 16 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 489 4 5 9 1.9 Nc1ccc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc1S(=O)(=O)O 10.1021/jm9003297
45273818 201627 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539732 201627 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
70683418 80746 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL2021587 80746 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](C(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
44583582 9978 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
5904 9978 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
59448166 9978 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
CHEMBL1207916 9978 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
CHEMBL455536 9978 3 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1021/jm9003297
45487837 205788 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 526 5 1 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(N)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585693 205788 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 526 5 1 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(N)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
11955421 205820 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 513 5 1 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585948 205820 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 513 5 1 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
66919940 89142 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 571 11 2 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C(C)(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172279 89142 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 571 11 2 9 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C(C)(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45271978 201802 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 454 7 2 6 1.6 COC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549308 201802 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 454 7 2 6 1.6 COC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271978 201802 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 454 7 2 6 1.6 COC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL549308 201802 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 454 7 2 6 1.6 COC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
167524 21439 3 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1205665 21439 3 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL131271 21439 3 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 636 6 5 12 3.5 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Cl)n3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
66919996 89144 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 555 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172280 89144 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 555 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44583582 9978 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
5904 9978 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
59448166 9978 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
CHEMBL1207916 9978 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
CHEMBL455536 9978 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 10.1016/j.bmcl.2022.128837
20299057 67032 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 423 3 4 7 2.9 Cc1c(N)cccc1Nc1cc(S(=O)(=O)O)c(N)c2c1C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
CHEMBL1672103 67032 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 423 3 4 7 2.9 Cc1c(N)cccc1Nc1cc(S(=O)(=O)O)c(N)c2c1C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
CHEMBL1741093 67032 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 423 3 4 7 2.9 Cc1c(N)cccc1Nc1cc(S(=O)(=O)O)c(N)c2c1C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
46233230 206280 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 14 2 9 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)COC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591874 206280 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 14 2 9 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)COC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232886 207708 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601694 207708 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
25114519 21718 1 None - 1 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 438 4 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208288 21718 1 None - 1 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 438 4 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL524064 21718 1 None - 1 Human 4.6 pKi = 4.6 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 438 4 4 7 2.7 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2C(=O)O)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45268619 202285 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 573 11 3 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553572 202285 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 573 11 3 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
70687668 80745 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL2021586 80745 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](C(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232932 207642 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 692 15 2 8 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601275 207642 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 692 15 2 8 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(C(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485853 204132 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569053 204132 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 626 17 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270323 202026 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551020 202026 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 566 9 3 8 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271092 203223 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563041 203223 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45487817 204056 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 499 5 1 7 4.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568566 204056 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 499 5 1 7 4.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
44129524 89140 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 2 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N(C)C3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172274 89140 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 2 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N(C)C3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45271092 203223 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL563041 203223 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 9 2 6 2.4 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45269465 203033 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 12 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561810 203033 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 12 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
66919958 89146 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 530 11 3 9 0.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(N)=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172282 89146 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 530 11 3 9 0.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(N)=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46233130 207303 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 537 9 2 6 3.2 CCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598821 207303 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 537 9 2 6 3.2 CCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45268594 202342 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 574 11 2 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL554782 202342 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 574 11 2 7 3.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCc3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233324 206417 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 574 11 2 7 3.6 CCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCc3ccccc3)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL592882 206417 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 574 11 2 7 3.6 CCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCc3ccccc3)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
45139949 207225 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 9 2 6 2.8 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC2CCC2)CC1 10.1021/jm901518t
CHEMBL598376 207225 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 9 2 6 2.8 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC2CCC2)CC1 10.1021/jm901518t
45139765 207301 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 8 2 6 2.4 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598816 207301 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 482 8 2 6 2.4 CC(C)OC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44128387 89130 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 627 12 3 10 -0.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(N)=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172264 89130 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 627 12 3 10 -0.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(N)=O)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46233096 208396 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 523 8 2 6 2.8 CCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL605847 208396 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 523 8 2 6 2.8 CCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485903 204297 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(C)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570108 204297 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(C)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45271984 201867 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549724 201867 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
10202847 205803 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 428 4 0 5 4.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585852 205803 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 428 4 0 5 4.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
45271984 201867 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL549724 201867 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 496 10 2 6 2.8 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232903 206018 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590006 206018 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45487843 203972 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 434 7 3 7 1.9 CCC(=O)N1CCN(c2nc(NC(=O)NCCC(=O)O)nc3sc(CC)cc23)CC1 10.1016/j.bmcl.2009.08.059
CHEMBL568127 203972 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 434 7 3 7 1.9 CCC(=O)N1CCN(c2nc(NC(=O)NCCC(=O)O)nc3sc(CC)cc23)CC1 10.1016/j.bmcl.2009.08.059
45487817 204056 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 499 5 1 7 4.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568566 204056 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 499 5 1 7 4.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
10109037 203893 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 358 3 0 5 2.9 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567695 203893 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 358 3 0 5 2.9 CCc1cc2c(N3CCN(C(=O)CC(F)(F)F)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
45485934 203755 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566613 203755 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 14 3 9 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485920 204524 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571584 204524 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
11950687 203732 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 558 8 3 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566438 203732 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 558 8 3 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
46233228 205295 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 694 12 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577854 205295 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 694 12 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139768 206407 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592810 206407 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485967 204324 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 707 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570238 204324 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 707 16 2 9 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CC(=O)N(CC)CC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
66855732 89099 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 14 3 10 1.6 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172148 89099 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 14 3 10 1.6 CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44443933 105062 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 486 10 4 11 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL274713 105062 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 486 10 4 11 1.7 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
46233237 205437 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 12 3 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579289 205437 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 12 3 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141341 205963 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589584 205963 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140366 207505 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 13 2 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600055 207505 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 13 2 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141341 205963 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589584 205963 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45142219 206047 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590208 206047 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.5 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140930 206073 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 2 8 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590364 206073 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 2 8 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140937 206201 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 16 2 7 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591227 206201 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 16 2 7 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232947 207678 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(N4CCOCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601487 207678 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 2 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(N4CCOCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485954 204333 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570285 204333 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 13 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
44631970 201628 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2022.128837
CHEMBL539733 201628 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2022.128837
45272869 202261 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL552972 202261 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140931 206127 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 594 11 3 8 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590741 206127 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 594 11 3 8 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232935 206025 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 708 17 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](OCC(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590069 206025 0 None - 1 Human 8.5 pKi = 8.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 708 17 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@@H](OCC(=O)N(CC)CC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485960 203905 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N(CC)CC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567772 203905 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 693 15 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N(CC)CC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485964 204347 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570388 204347 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(C(=O)N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233328 205419 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579081 205419 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 13 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140557 206143 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 3 7 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590798 206143 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 3 7 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485902 204204 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569629 204204 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 637 12 2 9 2.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(C)=O)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140939 206193 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591185 206193 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139587 206365 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 3 8 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592563 206365 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 12 3 8 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139950 206368 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCCCN3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592581 206368 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCC3CCCCN3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139766 206406 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592806 206406 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272869 202261 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552972 202261 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45140556 207050 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 3 7 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597150 207050 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 3 7 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232830 205952 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589520 205952 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 14 3 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45142221 205918 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 13 2 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589283 205918 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 13 2 8 3.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44128980 89094 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 715 14 3 10 2.2 COc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(OCC(=O)N4CCC[C@H]4C(=O)NC4CCC4)n(-c4ccccc4)n3)CC2)c1 10.1021/jm300771j
CHEMBL2172143 89094 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 715 14 3 10 2.2 COc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(OCC(=O)N4CCC[C@H]4C(=O)NC4CCC4)n(-c4ccccc4)n3)CC2)c1 10.1021/jm300771j
44129445 89132 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 655 13 3 10 0.6 CCNC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
CHEMBL2172266 89132 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 655 13 3 10 0.6 CCNC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
45485860 204240 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569771 204240 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 14 3 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44610759 204016 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 557 6 2 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3C[C@@H](O)C[C@H]3C(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568334 204016 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 557 6 2 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3C[C@@H](O)C[C@H]3C(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45487850 203775 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 554 6 1 7 4.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCCC(C(N)=O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566874 203775 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 554 6 1 7 4.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCCC(C(N)=O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
45268630 202867 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL560748 202867 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139401 207463 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 512 10 3 7 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599825 207463 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 512 10 3 7 2.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232937 206055 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(COC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590259 206055 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)C(CCC(=O)O)NC(=O)c2cc(N3CCC(COC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232924 207637 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601270 207637 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46233589 207053 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 9 1 6 3.4 CCCC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597158 207053 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 9 1 6 3.4 CCCC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
11649278 21687 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 474 4 4 8 2.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208091 21687 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 474 4 4 8 2.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496022 21687 0 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 474 4 4 8 2.3 Nc1c(S(=O)(=O)O)cc(Nc2ccc(S(=O)(=O)O)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45268630 202867 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560748 202867 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
121990 6863 15 None 10 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constantDisplacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant
ChEMBL 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 10.1016/j.bmcl.2022.128837
1710 6863 15 None 10 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constantDisplacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant
ChEMBL 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 10.1016/j.bmcl.2022.128837
1763 6863 15 None 10 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constantDisplacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant
ChEMBL 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 10.1016/j.bmcl.2022.128837
CHEMBL435402 6863 15 None 10 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constantDisplacement of [3H]-2MesADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant
ChEMBL 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 10.1016/j.bmcl.2022.128837
45487837 205788 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 526 5 1 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(N)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585693 205788 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 526 5 1 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(N)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
45270288 202051 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551217 202051 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270288 202051 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL551217 202051 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 527 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272881 201640 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539983 201640 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44129449 89114 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 660 12 2 9 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3c3ccccc3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172163 89114 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 660 12 2 9 2.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3c3ccccc3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45272881 201640 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL539983 201640 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 15 2 8 4.4 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140156 207405 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 10 2 6 3.0 CC(C)CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599400 207405 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 510 10 2 6 3.0 CC(C)CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272055 201672 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540737 201672 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45272055 201672 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL540737 201672 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 620 10 2 8 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485895 204044 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568498 204044 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270296 202108 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551620 202108 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
11955421 205820 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 513 5 1 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585948 205820 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 513 5 1 7 4.5 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCC(O)C3)nc2s1 10.1016/j.bmcl.2009.08.059
45270296 202108 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL551620 202108 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 497 9 3 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45273812 202535 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL557535 202535 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45271082 202258 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2ccnc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552921 202258 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 469 9 2 8 1.1 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2ccnc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233355 207328 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 545 9 2 7 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598998 207328 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 545 9 2 7 3.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45271145 201708 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 659 16 2 9 3.1 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL541745 201708 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 659 16 2 9 3.1 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45273812 202535 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL557535 202535 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 568 14 2 7 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45487800 205759 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 448 7 3 7 2.2 CCc1cc2c(N3CCN(C(=O)C(C)C)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585298 205759 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 448 7 3 7 2.2 CCc1cc2c(N3CCN(C(=O)C(C)C)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45272074 202122 0 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 467 9 2 6 2.3 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL551750 202122 0 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 467 9 2 6 2.3 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
46233323 208422 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 467 8 2 5 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)c2)CC1 10.1021/jm901518t
CHEMBL605964 208422 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 467 8 2 5 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)c2)CC1 10.1021/jm901518t
6451084 61736 51 None - 1 Human 4.4 pKi = 4.4 Binding
Displacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 718 12 9 14 3.3 O=C(/C=C/c1ccc(O)c2c1[C@H](C(=O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O 10.1016/j.ejmech.2021.113924
CHEMBL1615434 61736 51 None - 1 Human 4.4 pKi = 4.4 Binding
Displacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting methodDisplacement of [3H]2MeSADP from human P2Y12 expressed in U2OS cell membranes incubated for 60 mins by scintillation counting method
ChEMBL 718 12 9 14 3.3 O=C(/C=C/c1ccc(O)c2c1[C@H](C(=O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O 10.1016/j.ejmech.2021.113924
45487843 203972 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 434 7 3 7 1.9 CCC(=O)N1CCN(c2nc(NC(=O)NCCC(=O)O)nc3sc(CC)cc23)CC1 10.1016/j.bmcl.2009.08.059
CHEMBL568127 203972 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 434 7 3 7 1.9 CCC(=O)N1CCN(c2nc(NC(=O)NCCC(=O)O)nc3sc(CC)cc23)CC1 10.1016/j.bmcl.2009.08.059
45487841 203582 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 487 7 2 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL565618 203582 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 487 7 2 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCO)nc2s1 10.1016/j.bmcl.2009.08.059
45487809 203731 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 559 8 3 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cn4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566437 203731 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 559 8 3 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cn4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
44125995 89141 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 559 12 2 10 1.1 CCOC(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
CHEMBL2172278 89141 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 559 12 2 10 1.1 CCOC(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
45267776 203012 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 543 10 2 6 4.0 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561692 203012 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 543 10 2 6 4.0 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
46233322 207434 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 543 9 2 5 4.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)c2)CC1 10.1021/jm901518t
CHEMBL599606 207434 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 543 9 2 5 4.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)c2)CC1 10.1021/jm901518t
25124828 21703 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
25124828 21703 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208131 21703 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1208131 21703 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL499580 21703 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL499580 21703 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 600 6 5 11 4.0 Nc1c(S(=O)(=O)O)cc(Nc2cc(Nc3nc(Cl)nc(Cl)n3)cc(C(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45485891 203769 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566753 203769 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45487844 205821 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 420 6 3 7 1.5 CCc1cc2c(N3CCN(C(C)=O)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585950 205821 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 420 6 3 7 1.5 CCc1cc2c(N3CCN(C(C)=O)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45270314 201924 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL550206 201924 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45140746 208489 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 9 2 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL606408 208489 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 9 2 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
11955422 203660 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 512 5 1 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNCC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566037 203660 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 512 5 1 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNCC3)nc2s1 10.1016/j.bmcl.2009.08.059
44610760 204089 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 583 7 2 8 3.2 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3[C@H](C(N)=O)CC[C@@H]3C(N)=O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568774 204089 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 583 7 2 8 3.2 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3[C@H](C(N)=O)CC[C@@H]3C(N)=O)nc2s1 10.1016/j.bmcl.2009.08.059
45141131 205950 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589518 205950 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140929 207715 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 14 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL601704 207715 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 14 2 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141131 205950 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589518 205950 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CNC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232897 205995 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 692 15 2 8 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589889 205995 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 692 15 2 8 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232881 206006 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 16 2 8 4.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589971 206006 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 16 2 8 4.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485892 203814 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567189 203814 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 14 4 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCC3CCNC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233232 205363 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 666 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)CN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578482 205363 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 666 14 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)CN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485937 204026 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568384 204026 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 691 15 2 9 4.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCN4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139588 206405 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592802 206405 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 609 13 3 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485947 204325 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570242 204325 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232891 207711 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 3 8 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601697 207711 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 3 8 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45140166 206134 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590748 206134 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485880 204352 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 587 14 3 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570423 204352 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 587 14 3 9 2.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SCCO)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141987 205916 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 4.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589281 205916 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 4.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140364 206366 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 15 3 8 4.0 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592570 206366 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 15 3 8 4.0 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140159 206415 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592880 206415 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139406 207533 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 719 14 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600371 207533 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 719 14 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)C(F)(F)F)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232907 206019 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590007 206019 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 3 9 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45139958 206133 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 13 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590747 206133 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 13 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233235 206311 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 709 14 3 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NCC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592166 206311 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 709 14 3 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)NCC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485890 204262 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569915 204262 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 611 16 3 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCCN(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140935 206314 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592195 206314 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 639 12 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232898 207744 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 706 16 2 8 4.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601904 207744 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 706 16 2 8 4.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46233326 205348 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578271 205348 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 13 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OC)C3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233223 206308 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592163 206308 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232912 207750 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 14 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601910 207750 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 14 2 9 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45272054 201671 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 635 11 3 8 3.5 O=C(O)CC[C@H](NC(=O)c1cc(N2CCC(O)CC2)cc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CCCC2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL540736 201671 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 635 11 3 8 3.5 O=C(O)CC[C@H](NC(=O)c1cc(N2CCC(O)CC2)cc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCCC2CCCC2)CC1 10.1016/j.bmcl.2009.06.075
44128981 89095 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 712 14 3 9 3.0 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCC(C(=O)c2ccccc2)CC1 10.1021/jm300771j
CHEMBL2172144 89095 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 712 14 3 9 3.0 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCC(C(=O)c2ccccc2)CC1 10.1021/jm300771j
44129448 89135 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 683 12 3 10 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC(C)(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172269 89135 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 683 12 3 10 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC(C)(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
11955422 203660 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 512 5 1 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNCC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL566037 203660 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 512 5 1 7 4.3 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNCC3)nc2s1 10.1016/j.bmcl.2009.08.059
45485865 204143 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 599 12 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC(C)(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569127 204143 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 599 12 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC(C)(C)C)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
24829780 203244 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563183 203244 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44128900 89083 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 694 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCNC(C)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172131 89083 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 694 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCNC(C)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44128468 89108 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172157 89108 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
24829780 203244 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL563183 203244 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 9 3 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(O)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233175 206996 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 9 2 6 3.4 CCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596769 206996 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 9 2 6 3.4 CCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140157 207259 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 9 2 6 3.4 CC(C)(C)CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598588 207259 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 9 2 6 3.4 CC(C)(C)CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45271100 203453 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564552 203453 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45271100 203453 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL564552 203453 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 524 12 2 6 3.6 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233239 206339 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 736 14 2 9 5.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592408 206339 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 736 14 2 9 5.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139948 207224 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 8 2 6 3.3 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCCCC2)CC1 10.1021/jm901518t
CHEMBL598375 207224 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 8 2 6 3.3 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCCCC2)CC1 10.1021/jm901518t
1149185 203971 9 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 352 3 0 5 3.2 CCc1cc2c(N3CCN(C(=O)c4ccccc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568126 203971 9 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 352 3 0 5 3.2 CCc1cc2c(N3CCN(C(=O)c4ccccc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
45487842 205763 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 501 8 2 7 4.7 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCCO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585317 205763 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 501 8 2 7 4.7 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCCO)nc2s1 10.1016/j.bmcl.2009.08.059
45487813 203862 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 542 10 3 9 2.6 CCc1cc2c(N3CCN(C(=O)COc4cccc(OC)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567502 203862 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 542 10 3 9 2.6 CCc1cc2c(N3CCN(C(=O)COc4cccc(OC)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45140750 206286 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)CC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591945 206286 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)CC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140743 207227 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 511 9 2 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598386 207227 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 511 9 2 7 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140744 207261 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 13 2 7 3.6 CCCN(CCC)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL598594 207261 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 13 2 7 3.6 CCCN(CCC)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
45272842 202403 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL556239 202403 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44129525 89147 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 600 11 3 10 0.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC[C@@H](O)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172284 89147 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 600 11 3 10 0.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC[C@@H](O)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487800 205759 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 448 7 3 7 2.2 CCc1cc2c(N3CCN(C(=O)C(C)C)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585298 205759 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 448 7 3 7 2.2 CCc1cc2c(N3CCN(C(=O)C(C)C)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45140154 207369 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 9 2 6 3.2 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC2CCCC2)CC1 10.1021/jm901518t
CHEMBL599197 207369 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 9 2 6 3.2 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC2CCCC2)CC1 10.1021/jm901518t
45487844 205821 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 420 6 3 7 1.5 CCc1cc2c(N3CCN(C(C)=O)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585950 205821 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 420 6 3 7 1.5 CCc1cc2c(N3CCN(C(C)=O)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45270322 201561 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 9 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538415 201561 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 9 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45139947 207223 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 8 2 6 2.9 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCCC2)CC1 10.1021/jm901518t
CHEMBL598374 207223 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 508 8 2 6 2.9 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCCC2)CC1 10.1021/jm901518t
45269483 201572 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 603 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538645 201572 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 603 12 2 9 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCS(C)(=O)=O)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
66855932 89106 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 716 13 3 11 -0.1 CCOC(=O)N1CCN(C(=O)[C@H](CNS(C)(=O)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172155 89106 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 716 13 3 11 -0.1 CCOC(=O)N1CCN(C(=O)[C@H](CNS(C)(=O)=O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45270266 201851 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549594 201851 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 10 2 7 3.4 CCC(=O)ON1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
46233354 207459 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 9 2 6 3.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)c2)CC1 10.1021/jm901518t
CHEMBL599816 207459 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 544 9 2 6 3.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(-c3ccccc3)nc(-c3ccccc3)c2)CC1 10.1021/jm901518t
45267750 202706 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL559340 202706 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267750 202706 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL559340 202706 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140158 208423 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 10 2 7 1.6 COCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL605968 208423 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 10 2 7 1.6 COCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485939 203929 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567883 203929 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
44610759 204016 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 557 6 2 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3C[C@@H](O)C[C@H]3C(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568334 204016 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 557 6 2 8 3.9 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3C[C@@H](O)C[C@H]3C(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
44129136 89080 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 705 13 3 12 0.5 CCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172128 89080 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 705 13 3 12 0.5 CCOC(=O)N1CCN(C(=O)[C@H](CCc2nnn[nH]2)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
66855902 89101 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 707 13 3 10 1.7 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCC2)CC1 10.1021/jm300771j
CHEMBL2172150 89101 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 707 13 3 10 1.7 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OC2CCC2)CC1 10.1021/jm300771j
45141129 206120 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 12 2 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590673 206120 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 12 2 8 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141584 206420 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592885 206420 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 13 2 8 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232934 206033 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 680 15 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OCC(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590114 206033 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 680 15 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC[C@H](OCC(=O)N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
44443938 100950 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 510 8 4 10 2.5 OC[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccccc4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL249584 100950 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 510 8 4 10 2.5 OC[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccccc4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
9850430 100980 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 546 8 4 10 2.8 OC[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccc(F)c(F)c4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL249789 100980 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 546 8 4 10 2.8 OC[C@H]1C[C@@H](n2nnc3c(N[C@@H]4C[C@H]4c4ccc(F)c(F)c4)nc(SCCC(F)(F)F)nc32)[C@H](O)[C@@H]1O 10.1016/j.bmcl.2007.07.057
9846875 101119 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL250687 101119 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL535189 101119 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
18717762 101160 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 410 9 4 10 1.3 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL250847 101160 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 410 9 4 10 1.3 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](C(=O)O)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
45141985 205441 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 701 15 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579334 205441 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 701 15 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485885 203999 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL568257 203999 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 584 15 3 9 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232914 207775 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 705 14 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602109 207775 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 705 14 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485941 203800 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567064 203800 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(OCCOC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45142220 205868 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 16 2 9 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL588492 205868 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 16 2 9 3.5 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142452 206423 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592888 206423 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139589 207531 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 17 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600369 207531 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 17 2 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142451 207558 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 701 15 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600576 207558 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 701 15 2 9 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140367 207506 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600056 207506 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 664 13 2 8 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCC(N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142453 205917 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 15 2 8 4.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589282 205917 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 665 15 2 8 4.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141580 206067 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 593 12 2 7 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590328 206067 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 593 12 2 7 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140749 206277 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 12 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591839 206277 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 597 12 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232946 206057 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 13 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590261 206057 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 13 2 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(N(C)C)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232926 207638 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(N)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601271 207638 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 12 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(N)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485862 204257 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569910 204257 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270274 202537 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 562 9 2 5 5.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)n3)CC2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL557553 202537 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 562 9 2 5 5.0 Cc1cccc(N2CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c3cc(-c4ccccc4)cc(-c4ccccc4)n3)CC2)c1 10.1016/j.bmcl.2009.06.075
66854841 89097 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 743 14 3 10 2.4 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm300771j
CHEMBL2172146 89097 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 743 14 3 10 2.4 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm300771j
46233231 206310 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 652 14 3 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)CNC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592165 206310 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 652 14 3 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)CNC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141344 207140 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 4 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597772 207140 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 4 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485905 204300 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570150 204300 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 12 3 9 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(C(N)=O)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233236 205420 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 692 12 2 8 5.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL579094 205420 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 692 12 2 8 5.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139773 205835 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 15 2 7 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL586227 205835 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 15 2 7 4.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140368 207507 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 12 2 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600057 207507 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 636 12 2 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N3CCN(C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485919 203569 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCOCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565542 203569 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 679 13 2 10 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCOCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139403 206359 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592531 206359 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232913 207774 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 707 16 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602108 207774 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 707 16 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CC(=O)N(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232919 207779 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 665 12 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL602112 207779 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 665 12 2 8 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(=O)N(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
11585281 21702 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 567 6 5 11 2.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208129 21702 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 567 6 5 11 2.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL499428 21702 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 567 6 5 11 2.8 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3ncccn3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
25123181 21692 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
CHEMBL1208106 21692 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
CHEMBL496820 21692 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1016/j.ejmech.2021.113924
66856658 89105 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C[C@H]1C 10.1021/jm300771j
CHEMBL2172154 89105 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C[C@H]1C 10.1021/jm300771j
44631970 201628 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539733 201628 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44631970 201628 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL539733 201628 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 637 14 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
71449929 89131 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 641 12 3 10 0.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172265 89131 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 641 12 3 10 0.3 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487801 203624 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 512 9 3 8 2.6 CCc1cc2c(N3CCN(C(=O)COc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL565840 203624 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 512 9 3 8 2.6 CCc1cc2c(N3CCN(C(=O)COc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
66856790 89103 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)[C@@H](C)C1 10.1021/jm300771j
CHEMBL2172152 89103 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)[C@@H](C)C1 10.1021/jm300771j
45140927 205958 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CO)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589550 205958 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 10 3 8 2.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CO)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233133 206237 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 579 12 2 6 4.4 CCCCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591510 206237 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 579 12 2 6 4.4 CCCCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25123181 21692 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208106 21692 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496820 21692 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 499 5 4 7 5.1 Cc1cc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c2c(c1N)C(=O)c1ccccc1C2=O 10.1021/jm9003297
45485851 204211 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 597 13 2 9 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCO3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569681 204211 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 597 13 2 9 2.7 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCCO3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
46233132 207939 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 565 11 2 6 4.0 CCCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603333 207939 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 565 11 2 6 4.0 CCCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
66854424 89112 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 12 2 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172161 89112 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 12 2 10 1.5 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)N3CCCCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
66855084 89113 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 664 12 3 10 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3c3nc(C)c[nH]3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172162 89113 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 664 12 3 10 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3c3nc(C)c[nH]3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
44129447 89134 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 669 13 3 10 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172268 89134 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 669 13 3 10 1.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC(C)C)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
66920261 89145 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 569 12 2 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172281 89145 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 569 12 2 9 1.9 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)C3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45487801 203624 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 512 9 3 8 2.6 CCc1cc2c(N3CCN(C(=O)COc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL565840 203624 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 512 9 3 8 2.6 CCc1cc2c(N3CCN(C(=O)COc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45141133 205352 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578324 205352 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCC(OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233224 207436 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 2 6 4.2 CCCCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599634 207436 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 2 6 4.2 CCCCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232892 205990 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 14 3 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589828 205990 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 678 14 3 8 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45139957 207914 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 16 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603149 207914 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 16 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233225 205246 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(C)=O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577433 205246 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(C)=O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232906 205974 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 680 17 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOCCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589697 205974 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 680 17 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOCCC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232918 206021 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 12 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590009 206021 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 637 12 3 8 2.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(C(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
44631974 207746 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albuminInhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albumin
ChEMBL 676 12 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601906 207746 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albuminInhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albumin
ChEMBL 676 12 2 8 3.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
9846875 101119 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL250687 101119 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
CHEMBL535189 101119 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 456 8 4 10 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccccc2)c2nnn([C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c2n1 10.1016/j.bmcl.2007.07.057
66854759 89085 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 15 3 10 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172133 89085 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 15 3 10 1.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCCO)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45141771 206129 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(NC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590743 206129 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(NC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141984 206295 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592021 206295 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232888 205997 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589897 205997 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 636 13 3 8 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(N)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232901 206017 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 594 12 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590005 206017 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 594 12 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46232900 207747 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albuminInhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albumin
ChEMBL 690 13 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601907 207747 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albuminInhibition of human P2Y12 receptor expressed in CHO cells in presence of 0.4% human serum albumin
ChEMBL 690 13 2 8 4.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485909 204292 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CC(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570053 204292 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 680 14 2 10 1.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCN(CC(=O)N(C)C)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139586 206395 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592737 206395 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 595 12 3 8 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCCNC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139402 207439 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599637 207439 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 570 14 3 8 2.6 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45270314 201924 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL550206 201924 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 540 12 2 7 3.2 CCCCOc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
66854409 89110 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC(C(=O)NC4CCC4)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172159 89110 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CC(C(=O)NC4CCC4)C3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46233131 207334 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 551 10 2 6 3.6 CCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599020 207334 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 551 10 2 6 3.6 CCCCNC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25127813 21685 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 484 5 3 6 4.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208083 21685 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 484 5 3 6 4.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL495605 21685 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 484 5 3 6 4.6 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45142446 207139 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 484 8 3 7 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597765 207139 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 484 8 3 7 1.7 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25124162 67033 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 422 3 3 6 3.7 Cc1cc(C)cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1016/j.ejmech.2021.113924
CHEMBL1671994 67033 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 422 3 3 6 3.7 Cc1cc(C)cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1016/j.ejmech.2021.113924
CHEMBL1741096 67033 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human P2Y12 expressed in astrocytoma cellsBinding affinity to human P2Y12 expressed in astrocytoma cells
ChEMBL 422 3 3 6 3.7 Cc1cc(C)cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)c1 10.1016/j.ejmech.2021.113924
25128136 21660 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 566 6 4 9 4.1 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Oc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1207855 21660 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 566 6 4 9 4.1 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Oc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL446904 21660 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 566 6 4 9 4.1 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Oc3ccccc3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45273789 202686 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL559126 202686 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
45273789 202686 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
CHEMBL559126 202686 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 525 11 3 7 2.8 CCCNc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nc(-c2ccccc2)c1 10.1021/jm901518t
45141130 205920 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 648 12 2 8 3.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL589290 205920 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 648 12 2 8 3.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
44129446 89133 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 669 14 3 10 1.0 CCCNC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
CHEMBL2172267 89133 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 669 14 3 10 1.0 CCCNC(=O)[C@@H]1CCCN1C(=O)COc1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCC)CC2)nn1-c1ccccc1 10.1021/jm300771j
9969173 205255 2 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 366 4 0 5 3.1 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL577508 205255 2 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 366 4 0 5 3.1 CCc1cc2c(N3CCN(C(=O)Cc4ccccc4)CC3)ncnc2s1 10.1016/j.bmcl.2009.08.059
25123183 21708 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm1012193
25123183 21708 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm9003297
CHEMBL1208235 21708 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm1012193
CHEMBL1208235 21708 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm9003297
CHEMBL509572 21708 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm1012193
CHEMBL509572 21708 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 632 7 5 13 2.9 COc1nc(Cl)nc(Nc2ccc(Nc3cc(S(=O)(=O)O)c(N)c4c3C(=O)c3ccccc3C4=O)cc2S(=O)(=O)O)n1 10.1021/jm9003297
25124484 21522 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
25124484 21522 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1206415 21522 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1206415 21522 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL271672 21522 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL271672 21522 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2cccc(Cl)c2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45269454 202897 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561007 202897 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45142449 203109 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562344 203109 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45487821 203897 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 532 8 3 7 3.0 CCc1cc2c(N3CCN(C(=O)Cc4ccc(F)c(F)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567715 203897 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 532 8 3 7 3.0 CCc1cc2c(N3CCN(C(=O)Cc4ccc(F)c(F)c4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45269454 202897 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL561007 202897 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142449 203109 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL562344 203109 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 3 8 1.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
136677322 10069 24 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm1012193
1739 10069 24 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm1012193
656725 10069 24 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm1012193
CHEMBL1160031 10069 24 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 773 9 7 15 3.9 OS(=O)(=O)c1cc(Nc2ccc(c(c2)S(=O)(=O)O)Nc2nc(Cl)nc(n2)Nc2cccc(c2)S(=O)(=O)O)c2c(c1N)C(=O)c1c(C2=O)cccc1 10.1021/jm1012193
45270321 202298 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 648 12 3 8 3.7 NCC1CCN(c2cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N3CCN(C(=O)OCCC4CCCC4)CC3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553856 202298 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 648 12 3 8 3.7 NCC1CCN(c2cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N3CCN(C(=O)OCCC4CCCC4)CC3)nc(-c3ccccc3)c2)CC1 10.1016/j.bmcl.2009.06.075
45139400 207020 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596939 207020 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 556 13 2 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45273820 201629 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539734 201629 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 622 13 3 8 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267721 203501 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL564981 203501 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267721 203501 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL564981 203501 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 538 13 2 6 4.0 CCCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141585 206152 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590939 206152 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 651 14 2 8 4.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(C(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485942 204306 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570156 204306 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 668 16 2 10 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
46232948 207679 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 14 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(CNC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601488 207679 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 608 14 3 8 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CC(CNC)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
66855824 89138 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 13 3 10 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172272 89138 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 681 13 3 10 1.2 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
46232928 207640 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CN4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601273 207640 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 676 14 2 8 4.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CN4CCCC4)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485940 203539 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL565300 203539 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 624 13 2 9 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(OC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485916 203680 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL566176 203680 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 663 13 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N4CCCC4)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139590 207559 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 715 16 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600577 207559 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 715 16 2 9 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485913 204569 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 608 12 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571929 204569 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 608 12 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45139591 207196 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 12 3 7 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(N)=O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598160 207196 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 553 12 3 7 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(N)=O)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232880 206005 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 15 2 8 4.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589961 206005 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 15 2 8 4.4 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CN(CC)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45141583 205385 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 687 14 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL578714 205385 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 687 14 2 9 3.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(S(=O)(=O)CC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45142450 207556 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL600574 207556 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 681 14 2 9 4.0 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCN(C(=O)OCC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
5906 7811 1 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1016/j.bmcl.2022.128837
66855377 7811 1 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1016/j.bmcl.2022.128837
CHEMBL2172140 7811 1 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to P2Y12 (unknown origin) assessed as inhibition constantBinding affinity to P2Y12 (unknown origin) assessed as inhibition constant
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1016/j.bmcl.2022.128837
5906 7811 1 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1021/jm300771j
66855377 7811 1 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1021/jm300771j
CHEMBL2172140 7811 1 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 10.1021/jm300771j
44129369 89102 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)[C@H](C)C1 10.1021/jm300771j
CHEMBL2172151 89102 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)[C@H](C)C1 10.1021/jm300771j
45140933 206226 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591427 206226 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 12 2 8 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(=O)N3CCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139952 207023 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 13 2 7 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596961 207023 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 13 2 7 3.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139956 207913 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 611 15 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603148 207913 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 611 15 3 8 2.6 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232889 206015 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590003 206015 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 650 13 3 8 3.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(C(=O)NC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485883 204260 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 625 13 2 8 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569913 204260 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 625 13 2 8 5.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(SC3CCCCC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
25123505 21694 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 453 4 5 8 2.3 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc(C(=O)O)c1 10.1021/jm9003297
CHEMBL1208113 21694 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 453 4 5 8 2.3 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc(C(=O)O)c1 10.1021/jm9003297
CHEMBL498038 21694 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 453 4 5 8 2.3 Nc1cc(Nc2cc(S(=O)(=O)O)c(N)c3c2C(=O)c2ccccc2C3=O)cc(C(=O)O)c1 10.1021/jm9003297
44129371 89098 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 729 13 3 10 2.2 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)Oc2ccccc2)CC1 10.1021/jm300771j
CHEMBL2172147 89098 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 729 13 3 10 2.2 O=C(O)CC[C@H](NC(=O)c1cc(OCC(=O)N2CCC[C@H]2C(=O)NC2CCC2)n(-c2ccccc2)n1)C(=O)N1CCN(C(=O)Oc2ccccc2)CC1 10.1021/jm300771j
45485852 204203 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 612 16 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569617 204203 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 612 16 2 9 2.9 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN(CC)CC)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45270267 201874 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 472 7 1 6 3.2 CCC(=O)ON1CCN(C(=O)CNC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL549797 201874 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 472 7 1 6 3.2 CCC(=O)ON1CCN(C(=O)CNC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
46233357 208359 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 472 6 1 5 3.4 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL605565 208359 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 472 6 1 5 3.4 CCOC(=O)N1CCN(C(=O)CNC(=O)c2cc(-c3ccccc3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
13782419 21523 2 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1206416 21523 2 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL271673 21523 2 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 428 3 3 6 3.7 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Cl)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
11670815 203979 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 517 8 3 8 3.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC[C@@H](O)CO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568148 203979 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 517 8 3 8 3.6 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NC[C@@H](O)CO)nc2s1 10.1016/j.bmcl.2009.08.059
45273782 202287 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL553654 202287 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45273782 202287 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL553654 202287 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 581 11 3 8 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45487842 205763 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 501 8 2 7 4.7 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCCO)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585317 205763 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 501 8 2 7 4.7 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCCO)nc2s1 10.1016/j.bmcl.2009.08.059
45487790 205761 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 526 10 3 8 3.0 CCc1cc2c(N3CCN(C(=O)CCOc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL585306 205761 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGPBinding affinity to human recombinant P2Y12 receptor expressed in CHO cell membrane in presence of HSA and human AGP
ChEMBL 526 10 3 8 3.0 CCc1cc2c(N3CCN(C(=O)CCOc4ccccc4)CC3)nc(NC(=O)NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
45139946 206990 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 492 9 2 6 2.0 C#CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL596733 206990 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 492 9 2 6 2.0 C#CCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
20638786 161741 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 396 9 4 10 1.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](CO)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
CHEMBL401158 161741 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [125I] labeled ligand from human P2Y12 receptor in human plateletsDisplacement of [125I] labeled ligand from human P2Y12 receptor in human platelets
ChEMBL 396 9 4 10 1.2 CCCCNc1nc(SCCC)nc2c1nnn2[C@@H]1C[C@H](CO)[C@@H](O)[C@H]1O 10.1016/j.bmcl.2007.07.057
11950159 203894 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 515 8 2 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL567702 203894 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 515 8 2 7 4.8 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(NCCC(=O)O)nc2s1 10.1016/j.bmcl.2009.08.059
46233176 208150 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 2 6 3.8 CCCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL604497 208150 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 567 10 2 6 3.8 CCCCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232885 206014 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 15 2 8 4.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590002 206014 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 690 15 2 8 4.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(CCN4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485948 204343 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570384 204343 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 682 17 2 10 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(COCCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140753 206140 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 2 7 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590771 206140 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 2 7 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232905 205967 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 652 15 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589616 205967 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 652 15 2 9 3.0 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45485945 203857 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567468 203857 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 638 14 2 9 3.4 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(COC)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485951 204330 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL570271 204330 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 652 15 2 9 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CCOC)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485899 204523 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL571583 204523 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 609 12 3 9 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(N)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45140752 206149 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590856 206149 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 582 15 2 7 3.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140362 206220 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 15 3 8 2.9 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591367 206220 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 15 3 8 2.9 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232909 206003 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 16 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL589927 206003 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 679 16 2 9 3.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
46233227 206309 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 693 13 2 9 4.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)C3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592164 206309 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 693 13 2 9 4.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)C3CCOCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232908 207748 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 665 15 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601908 207748 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 665 15 2 9 2.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCN(C)C)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45140163 206111 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 652 16 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590602 206111 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 652 16 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(C(=O)N(C)CCCN(C)C)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140555 206160 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 606 13 2 6 5.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CC3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590989 206160 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 606 13 2 6 5.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(CC3CCCCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139954 207402 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 3 8 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599397 207402 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 569 14 3 8 2.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCN)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232910 207749 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 700 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCS(C)(=O)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL601909 207749 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 700 15 2 10 2.3 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCN(CCS(C)(=O)=O)CC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45269484 202444 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 671 14 2 9 3.1 CN(CCS(C)(=O)=O)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCCC3CCCC3)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
CHEMBL556493 202444 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 671 14 2 9 3.1 CN(CCS(C)(=O)=O)c1cc(C(=O)N[C@@H](CCC(=O)O)C(=O)N2CCN(C(=O)OCCC3CCCC3)CC2)nc(-c2ccccc2)c1 10.1016/j.bmcl.2009.06.075
66857005 89104 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C[C@@H]1C 10.1021/jm300771j
CHEMBL2172153 89104 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 695 13 3 10 1.6 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C[C@@H]1C 10.1021/jm300771j
45270295 201550 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 14 2 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL538171 201550 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 625 14 2 8 3.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC(CC)C(=O)N(CC)CC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
44128983 89092 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 16 4 10 2.0 CCCCOC(=O)NC1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C1 10.1021/jm300771j
CHEMBL2172141 89092 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 709 16 4 10 2.0 CCCCOC(=O)NC1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@H]3C(=O)NC3CCC3)n(-c3ccccc3)n2)C1 10.1021/jm300771j
45487838 204088 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 608 5 0 7 5.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCN(C(=O)C(F)(F)F)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
CHEMBL568772 204088 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human recombinant P2Y12 receptor expressed on CHO cell membraneBinding affinity to human recombinant P2Y12 receptor expressed on CHO cell membrane
ChEMBL 608 5 0 7 5.1 CCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCN(C(=O)C(F)(F)F)CC3)nc2s1 10.1016/j.bmcl.2009.08.059
46233095 206197 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 592 9 1 7 3.5 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(S(=O)(=O)c2ccccc2)CC1 10.1021/jm901518t
CHEMBL591212 206197 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 592 9 1 7 3.5 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(S(=O)(=O)c2ccccc2)CC1 10.1021/jm901518t
46233134 206243 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 571 8 2 6 4.3 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)Nc2ccccc2)CC1 10.1021/jm901518t
CHEMBL591536 206243 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 571 8 2 6 4.3 CC(C)(C)OC(=O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)Nc2ccccc2)CC1 10.1021/jm901518t
16681707 7546 7 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/jm300771j
1767 7546 7 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/jm300771j
CHEMBL2172275 7546 7 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 586 11 2 9 2.5 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1nc2cc(C)ccc2c(c1)OC(C(=O)OCC)(C)C)CCC(=O)O 10.1021/jm300771j
46233451 207169 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL597980 207169 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 11 3 8 1.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N(C)CCO)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
25128135 21691 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 502 5 3 7 5.2 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Sc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1208102 21691 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 502 5 3 7 5.2 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Sc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL496620 21691 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 502 5 3 7 5.2 Nc1c(S(=O)(=O)O)cc(Nc2ccc(Sc3ccccc3)cc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45140161 206261 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 2 7 4.8 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL591691 206261 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 596 16 2 7 4.8 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
168293759 198946 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]-2MeS-ADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant incubated for 1 hr by competitive binding assayDisplacement of [33P]-2MeS-ADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant incubated for 1 hr by competitive binding assay
ChEMBL 527 5 2 8 2.7 NCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNC(=O)C3)nc2s1 10.1016/j.bmcl.2022.128837
CHEMBL5203993 198946 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]-2MeS-ADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant incubated for 1 hr by competitive binding assayDisplacement of [33P]-2MeS-ADP from recombinant human P2Y12 transfected in HEK cell membrane assessed as inhibition constant incubated for 1 hr by competitive binding assay
ChEMBL 527 5 2 8 2.7 NCc1cc2c(N3CCN(C(=O)c4ccc(-c5ccccc5)cc4)CC3)nc(N3CCNC(=O)C3)nc2s1 10.1016/j.bmcl.2022.128837
46233174 207468 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 539 8 2 6 3.0 CCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL599843 207468 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 539 8 2 6 3.0 CCNC(=S)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cccc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141773 207909 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL603144 207909 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 662 13 2 8 4.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCC(N4CCCC4)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233226 205265 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 677 12 2 8 4.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)C(F)(F)F)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577653 205265 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 677 12 2 8 4.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)C(F)(F)F)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46233238 206338 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 722 13 2 9 5.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592407 206338 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 722 13 2 9 5.1 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)c2cc(NC(=O)N3CCC(OC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45485921 203797 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL567050 203797 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 623 13 3 9 2.8 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2nc(-c3ccccc3)cc(N3CCC(CN)CC3)n2)CC1 10.1016/j.bmcl.2009.09.017
45485894 204232 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
CHEMBL569742 204232 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assayBinding affinity at human recombinant P2Y12 receptor expressed in CHO cells by radioligand binding assay
ChEMBL 651 14 3 9 3.9 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NC3CCN(C(C)C)CC3)nc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.09.017
45141345 205248 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 15 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL577454 205248 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 653 15 2 9 3.3 CCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45140363 206380 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592671 206380 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 623 14 3 8 3.7 CCCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141578 206058 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 15 3 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL590262 206058 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 583 15 3 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45272861 202260 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL552971 202260 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 584 15 2 8 3.2 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45141774 206421 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 16 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL592886 206421 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 667 16 2 9 3.7 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCN(CCOC)CC3)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
46232929 206053 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CNC(C)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
CHEMBL590257 206053 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of human P2Y12 receptor expressed in CHO cellsInhibition of human P2Y12 receptor expressed in CHO cells
ChEMBL 664 14 3 8 3.5 CCCCCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(N3CCCC(CNC(C)=O)C3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.12.110
45267728 202985 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL561484 202985 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 542 12 2 8 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45268641 201617 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 579 11 3 8 2.3 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL539661 201617 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 579 11 3 8 2.3 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC3CCNCC3)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45142447 207202 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 512 10 2 7 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL598177 207202 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 512 10 2 7 2.4 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
45139764 207262 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 8 2 6 2.6 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC(F)(F)F)CC1 10.1021/jm901518t
CHEMBL598612 207262 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 522 8 2 6 2.6 O=C(O)CC[C@H](NC(=O)c1cccc(-c2ccccc2)n1)C(=O)N1CCN(C(=O)OCC(F)(F)F)CC1 10.1021/jm901518t
45269473 203119 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 13 2 8 2.2 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL562406 203119 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 554 13 2 8 2.2 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
71462475 89137 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@@H]3C(=O)NC3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
CHEMBL2172271 89137 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
ChEMBL 667 13 3 10 0.8 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCC(=O)N3CCC[C@@H]3C(=O)NC3CC3)n(-c3ccccc3)n2)CC1 10.1021/jm300771j
45267722 202879 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL560882 202879 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45267722 202879 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL560882 202879 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 498 9 2 7 2.0 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
22916 21497 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
22916 21497 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL1206272 21497 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL1206272 21497 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
CHEMBL256057 21497 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm1012193
CHEMBL256057 21497 22 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [3H]PSB0413 from human platelet P2Y12 receptorDisplacement of [3H]PSB0413 from human platelet P2Y12 receptor
ChEMBL 394 3 3 6 3.0 Nc1c(S(=O)(=O)O)cc(Nc2ccccc2)c2c1C(=O)c1ccccc1C2=O 10.1021/jm9003297
45270300 202176 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL552022 202176 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45273811 203276 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 13 2 7 3.4 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
CHEMBL563429 203276 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human recombinant P2Y12 receptor expressed in CHO cellsBinding affinity to human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 552 13 2 7 3.4 C=CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(OCCCC)cc(-c3ccccc3)n2)CC1 10.1016/j.bmcl.2009.06.075
45270300 202176 0 None - 1 Human 7.0 pKi = 7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
CHEMBL552022 202176 0 None - 1 Human 7.0 pKi = 7 Binding
Displacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cellsDisplacement of [33P]ADP from human recombinant P2Y12 receptor expressed in CHO cells
ChEMBL 541 12 3 8 2.1 CCOC(=O)N1CCN(C(=O)[C@H](CCC(=O)O)NC(=O)c2cc(NCCOC)cc(-c3ccccc3)n2)CC1 10.1021/jm901518t
1756 7251 10 None - 1 Human 8.2 pKd = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 23495690
5310954 7251 10 None - 1 Human 8.2 pKd = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 23495690
CHEMBL336292 7251 10 None - 1 Human 8.2 pKd = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 647 11 7 14 1.1 CCCSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O 23495690
60606 68334 73 None - 1 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 None
CHEMBL1771 68334 73 None - 1 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 None
DB00758 68334 73 None - 1 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 321 3 0 4 3.7 COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1 None
1765 10589 98 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
4184 10589 98 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
9871419 10589 98 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
CHEMBL398435 10589 98 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
DB08816 10589 98 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting methodDisplacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method
Drug Central 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO None
1765 10589 98 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
4184 10589 98 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
9871419 10589 98 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
CHEMBL398435 10589 98 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
DB08816 10589 98 None - 1 Human 8.7 pKi = 8.7 Binding
Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.Binding data obtained using washed platelets in 96-well plates, with [<sup>125</sup>I]-P2Y<sub>12</sub> antagonist as radioligand.
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 17827008
1712 7076 69 None - 1 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11196645
6022 7076 69 None - 1 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11196645
CHEMBL14830 7076 69 None - 1 Human 5.9 pKi = 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 427 6 6 12 -1.7 O[C@@H]1[C@@H](COP(=O)(OP(=O)(O)O)O)O[C@H]([C@@H]1O)n1cnc2c1ncnc2N 11196645
44126037 7895 2 None - 1 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 22984835
5905 7895 2 None - 1 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 22984835
CHEMBL2172277 7895 2 None - 1 Human 6.9 pKi = 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 599 12 2 10 2.0 CCOC(=O)N1CCN(CC1)C(=O)[C@@H](NC(=O)c1cc(n(n1)c1ccccc1)OC1(CCC1)C(=O)OCC)CCC(=O)O 22984835
44583582 9978 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
5904 9978 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
59448166 9978 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
CHEMBL1207916 9978 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
CHEMBL455536 9978 3 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 609 8 3 11 3.1 [Na]OS(=O)(=O)c1cc(ccc1Nc1ccccc1)Nc1cc(c(c2c1C(=O)c1ccccc1C2=O)N)S(=O)(=O)O[Na] 19463000
1765 10589 98 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
4184 10589 98 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
9871419 10589 98 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
CHEMBL398435 10589 98 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
DB08816 10589 98 None - 1 Human 7.9 pKi = 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 22984835
23649325 7329 56 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24215345
23649325 7329 56 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24670650
7360 7329 56 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24215345
7360 7329 56 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24670650
CHEMBL2419490 7329 56 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24215345
CHEMBL2419490 7329 56 None - 1 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 470 7 1 8 2.3 CCOC(=O)c1cc(C#N)c(nc1C)N1CCC(CC1)C(=O)NS(=O)(=O)Cc1ccccc1 24670650
5906 7811 1 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 22984835
66855377 7811 1 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 22984835
CHEMBL2172140 7811 1 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 637 12 2 9 1.7 CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)c1nn(c(c1)OCC(=O)N1CCC[C@H]1C(=O)NC1CCC1)c1ccccc1 22984835
121990 6863 15 None 10 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11196645
1710 6863 15 None 10 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11196645
1763 6863 15 None 10 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11196645
CHEMBL435402 6863 15 None 10 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 473 7 6 13 -1.0 CSc1nc(N)c2c(n1)n(cn2)[C@@H]1O[C@@H]([C@H]([C@H]1O)O)COP(=O)(OP(=O)(O)O)O 11196645
10000627 9790 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 2 1 2 0.8 Cl[Hg]c1ccc(cc1)S(=O)(=O)O 15199474
11136 9790 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 2 1 2 0.8 Cl[Hg]c1ccc(cc1)S(=O)(=O)O 15199474
1773 9790 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 2 1 2 0.8 Cl[Hg]c1ccc(cc1)S(=O)(=O)O 15199474
56947084 9790 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 2 1 2 0.8 Cl[Hg]c1ccc(cc1)S(=O)(=O)O 15199474
10066813 7743 0 None - 1 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 355 4 2 5 2.6 COC(=O)[C@H](c1ccccc1Cl)N1CCC(/C(=C\C(=O)O)/C1)S 15199474
1772 7743 0 None - 1 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 355 4 2 5 2.6 COC(=O)[C@H](c1ccccc1Cl)N1CCC(/C(=C\C(=O)O)/C1)S 15199474